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Summary 
The study of the neurobiological mechanisms which underpin the generation of 
anxiety has garnered significant attention due to the prevalence of anxiety 
disorders and the distress these pathologies can have on the individual, their 
family and society in general. However, the term ‘anxiety’ is not unitary but 
encompasses a diverse range of affective, cognitive, endocrine and behavioural 
processes. Previous studies have identified a population of inhibitory 
strychnine-sensitive glycine receptors, which are expressed on the serotonergic 
neurons which originate from the dorsal raphe nucleus. In addition, the 
serotonergic neurons of the dorsal raphe nucleus, which mediate the release of 
the neurotransmitter serotonin, have been implicated as a component of the 
neurocircuitry which underpins the generation of an anxious state. Therefore, 
the receptor antagonist strychnine was administered into the dorsal raphe 
nucleus of Sprague-Dawley rats and behaviour was investigated in the open 
field, elevated plus-maze and locomotor activity box.  
The intracerebral microinjection of strychnine into the dorsal raphe nucleus had 
no effect on anxiety-like behaviours or locomotor activity in animals exposed to 
the open field. The elevated plus-maze methodology was validated, prior to the 
investigation of the strychnine-sensitive glycine receptors, by replicating the 
previously reported anxiolytic effects in response to the systemic administration 
of chlordiazepoxide. Animals were divided into two groups and either remained 
in the home cage or were repeatedly exposed (1 hr/daily) to an elevated open 
platform stressor over 10 days prior to testing in the elevated plus-maze. In the 
elevated plus-maze, the administration of strychnine into the dorsal raphe 
nucleus selectively reversed the increase in the percentage of the total time 
spent exploring the open runways of animals pre-exposed to the elevated open 

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platform stressor. However, there was no effect of strychnine on the anxiety-like 
behaviours of animals which remained in the home cage prior to testing in the 
elevated plus-maze. In addition, the administration of strychnine into the dorsal 
raphe nucleus did not significantly influence the locomotor activity in either 
group. However, the administration of the endogenous agonist glycine into the 
dorsal raphe nucleus did not appear to elicit an anxiolytic-like effect. Therefore, 
the data suggest that the strychnine-sensitive glycine receptors of the dorsal 
raphe nucleus may play a role in the habituation to an inescapable stressor.  
Furthermore, previous studies have identified that the strychnine-sensitive 
glycine receptors expressed in the dorsal raphe nucleus are potentiated by low, 
physiologically relevant, concentrations of ethanol. Therefore, it was 
hypothesised that a component of the anxiolytic properties of ethanol may be 
mediated by the strychnine-sensitive glycine receptors of the dorsal raphe 
nucleus. However in response to the systemic administration of ethanol, the 
anxiolytic properties of ethanol in the elevated plus-maze appeared to be 
masked by the sedative component of the drug. Therefore, an alternative route 
of administering ethanol was investigated. The intracerebroventricular 
administration of ethanol appeared to elicit an anxiolytic-like effect, as 
measured by the elevated plus-maze, in the absence of an overt change in 
locomotor activity. Therefore, the effect of concurrent intracerebral 
administration of strychnine into the dorsal raphe nucleus and ethanol into the 
lateral ventricle was investigated in the elevated plus-maze and a locomotor 
activity box. Contrary to the original hypothesis, the administration of strychnine 
into the dorsal raphe nucleus did not reverse a component of the anxiolytic 
effects of the intracerebroventricular administration of ethanol in the elevated 
plus-maze. However, contrary to the previous studies in the elevated plus-
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maze, the administration of strychnine into the dorsal raphe nucleus reduced 
the locomotor activity of the animals administered the artificial cerebrospinal 
fluid vehicle, but not ethanol, into the lateral ventricle. In addition, the 
administration of strychnine into the dorsal raphe nucleus reduced the duration 
of the trial time spent exploring the central zone of the locomotor activity box 
suggesting an anxiogenic-like effect. In addition, the administration of ethanol 
into the dorsal raphe nucleus was investigated in the elevated plus-maze. 
However, the administration of ethanol into the dorsal raphe nucleus did not 
significantly influence either the indices of anxiety-like behaviours or the 
locomotor activity in the elevated plus-maze. However, this may have been due 
to the diffusion of ethanol from the target site. 
Collectively, the results of the present study suggest that the administration of 
strychnine into the dorsal raphe nucleus mediates the suppression of locomotor 
activity and an anxiogenic-like effect. However, these effects appear to depend 
upon the basal anxiety state of the animal. At present, the data do not support 
the hypothesis of an interaction between the strychnine-sensitive glycine 
receptors of the dorsal raphe nucleus and the anxiolytic properties of ethanol. 
However, potentially confounding variables associated with the methodology 
may have masked measurable behavioural in response to the administration of 
ethanol. Therefore, the interpretation of the results must be considered in the 
context of these limitations. However, additional neurochemical and 
physiological measures could be recruited to the study to further elucidate the 
role of the strychnine-sensitive glycine receptors localised within the dorsal 
raphe nucleus.  

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The aims of the present study 
The principal aim of the project was to investigate the role of strychnine-
sensitive glycine receptors in the DRN of the rat. Its specific objectives were to: 
a. test the hypothesis that stimulation of the receptors elicited anxiolytic-like 
behaviour; 
b. explore the potential interaction between the receptors and the anxiolytic 
properties of ethanol.
1 

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 1.1. Anxiety 
The term ‘anxiety’ refers to an emotional state generated in response to future 
events which have an ambiguous outcome. Anxiety can become pathological; 
however, it is also an important evolutionary adaptation which serves to protect 
healthy individuals from harm in potentially threatening situations. Pathological 
anxiety is a common condition and has received extensive investigation due to 
the distress caused to the individual, their family and society in general. 
Although psychological therapies have been beneficial, in the majority of cases 
pharmacological interventions are the most common and efficacious treatments 
(Sandford et al, 2000). The expression of anxiety involves three critical 
components - the evaluation of the threat, the subjective experience of the 
situation and the expression of an anxious state (LeDoux, 2003). Therefore 
anxiety is the manifestation of complex cognitive, affective and behavioural 
processes. Under non-pathological conditions, the expression of anxiety has 
evolved to suppress responses which may increase the likelihood of 
disadvantageous outcomes. Classically, this was considered to consist of flight, 
fight or freezing behaviours (Cannon, 1929) but has been expanded to include 
approach-avoidance, anticipatory fear coupled with an increase in arousal 
(Yerkes, 1921). The study of anxiety overlaps both neurobiological and 
psychological disciplines and therefore what constitutes the term ‘anxiety’ 
continues to evolve. Physiological measures such as increased arterial blood 
pressure, tachycardia and excessive secretion of glucocorticoids are informative 
but are not definitive of anxiety per se (Millan, 2003). However, the study of 
individuals diagnosed with ‘anxiety disorders’ and the investigation of the 
diverse pharmacological agents which are effective in their treatment has 
3 
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implicated key components in the neuronal mechanisms which underpin the 
expression of anxiety.       
1.1.1. Anxiety disorders 
Anxiety is a normal emotional state in healthy individuals. However, when it 
interferes with the normal day to day functioning of an individual it can be 
severely debilitating. It can be diagnosed as a symptom of a wider psychiatric 
disorder or the primary symptom in a group of distinct illnesses, which share 
some similar characteristics, collectively referred to as the ‘anxiety disorders’ 
(Sandford et al, 2000). The expression of anxiety is associated with an increase 
in physiological measures of arousal in healthy individuals. However, the clinical 
diagnosis of distinct ‘anxiety disorders’ would suggest that pathological anxiety 
is not simply a maladaptive state of arousal. Therefore, the term anxiety is not a 
unitary term by reflects a diverse array of neurological processes. This diversity 
was reflected in the two systems of categorical classification of the anxiety 
disorders – the ICD-10 (World Health Organisation, 1992) and DSM-IV systems 
(American Psychiatric Association, 1992). Both systems share commonalities 
and include panic disorder, generalised anxiety disorder, agoraphobia, specific 
phobia, social phobia, obsessive compulsive disorder, acute stress disorder and 
post-traumatic stress disorder. In 2013, the publication of the DSM-5 system 
introduced a number of changes to the DSM-IV system of characterising the 
anxiety disorders. These changes included the dissociation of obsessive 
compulsive disorder, post-traumatic stress disorder and acute stress disorder 
into distinct chapters. However, the sequential order of these chapters reflects 
the close relationships between them 
(http://www.dsm5.org/Documents/changes%20from%20dsm-iv-
tr%20to%20dsm-5.pdf; accessed 10/10/13). 
4 

1.1.2. The distinction between state and trait anxiety 
It is important to distinguish between the ‘the anxious state’ and ‘trait anxiety’. 
The ‘anxious state’ refers to the expression of an anxious response at a 
particular time in response to a specific event which typically becomes 
diminished following its resolution. Therefore not only does the individual’s 
response change over time, but the subjective experience of the aversive event 
changes over time. However, ‘trait’ anxiety refers to the persistent manifestation 
of high anxiety which is characteristic of the individual and influences both 
environmental and social interactions. In animals, the behavioural tests of 
anxiety-like behaviours have been used to induce an ‘anxious state’ by the 
presentation of a punished response or a novel environment. However, the 
modelling of ‘trait’ anxiety in animal models is more difficult.  
1.1.3. The peripheral versus central origins of anxiety 
Historically, emotional states were thought to be derived from the peripheral and 
not the central nervous system. James and Lange proposed that the expression 
of emotion was evoked by the feedback of peripheral sensory receptors 
(reviewed by Pratt, 1992). Therefore the expression of emotional states was 
initiated by physiological changes in the periphery. However, this view was 
challenged by several experimental findings. Cannon (1927) reported that the 
transaction of the spinal cord at the cervical level in dogs did not abolish normal 
rage reactions despite the severing of sensory receptor feedback. Later 
experiments investigated the peripheral administration of adrenaline, which 
does not cross the blood-brain barrier, in healthy volunteers subjected to 
psychological cues (Schachter and Singer, 1962). The subjective experience of 
the individuals was predominantly dependent on the psychological cues as 
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opposed to the administration of adrenaline suggesting that the generation of 
emotion is central in origin. However, the activation of the sympathetic nervous 
system mediates the expression of the physiological symptoms of anxiety in 
healthy individuals. These include tachycardia, sweating, flushing and shaking 
in addition to motor tension (Davies et al, 2010). One exception has been 
reported in patients diagnosed with panic disorder. These individuals commonly 
misinterpret innocuous physical symptoms as sign of illness or an impending 
panic attack (Clark, 1986). In a process referred to as ‘catastrophic cognitive 
misinterpretation’, this misinterpretation of physical symptoms generates anxiety 
in the individual which activates the sympathetic nervous system. The activation 
of the sympathetic nervous system exacerbates the physical symptoms which 
were initially misinterpreted, generating further anxiety, and this cycle ultimately 
induces a panic attack.  
1.1.4. The investigation of anxiety in animals  
Our understanding of anxiety is predominantly derived from physiological and 
behavioural studies in animals in addition to functional imaging studies in 
humans. Functional imaging studies have provided insight into the mechanisms 
of pathological anxiety and the more subjective aspects of normal anxiety. 
However, animal studies have proven to be a more useful tool in the 
investigation of the expression and evaluation components of anxiety (Pratt, 
1992). In such studies, behavioural measures such as punished responding, 
approach-avoidance and freezing behaviours have been assumed to reflect the 
emotional state of the animal (Millan, 2003). The behavioural tests of anxiety 
are broadly categorised into two groups – those that evoke an anxious state 
through the presentation of a conditioned stressor and those that generate an 
anxious state through the presentation of an unconditioned stressor.  
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Conflict tasks, such as the Geller-Seifter, Skinner and Vogel tasks, present a 
reward (i.e. food or water) in the absence and presence of a punishing stimulus 
(i.e. shock). Geller et al. (1960) reported that rats were trained to press a lever 
for a food reward in the presence of a visible cue. However, in subsequent trials 
the lever still presented the food reward but was paired with a concurrent 
electric shock to the feet. The rats showed a marked suppression of lever 
pressing during the punished trials. Previously, a similar task had been 
developed by Estes and Skinner (1941). In response to a lever press, a food 
reward is presented and after a brief delay an acoustic tone sounds, which is 
followed by a foot shock. Response inhibition occurs after the animal has 
received several pairs of tone and shock and an association between the two 
forms. Upon the onset of the tone, responses of the animal for the food reward 
are decreased until cessation of the tone itself.   
Anxiolytic drugs have been found to reproducibly increase punished responding 
for the reward. Therefore, punished responding is considered a measure of 
anxiety-like behaviours. Although these conflict tasks have been found to be 
reliable and reproducible in the investigation of a number of anxiolytic drugs, 
they require training schedules and typically rely upon food restriction or water 
deprivation to induce the motivational drive to respond for the reward.  
More ethological tests of anxiety have utilised the innate fear of novel 
environments as the unconditioned stressor to generate anxiety. These tests 
include the elevated plus-maze, the open field, the social interaction test and 
the light-dark box (Pellow et al, 1985; Hall, 1934; File and Pope, 1974; Lorenzini 
et al, 1984). As the animals do not require training, these tasks have become 
increasingly popular in behavioural studies due to the simplicity and short 
duration of the experimental protocol. However, there is a relative lack of 
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reproducibility and reliability in such tasks due to the array of methodological 
differences in the literature (e.g. dimensions, light levels, handling etc.).  
The results of behavioural tests in animal studies must therefore be considered 
in the context of the test and the nature of the stressor used (e.g. conditioned 
versus unconditioned) to induce an anxious state. In part, this may account for 
differences in the effects (i.e. anxiolytic, anxiogenic or no effect) of experimental 
treatments tested in a battery of such tasks. In addition, the diverse nature of 
the tests and the stimuli used to elicit the expression of anxiety reflects the 
diversity of defensive behaviours which are sensitive to pharmacological 
manipulation. 
1.1.5. Hierarchy of defensive behaviours 
Using an ethological approach, Blanchard et al. (2011) investigated factors 
which determine the expression of specific defensive behaviours such as 
avoidance, freezing, escape and attack. The authors reported that in the 
absence of an escape route, wild rats exposed to a human stressor elicited 
freezing behaviours when the proximity was greater than 1 m. However, 
defensive attack was observed when the proximity was reduced to less than 0.5 
m (Blanchard and Blanchard, 2011). Conversely, the addition of an escape 
route elicited flight as opposed to freezing behaviours (Blanchard and 
Blanchard, 1989). Therefore, the proximity of the threat was a reliable 
determinant of the defensive strategy adopted (Blanchard et al, 2011). In 
addition, Blanchard and Blanchard (1989) reported differences in the defensive 
strategy adopted by animals presented with a predator stressor and those 
presented with the odour of the predator. Exposure of rats to a cat odor block 
increased risk assessment as measured by an increased incidence of stretch-
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attend movements, freezing and avoidance behaviours (Blanchard et al, 1990b; 
Blanchard et al, 2001).  
The authors coined the term ‘defensive distance’ (i.e. the proximity of the threat) 
as a critical determinant of the defensive strategy adopted by the animal in 
response to threatening stimuli. The presence of a proximal threat elicits either 
flight or fight responses depending on environmental factors (i.e. the potential 
for escape or hiding), which are considered fear mediated responses. However, 
the presence of a distal or potential threat initiates risk assessment behaviours 
which are thought to reflect anxiety-like processes (Blanchard et al, 2011). The 
authors reported that the initiation of risk assessment behaviours and the 
evaluation of the threat were a critical determinant of the defensive strategy 
adopted (Blanchard et al, 2011).  
McNaughton and Corr (2004) suggested that the appropriate defensive 
behaviour elicited may be mediated by distinct neuronal systems within the 
circuitry of anxiety. This hierarchy of defensive behaviours suggests that more 
primitive defensive responses such as fight/flight are mediated by lower level 
nuclei in the hierarchy, such as the periaquductal grey (PAG) and locus 
coeruleus, in response to immanent proximal threats. An intermediate level, 
comprising the amygdala and septo-hippocampal system, mediates defensive 
strategies in response to distal threats. Whereas higher centres, such as the 
prefrontal cortex, mediate the defensive behaviours in response to perceived or 
potential threats which may require more complex cognitive responses. In this 
arrangement, the higher levels are able to feedback down to inhibit the 
responses of the lower levels in the hierarchy (figure 1.1.; McNaughton and 
Corr, 2004). 
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Figure 1.1. – The hierarchical organisation of the neuroanatomical substrates of 
defensive behaviours. The hierarchy of defensive behaviours is derived from the work of 
Blanchard and Blanchard (2011) who reported that the defensive response of an animal was 
influenced by the proximity of the threat. Therefore, McNaughton and Corr (2004) hypothesised 
that the neuroanatomical substrates which mediate these defensive responses may be 
organised in a similar hierarchical arrangement. Threats such as a proximal predator or a 
dominant conspecific induce flight/fight responses mediated by the PAG. However, distal or 
perceived threats are mediated by higher cognitive centres as the defensive response requires 
more complex defensive strategies. Adapted from Gray and McNaughton (2003).  
1.2. Neurocircuitry of anxiety 
The neuroanatomy of anxiety is historically associated with the Papez circuit of 
emotion, which includes the hypothalamus, anterior thalamus, cingulate gyrus 
and hippocampus (Papez, 1937). Papez (1937) proposed that sensory 
information from the periphery is projected to the mammillary body of the 
hypothalamus via the thalamus. This is then relayed to cortical structures via 
the cingulate gyrus which is considered the site of the subjective emotional 
experience. Projections back to the hypothalamus, via the hippocampus, 
mediate the downstream expression of emotion (Papez, 1937).  
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More recent studies have implicated a number of anatomical substrates omitted 
in the original Papez circuit which play a role in the mediation of anxiety. 
Systematic analysis of the connectivity of these nuclei has led to the 
investigation of distinct neuronal systems which mediate specific responses to 
aversive stimuli. These include the ‘defensive system’ which mediates the 
immediate responses to proximal threats and is analogous to panic attacks 
(Sandford et al, 2000). Another is the ‘behavioural inhibition system’ which was 
originally proposed by Gray (reviewed by Gray and McNaughton, 2003). This 
system is thought to mediate the suppression of behaviours which increase the 
likelihood of adverse events and this may include the inhibition of behaviours 
mediated by the defensive system (Sandford et al, 2000). These two systems 
have been the most extensively investigated and are thought to work in concert 
with one another but others are likely to play a role. In the present review, 
specific anatomical substrates of the circuitry are discussed in brief with an 
emphasis on the role of the neurotransmitter serotonin at such centres when 
appropriate.  
1.2.1. Hypothalamic Nuclei 
The role of the hypothalamus in the mediation of anxiety is twofold. Firstly, the 
hypothalamus is an important component in the initiation of both the 
cardiovascular and endocrine responses to stressful stimuli due to the role of 
the paraventricular nucleus (PVN) in the hypothalamic-pituitary-adrenal (HPA) 
axis. The activation of the HPA axis is considered a hallmark of the stress 
response (DiMicco et al, 2002). Stress-induced increases in glucocorticoids are 
evoked by the release of adrenal corticotrophic hormone (ACTH), which is 
triggered by the secretion of corticotrophin releasing factor (CRF) into the 
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hypothalamic portal system at the median eminence (DiMicco et al, 2002). The 
neurons of the PVN synthesise CRF (Jankord and Herman, 2008). In addition, 
the projections from the PVN to the spinal cord are thought to mediate the 
cardiovascular responses to stress. Microinjection of the GABAA receptor 
antagonist bicuculline, the excitatory kainic acid and NMDA into the PVN have 
been reported to increase heart rate and blood pressure mimicking responses 
to stress (Haywood et al, 2001; Schlenker et al, 2001; DiMicco et al, 2002).  
In addition, the hypothalamic nuclei have been implicated in the mediation of 
the behavioural responses to anxiogenic stimuli. Disinhibition of the 
dorsomedial nucleus (DMN), induced by the central administration of the 
GABAA receptor antagonist bicuculline, evokes tachycardia, increased secretion 
of ACTH, and an anxiogenic-like phenotype in the social interaction test and 
elevated plus-maze (Shekhar, 1993; Shekhar et al, 1993; Shekhar and Katner, 
1995). Conversely, the intra-DMN administration of the GABAA receptor agonist 
muscimol induced an anxiolytic-like effect in both tests (Shekhar, 1993; Shekhar 
and Katner, 1995). In addition, the administration of chlordiazepoxide, diazepam 
and midazolam into the mammillary body, which is a component of the original 
Papez circuit, were reported to increase punished responding in a Geller-Seifter 
conflict task (reviewed by Menard and Treit, 1999). The contribution of the 
individual hypothalamic nuclei to the mediation of defensive behaviours remains 
to be determined and may be mediated, in part, by distinct circuits within the 
hypothalamus itself. Canteras et al. (2012) proposed a predator-responsive 
medial hypothalamic circuit and a distinct social/reproductive medial 
hypothalamic circuit based on c-fos immunoreactivity in response to predator 
associated cues.  
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1.2.2. Amygdala 
The amygdala is extensively interconnected with the cortex, locus coeruleus, 
midbrain, striatum and brain stem (Sandford et al, 2000) and plays a role in the 
mediation of the locomotor, neuroendocrine, autonomic and respiratory 
responses to aversive stimuli. Lesioning, stimulation and neurochemical studies 
have shown that the amygdala is a critical component in the expression, 
conditioning and extinction of fear and acute anxiety (Davis, 1992; LeDoux, 
1995). The primary output from the amygdala originates from the central 
nucleus and terminates in the PAG, brainstem and hypothalamus (Killcross et 
al, 1997). The lateral and basolateral nuclei receive cortical and subcortical 
(predominantly from the thalamus) sensory inputs (McCool and Chappell, 2007; 
LeDoux, 1995). Killcross et al. (1997) determined that lesions of both the 
basolateral and central nuclei of the amygdala prevented the formation of an 
association between a conditioned stimulus and a punishment in a modified 
Geller-Seifter test. However, lesioning of the basolateral or central nucleus of 
the amygdala alone did not abolish the formation of an association as 
anticipated but altered the behavioural expression of the association 
demonstrating that these nuclei mediate specific components of fear-
conditioning (Killcross et al, 1997). 
The lateral amygdaloid nucleus of the rat receives extensive serotonergic 
innervation, however, the central and medial nuclei receive relatively little 
serotonergic innervation (Hensler, 2006). The effects of pharmacological 
manipulations of the serotonergic transmission in the amygdala have been 
investigated. The administration of the 5-HT1A agonist 8-OH DPAT into the 
basolateral amygdala induced anxiogenic-like effects in both the Geller-Seifter 
(Hodges et al, 1987) and social interaction tests (Gonzalez et al, 1996) 
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suggesting that activation of the 5-HT1A receptor in the amygdala may 
exacerbate fear responses. However, the nature of the threatening stimulus 
may also be important as the administration of 8-OH DPAT into the basolateral 
amygdala failed to influence anxiety-like behaviours in the elevated plus-maze 
(Gonzalez et al, 1996). Similarly, the administration of 5-HT2 antagonists 
methysergide and ketanserine into the basolateral amygdala generated 
conflicting results in the Geller-Seifter task (anxiolytic; Hodges et al, 1987) and 
the elevated plus maze (anxiogenic; Zangrossi Jr. and Graeff, 1994) 
respectively. The intra-amygdala administration of the 5-HT3 antagonist 
ondansetron has been reported to be anxiolytic in the social interaction test but 
not the Vogel conflict task (Higgins et al, 1991). Collectively, the data suggest 
that the role of serotonergic transmission in the amygdala in the mediation of 
anxiety may be receptor specific and may also be dependant upon the nature of 
the aversive stimulus. 
Using the Spielberger’s state trait anxiety inventory and a visual analogue scale, 
the effect of lesions to the left hemisphere amygdala in two human patients 
were investigated (Masaoka et al, 2003). In the basal resting state, both 
patients were reported to have high levels of state and trait anxiety (Masaoka et 
al, 2003). However, indices of state and trait anxiety were found to be reduced 
in the basal state following surgery (Masaoka et al, 2003). In anticipation of a 
shock administered following a warning, lesioning of the left hemisphere 
amygdala was found to reduce state anxiety (Masaoka et al, 2003). In addition, 
a reduction in respiratory rate and skin conductance response of the patients 
was reported when compared before and after surgery (Masaoka et al, 2003). 
1.2.3. Septo-hippocampal system 
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In 1982, Gray and McNaughton proposed that anxiolytic drugs act upon a 
‘behavioural inhibition system’ which involves the septo-hippocampal system 
(McNaughton and Gray, 2000). The hypothesis arose from the observation that 
lesions of the septo-hippocampus induce a behavioural phenotype similar to 
that of anxiolytic drugs (McNaughton and Gray, 2000). In this system, the septo-
hippocampus serves as a comparator of inputs signalling the current state 
versus the predicted state of an event. In the event of a mismatch, which can be 
generated by aversive stimuli such as punished responding, reward omission 
and novel stimuli, output from the septo-hippocampal system facilitates 
behavioural inhibition in an attempt reconcile the mismatch. 
A range of anxiolytic drugs (including buspirone, ethanol and imipramine) have 
been reported to impair the control of theta activity in the hippocampus, which 
originates from the pacemaker input of the medial septal area (McNaughton and 
Gray, 2000). As the occurrence of theta activity in the hippocampus is 
associated with arousal, this offers a possible link by which anxiolytic 
compounds may alter the expression of the anxious state. 
The serotonergic innervations to the hippocampus are mediated by both the 
dorsal raphe nucleus (DRN) and the median raphe nucleus (MRN). The dorsal 
hippocampus is innervated exclusively by serotonergic neurons originating from 
the MRN. However, the ventral hippocampus receives afferent innervation from 
both nuclei (Azmitia and Segal, 1978). The potentiation of GABAergic 
transmission in the dorsal hippocampus elicits an anxiolytic effect in the majority 
of studies. In agreement, the administration of midazolam into the dorsal 
hippocampus is reported to be anxiolytic in the open field (Stefanski et al, 
1993), the Vogel conflict task (Stefanski et al, 1993; Plaznick et al, 1994) and 
social interaction test (Gonzalez et al, 1998) but not the elevated plus-maze 
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(Gonzalez et al, 1998). However, the role of serotonergic transmission in the 
dorsal hippocampus appears to be dependant upon the nature of the stressor 
and the dose of the substance administered. The administration of 8-OH DPAT 
is reported to induce anxiogenic effects in the social interaction test (Andrews et 
al, 1994; File et al, 1996) and in the elevated plus-maze in maze experienced 
rats (File et al, 1996). However, studies have reported anxiolytic effects of 8-OH 
DPAT administered into the dorsal hippocampus in the open field (Stefanski et 
al, 1993), Vogel conflict task (Stefanski et al, 1993; Przegalinski et al, 1994), the 
ultrasonic vocalisation test (Schreiber and De Vry, 1993) and a passive 
avoidance task (Carli et al, 1993). The anxiolytic effects reported are typically in 
response to the administration of higher doses than those reported to elicit 
anxiogenic effects. The dose dependent effects may reflect the distinct 
contributions both pre and post-synaptic 5-HT1A receptors to the behavioural 
effect at a particular dose or the diffusion of 8-OH DPAT to distal sites at higher 
doses (File et al, 2000). 
The intra-ventral hippocampal administration of 8-OH DPAT has no effect in 
either the social interaction test or elevated plus-maze (Hogg et al, 1994; File 
and Gonzalez, 1996). However, the administration of the antagonist tertatolol 
into the ventral hippocampus is reported to elicit anxiolytic-like effects in the 
elevated plus-maze in animals naïve and experienced with the maze (File and 
Gonzalez, 1996). Using microdialysis, Rex et al. (2005) reported that exposure 
to the elevated plus-maze increased serotonin overflow in the ventral 
hippocampus. Therefore, the anxiolytic-like effect of tertatolol administration 
may reflect the endogenous serotonergic tone induced by the elevated plus-
maze.  
1.2.4. Periaqueductal grey 
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The periaqueductal grey (PAG) has been implicated as component in the 
circuitry which mediates the expression of fear behaviours in response to a 
range of stressors (Canteras et al, 2012). Delgado et al. (1954) showed that 
animals learn to respond in order to cease the stimulation of the dorsal PAG. 
Therefore, the stimulation of the dorsal PAG appears to an aversive stimulus in 
itself and has been investigated as a test of anxiety (Graeff, 2004). The 
systemic administration of the 5-HT synthesis inhibitor PCPA or the 5-HT 
receptor antagonist cyproheptadine facilitate the ‘switching off’ of the stimulation 
of the dorsal PAG suggesting an anxiogenic-like effect (Kiser et al, 1978b; 
Schenberg and Graeff, 1978). Conversely, the facilitation of serotonergic 
transmission induced by the systemic administration of 5-hydroxytryptophan (5-
HTP), chlorimipramine, and the stimulation of the DRN all reduced ‘switching-
off’ of the stimulation of the dorsal PAG suggesting an anxiolytic-like effect 
(Kiser et al, 1978a; Kiser et al, 1980). However, the systemic administration of 
chlordiazepoxide also reduced the ‘switching-off’ response (Schenberg and 
Graeff, 1978). In classical conflict tasks, the administration of benzodiazepines 
and 5-HT receptor antagonists are typically associated with anxiolytic-like 
effects and not opposing effects as was reported in response to the stimulation 
of the dorsal PAG. 
This apparent contradiction was resolved by Graeff and Rawlins (1980). Rats 
were trained to press a lever for a food reward and subsequently divided into 
two groups. Each group was presented with a punished stimulus paired with the 
lever pressing response, however, one group received a mild foot-shock and 
the other received a brief stimulation of the dorsal PAG. Following a lesion of 
the lateral septum in both groups, punished responding in animals which 
received the mild-shock was increased. However, rats which received the mild 
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stimulation of dorsal PAG showed no increase in the rate of punished 
responding. Therefore, the results suggested that the dorsal PAG is a 
component of the brain defence system in which serotonin originating from the 
DRN acts to inhibit aversive responding. This circuit may be distinct from the 
behavioural inhibition system, in which serotonin facilitates inhibition (Graeff, 
2004). 
In addition to maintaining ‘switching-off’ responding, the stimulation of the dorsal 
PAG has been associated with an increase in flight, fight and aggressive 
postures in rats (Graeff, 2004). Similarly, Schmitt et al. (1986) reported that the 
administration of GABAA receptor antagonists into the dorsal PAG elicited 
aimless vertical jumps, alternating with periods of immobility and freezing. In 
humans, the stimulation of the dorsal PAG elicits feelings of fear, impending 
death and the desire to flee (reviewed by Graeff, 2004). Furthermore, patients 
showed palpitations, blushing of the face and neck and respiratory arrest or 
hyperventilation. Therefore, the dorsal PAG has been implicated in pathology of 
panic attacks due to the similarities in the symptoms presented in patients 
diagnosed with panic disorder. 
1.2.5. Prefrontal cortex 
An important aspect of anxiety is the subjective experience of the aversive 
event. The subjective experience is dependant on the ability of the individual to 
alter the onset, duration, intensity or termination of the aversive event (Maier 
and Watkins, 2010). The ventromedial prefrontal cortex (vmPFC) has been 
implicated in mediating the psychological effects of behavioural control.  
Animals received escapable or yoked inescapable tail shocks, with only one 
animal capable of terminating the shock via a wheel in the testing box (Amat et 
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al, 2005). Inescapable shocks induced a behavioural phenotype thought to 
reflect a persistent state of anxiety (Maier and Watkins, 1998). However, 
individuals subjected to escapable shocks did not exhibit this behavioural 
phenotype despite both animals receiving identical number of shocks of equal 
intensity and duration. Although inescapable stress activates the serotonergic 
neurons originating in the DRN more than equal controllable stress (Bland et al, 
2003) the DRN is unlikely to process behavioural control. Anatomically, the lack 
of direct sensory and motor inputs in addition to the size of the DRN (11,500-
15,191 serotonergic neurons in the rat; Vertes and Linley, 2008) suggest this 
nucleus does not have the required information or processing capacity to 
determine behavioural control. However, the DRN receives cortical inputs via 
glutamatergic innervations from the infralimbic and prelimbic areas of the 
vmPFC which terminate on GABAergic interneurons in the DRN (Vertes, 2004; 
Jankowski and Sesack, 2004; Celada et al, 2001). Therefore, Amat et al. (2005) 
investigated the role of the vmPFC in mediating behavioural control by locally 
administering the GABAA receptor agonist muscimol immediately prior to 
escapable and yoked inescapable stress. The administration of muscimol into 
the vmPFC prior to escapable stress evoked a prolonged increase in serotonin 
overflow in the DRN comparable to that observed in the animals exposed to the 
inescapable shocks (Amat et al, 2005). In addition, the intra-vmPFC 
administration of muscimol prior to escapable shocks increased the latency of 
shuttlebox escape (Amat et al, 2005) and reduced social investigation of a 
juvenile conspecific (Christianson et al, 2009) characteristic of yoked animals 
which received inescapable stress. Conversely, the administration of the 
GABAA receptor antagonist picrotoxin into the vmPFC ameliorated the 
behavioural effect of inescapable stress and induced a behavioural phenotype 
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comparable to animals which received escapable stress (Amat et al, 2008; 
Christianson et al, 2009). 
1.2.6. Locus coeruleus 
The role of noradrenaline in anxiety has been implicated by the finding that the 
2 adrenergic agonist clonidine has therapeutic value in the treatment of anxiety 
disorders (Hoehn-Saric et al, 1981; Uhde et al, 1989; Charney and Heninger, 
1986). Conversely, the administration of yohimbine and piperoxam are reported 
to increase the subjective experience of fear and panic in both animals and 
humans (Iversen, 1984). In the startle response task, the administration of 
adrenergic agonists and antagonists are reported to be anxiogenic and 
anxiolytic respectively (Davis et al, 1979). Furthermore, the electrical stimulation 
of the locus coeruleus in animals is reported to induce anxiogenic behaviours in 
animals which are similar to anxiety in humans (Tanaka et al, 2000). This 
anxiogenic-like effect is blocked by lesions to the locus coeruleus and by 
noradrenergic antagonists (Uhde et al, 1984). In response to a variety of 
stressors, Tanaka et al. (2000) reported that noradrenergic overflow is 
increased in the hypothalamus, the amygdala, locus coeruleus, cerebral cortex 
and hippocampus. These increases were dependent on the controllability and 
predictability of the stressor. Therefore, the locus coeruleus has been implicated 
in the mediation of the fundamental ‘alarm reaction’ to aversive stimuli 
(Redmond, 1986; Charney and Heninger, 1986). 
1.3. Brain serotonergic pathways as a target of anxiolytic drugs 
1.3.1. The serotonergic system 
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Historically, the name serotonin described a “serum” factor that affected blood 
vessel “tonus” causing vasoconstriction and increasing gut motility (reviewed by 
Jacobs and Azmitia, 1992). In the mid-twentieth century, the endogenous 
compound was isolated, synthesised and the molecular formula elucidated. 
Serotonin was proposed as a neurotransmitter shortly after as it was found in 
varying concentrations throughout the mammalian CNS. Using the Falck-Hillarp 
histochemical fluorescence technique, Dahlstrom and Fuxe (1964) identified the 
localisation of serotonergic cell bodies and axon terminals in the rat brain. The 
serotonergic system of the CNS comprises eight distinct nuclei located at the 
midbrain (Lechin et al, 2006). The serotonergic nuclei were labelled B1 to B9 in 
order of their position along the saggital axis (Dahlstrom and Fuxe, 1964). With 
the exception of the B9 neurons (referred to as the supralemniscal nucleus), the 
serotonergic nuclei are located along at the midline of the brain. Therefore, the 
nuclei were referred to as the “raphe” nuclei which means “seam” (Vertes and 
Linley, 2008). The alpha-numeric nomenclature of the nuclei was replaced by 
names which reflect the anatomical location, however, the exception are B9 
neurons which have retained the original nomenclature (reviewed by Vertes and 
Linley, 2008). 
The raphe pallidus (B1), raphe obscurus (B2), raphe magnus (B3) and parts of 
the lateral reticular formation (B1/B3) are referred to as the caudal raphe 
complex and are located in the lower pons and the medulla. Projections from 
these nuclei typically descend to the brainstem and spinal cord and are 
implicated in the circuitry of cardiovascular, respiratory and ingestive control. 
The rostral raphe complex, which is predominantly located in the pons, is 
comprised of the caudal linear nucleus (B8), the DRN (B6 and B7) and the 
median raphe nucleus (MRN; B8 and B5) and are the origin of ascending 
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serotonergic projections to the forebrain (Hornung, 2003). The major site of 
serotonin synthesis in the central nervous system (CNS) is the DRN and, to a 
lesser extent, the MRN in the midbrain (Pineyro and Blier, 1999). There are 
three major ascending serotonergic pathways to the forebrain consisting of 
highly collateralised projections which extensively innervate the forebrain. In 
addition to anxiety, serotonergic transmission has been implicated in mediating 
the sleep-wake cycle, food intake and sexual behaviour (Barnes and Sharp, 
1999).  
1.3.2. Role of serotonergic transmission in anxiety 
The neurotransmitter serotonin has been implicated in the mediation of anxiety 
for a long time. Historically, the benzodiazepines were reported to reduce the 
turnover and release of catecholamines and indolamines such as serotonin in 
the brain (Wise et al, 1972). Therefore, it was proposed that the anxiolytic effect 
of the benzodiazepines was, in part, due to the suppression of serotonergic 
transmission. In addition, several lines of clinical evidence support the 
hypothesis that serotonin is an important mediator of anxiety. The 
administration of the 5-HT agonist m-chlorophenylpiperazine (mCPP) is 
anxiogenic in patients with panic disorder (Charney et al, 1987), obsessive 
compulsive disorder (Zohar et al, 1987) and at high doses in healthy individuals 
(Charney et al, 1987). Similarly, the serotonin re-uptake inhibitior fenfluramine is 
reported to be anxiogenic in patients diagnosed with panic disorder, social 
phobia and healthy individuals (Targum, 1990; Tancer et al, 1994). In 
agreement, serotonin metabolites are reduced in the cerebrospinal fluid of 
patients with impulsivity disorders which show reduced aversive processing and 
behavioural disinhibition (Linnoila and Virkkunen, 1992). However, the 
administration of L-tryptophan and 5-HTP, the metabolic precursors of 
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serotonin, have been reported to induce sedation and anxiolysis (Charney et al, 
1987; Nutt and Cowen, 1987; Westenberg and den Boer, 1989). In addition, the 
clinical efficacy of the selective reuptake inhibitors in the treatment of the 
anxiety disorders would support the hypothesis that serotonin mediates anxiety 
(Lydiard et al, 1996). However, the clinical evidence appears contradictory in 
the specific role that serotonin plays in the mediation of anxiety. 
Early work on the reduction in serotonergic transmission found that the 
serotonin antagonists cinanserin, cyproheptadine, methysergide and lysergic 
diethylamide released response suppression in rats. Similarly, the depletion of 
serotonin using p-chloroamphetamine produced a marked increase in punished 
responding (reviewed by Iversen, 1984). Lesioning of the serotonergic system 
have been reported following the administration of the toxin 5,7-
dihydroxytryptamine (5,7-DHT). When administered into the ventral tegmental 
area, 5,7-DHT is reported to release punished responding in a Geller-Seifter 
task and impair the acquisition of response suppression to the shock (Tye et al, 
1977). The 5,7-DHT lesion of the ventral tegmental area is reported to deplete 
serotonin in the hypothalamus, limbic and cortical structures but leaves the 
dorsal serotonergic projections to the striatum relatively intact. The lesion did 
not induce a stimulation of motor activity and therefore suggests that the effect 
on response suppression was due to an anxiolytic-like effect (Tye et al, 1979). 
Therefore, the suppression of the serotonergic system appears to mimic the 
anxiolytic-like effects of the benzodiazepines in punished conflict tasks. 
Historically, serotonin has been implicated in the mediation of aversive 
processing (Deakin and Graeff, 1991; Kranz et al, 2010) and behavioural 
inhibition (Soubrié, 1986).  
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The pathology of depression is associated with the reduction in serotonergic 
transmission and is characterised by reduced behavioural vigor and enhanced 
aversive processing (Deakin and Graeff, 1991; Eshel and Roiser, 2010; Clark et 
al, 2009). Given that anxiety and depression are often expressed as co-
morbidities in patients and the clinical efficacy of the SSRIs in the treatment of 
both depression and many anxiety disorders, it is difficult to reconcile that 
serotonin is simply anxiogenic. This apparent contradiction was investigated by 
Graeff et al. (1996) who proposed that serotonin plays a dual role in the 
mediation of anxiety.  
As discussed previously, serotonin suppresses the responses which terminate 
the electrical stimulation of the PAG in a similar manner to the benzodiazepines. 
Therefore, Graeff et al. (1996) proposed that distinct pathways and receptor 
subtypes mediate the anxiolytic and anxiogenic effects of serotonin. 
Serotonergic projections originating in the DRN terminate in the amygdala and 
prefrontal cortex and facilitate active escape or avoidance behaviours in 
response to potential or distal threats (figure 1.2.). These strategies require 
learning and are thought to relate to conditioned fear, anticipatory anxiety and 
generalised anxiety disorder. In contrast, the serotonergic innervations from the 
DRN to the PVN and PAG matter inhibit the primitive fight/flight responses 
triggered in response to proximal threat, acute pain or asphyxia that may relate 
to panic disorders (figure 1.2.). In the absence of behavioural control, an acute 
stressor can become a chronic stressor. In response to chronic stress, as 
opposed to acute stress, Graeff et al. (1996) suggest the projections from the 
MRN to the hippocampus promote resistance to the stressor by disconnecting 
the stressor from social and appetitive neurobiological processes. Therefore,  
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Figure 1.2. –The serotonergic system plays a modulatory role at each level of the 
proposed neuronal hierarchy of defensive behaviours. Serotonergic afferent projections 
terminate in higher order centres such as the amygdala, the septo-hippocampal system, the 
cingulate and prefrontal cortices to facilitate avoidance behaviours in response to distal or more 
cognitively complex threats. However, the serotonergic afferents which terminate in the 
periaqueductal grey and hypothalamus inhibit the primitive fight/flight responses evoked by 
proximal threats, asphyxia and acute pain. Adapted from Graeff et al, 1996 and McNaughton 
and Corr (2004). 
this process would allow for the individual to continue functioning normally 
despite on-going aversive events, however, its dysfunction would likely 
contribute to the pathology of depression. 
More recently, the role of serotonin in both valence (reward versus punishment) 
and activity (invigoration or inhibition) has been expanded upon (Boureau and 
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Dayan, 2011). Serotonin is most commonly associated with the inhibition of 
punished responses therefore coupling negative affect with behavioural 
inhibition (Soubrié, 1986). However, Boureau and Dayan (2011) have proposed 
that the two effects are dissociable as serotonin has been implicated in both 
behavioural inhibition (Graeff et al, 1996; Gray and McNaughton, 2003) and 
active avoidance (Bland et al, 2003) in response to adverse events. Boureau 
and Dayan (2011) propose a model where serotonin acts cooperatively with 
dopamine to maximise rewards and minimise the likelihood of aversive events 
in the most energy efficient manner. In this model, Boureau and Dayan (2011) 
suggest that dopamine and serotonin represent opposite ends in the spectrum 
of affective valence and motor activity. Therefore serotonin, in conjucture with 
dopamine, may be able to mediate both active responses (such as escape or 
avoidance) and behavioural inhibition (such as freezing) in response to aversive 
stimuli. In addition, Cools et al. (2011) have suggested that the tonic release of 
serotonin signals the anticipated valence associated with future events (i.e. the 
likelihood of aversive outcomes) whilst the phasic release of serotonin acts to 
signal the valence of experienced events (i.e. the outcome of the event). 
Therefore, serotonin may act as a predictive index of aversive events and this 
may play an important role in the formation of Pavlovian associations in 
response to aversive events.  
1.4. Dorsal raphe nucleus 
In rats, the DRN (B7 and B6) is situated in the pons directly ventral to the 
cerebral aqueduct which traverses the PAG (figure 1.3.). Along the coronal axis, 
the DRN is subdivided into lateral (or lateral wings) and medial subdomains 
(figure 1.3.). The latter is further compartmentalised into the dorsomedial, 
ventromedial and interfascicular domains (figure 1.3.). The medial subdivisions 
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extend through the rostral and middle aspects along the sagittal plane, 
however, are absent in the caudal domain (Michelsen et al., 2007). The majority 
of neurons which comprise the DRN synthesise the neurotransmitter serotonin. 
In cats, the estimated 24,000 serotonergic neurons reflect 70% of the total 
neuronal population of the DRN (reviewed by Jacobs and Azmitia, 1992). 
Similar estimates have been reported in the rat DRN and human DRN 
(Descarries et al, 1982; Yasufuku-Takano et al, 2008; Baker et al, 1991). In the 
rostral and medial domains, the serotonergic neurons of the DRN are densely 
populated at the midline and become increasingly diffuse in the lateral wings 
(Vertes and Linley, 2008).  
The electrophysiological properties of the serotonergic neurons of the DRN 
were originally characterised in anaesthetised rats and cats (Aghajanian et al, 
1978; Jacobs and Azmitia, 1992). The serotonergic neurons were 
hyperpolarised by the focal application of serotonin, which is mediated by the 
inhibitory 5-HT1A autoreceptor (Sprouse and Aghajanian, 1986; Sotelo et al, 
1990). In addition, a proportion of non-serotonergic neurons also express the 5-
HT1A autoreceptor (Kirby et al, 2003; Yasufuku-Takano et al, 2008). In the DRN, 
the 5-HT1A autoreceptor is a G-protein coupled receptor linked to potassium 
channels which induce the hyperpolarisation of the membrane by increasing 
potassium conductance in response to increased extracellular serotonin 
(Aghajanian and Lakosi, 1984; Adell et al, 2002). A secondary inhibitory 
mechanism is also mediated by the activation of 5-HT2A receptors which are 
expressed on the GABAergic inhibitory inputs to the serotonergic neurons 
(Lechin et al, 2006; Martin-Ruiz et al, 2001a). 
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Until the mid-seventies, the DRN was considered exclusively serotonergic, 
however, additional neurotransmitters and peptides have been reported. 
Dopaminergic neurons are located in ventromedial and dorsorostral regions of 
 
Figure 1.3. –The localisation of the DRN in the sagittal and coronal plane of the rat brain 
and the subdivisions of the DRN. In the sagittal section (lateral = -0.1 mm), the DRN (shown 
in green) is situated in the pons and is bordered rostrally by the trochlear nucleus and caudally 
by the dorsal tegmental nucleus (panel A). The DRN is situated at the midline and is located 
ventral to the cerebral aqueduct (CA) and dorsal to the medial longitudinal fasciculus in the 
coronal plane (AP = -7.8 mm; panel B). The DRN, in the coronal plane, is subdivided into the 
medial and lateral domains (LW). The former is further subdivided into the dorsomedial (DM), 
ventromedial (VM) and interfascicular domains (IF; AP = -7.8 mm; panel C). Figures adapted 
from Paxinos and Watson (1998). 
the DRN (Ochi and Schimizu, 1978; Stratford and Wirtshafter, 1990). The 
expression of both the phosphate activated glutaminase and vesicular 
glutamate transporter-3 (VGLUT3) in the serotonergic and non-serotonergic 
neurons of the DRN suggest that the excitatory amino acid glutamate is 
synthesised in the DRN (Kaneko et al, 1990; Mintz and Scott, 2006; Jackson et 
al, 2009). Similarly, the expression of nitric oxide synthase in the serotonergic 
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neurons of the DRN may also suggest that that nitric oxide may act as a 
neurotransmitter in the DRN (Dun et al, 1994). 
A number of neuroactive peptides have been reported to have influence the 
serotonergic transmission of the DRN. Immunoreactivity for corticotrophin 
releasing factor (CRF) has been found in both the dorsomedial and lateral 
wings of the DRN and co-localises with the serotonergic neurons (Commons et 
al, 2003). Anterograde tracing has identified that CRF-containing neurons of the 
DRN predominantly project to the amygdala and the dorsal hypothalamic area 
(Commons et al, 2003). In addition, there is evidence to suggest the expression 
of neuropeptide Y, substance P and galanin in the DRN (Pau et al, 1998; Baker 
et al, 1991; Le Maître et al, 2013).  
1.4.1. The serotonergic neurons of the dorsal raphe nucleus 
Typically, the serotonergic neurons of the DRN are densely packed, large (30-
40 m) and fusiform in shape (Vertes and Linley, 2008). In contrast, the 
serotonergic neurons of the MRN are more diffusely localised and are relatively 
small (10-12 m) and oval (Vertes and Linley, 2008). Baker et al. (1990) 
reported morphologically distinct populations of serotonergic neurons in the 
human DRN. In agreement, Steinbusch et al. (1981) described the morphology 
of the serotonergic neurons in the rat DRN as small round, medium-sized 
fusiform, bipolar or large fusiform. Therefore, the serotonergic neurons of the 
DRN are heterogeneous and their topographical arrangement may reflect 
distinct functional roles (Abrams et al, 2004). Similarly, electrophysiological 
studies in the rat have described two distinct populations, termed type I (typical) 
and type II (atypical), based on firing properties and localisation (Abrams et al, 
2004). 
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In addition, the mechanisms by which serotonin is released from the 
serotonergic neurons appears to be complex. Axonal varicosities containing 
vesicles suggest that the neurons store and release serotonin at discrete 
synapses (Adell et al, 2002). Serotonin release from the raphe nuclei is 
predominantly induced by action potential propagation, which is both tetrotoxin 
sensitive and Ca2+-dependent (Adell et al, 2002). However, a volume or 
paracrine release mechanism may also exist which may be mediated by 
depolarisation-induced reversal of the serotonin transporter (Richerson and Wu, 
2003). The type D axons of serotonergic neurons originating in the DRN are 
typically small with fine varicosities (Michelsen et al, 2007). The presence of 
vesicles at varicosities lacking synaptic junctions implies serotonergic type D 
axons predominantly utilise a paracrine release mechanism as opposed to a 
synaptic mechanism (Bunin and Wightman, 1999; Adell et al, 2002). 
1.4.2. The afferent innervations of the dorsal raphe nucleus 
The afferent innervations of the DRN encompass a number of neurotransmitters 
and peptides originating from nuclei implicated in the expression of the anxious 
state. Initially, studies using horseradish peroxidase and wheat germ agglutinin-
horseradish peroxidase demonstrated an extensive afferent innervation from 
the lateral hebenula, in addition to minor descending afferents from the bed 
nucleus of stria terminalis, the horizontal band of Broca, the prefrontal cortex, 
the preoptic area and posterior hypothalamus (Aghajanian and Wang, 1977; 
Kalén et al, 1985).  
The previously described afferents were refined and added to by Peyron et al. 
(1998) using anterograde and retrograde tracers. The administration of cholera 
toxin b into the DRN demonstrated cortical afferents originating from the orbital, 
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cingulated, infralimbic, dorsal peduncular and insular cortices. Using 
anterograde tracing, the projections from the prelimbic cortex were found to 
terminate in the dorsal region of the middle DRN and lateral wings. The DRN 
receives afferent innervations from the lateral, dorsal and posterior 
hypothalamic areas. In particular, there is a large afferent innervation from the 
arcuate nucleus, the ventromedial and dorsomedial hypothalamic nuclei and a 
moderate innervation from the parvocellular hypothalamic nucleus. In addition, 
there was a small innervation from the tuberomammillary nucleus to the DRN 
which is thought to be histaminergic (figure 1.4.). Additional afferent 
innervations were found to originate in the central nucleus of the amygdala, the 
ventral pallidum, the claustrum, the lateral and medial septum, the lateral, 
ventral and medial parts of the bed nucleus of stria terminalis, the medial and 
lateral preoptic areas, the medial preoptic nucleus and the medial portion of the 
lateral habenula (figure 1.4.). 
The pharmacology of many of these afferent innervations has been 
characterised using electrophysiological and neurochemical techniques. 
Interconnectivity of the raphe nuclei has been reported in both the adult brain of 
the cat and rat and is serotonergic in nature (Jacobs and Azmitia, 1992). The 
principle serotonergic afferent innervation to the DRN originates from the MRN, 
which in turn is reciprocally innervated by the DRN (Jacobs and Azmitia, 1992; 
figure 1.4.). The reciprocal innervations from the serotonergic neurons mediate 
the activation of 5-HT2A/2C receptors which, in turn, facilitate the GABAergic 
inhibition of the serotonergic neurons (Liu et al, 2000; Serrats et al, 2005). 
Afferent innervation originating from the medial preoptic area, the lateral 
hypothalamic nuclei, the VTA and the substantia nigra is dopaminergic in nature 
(Adell et al, 2002; figure 1.4.). In agreement, the systemic, but not local, 
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administration of D1 and D2 receptor agonists facilitates serotonergic activity in 
the DRN (Martín-Ruiz et al, 2001b). However, the afferent innervations from the 
arcuate and dorsomedial hypothalamic nuclei are not dopaminergic but are 
thought mediate the release neuropeptides and histamine (Jacobs and Azmitia, 
1992; figure 1.4.). 
Excitatory noradrenergic afferent innervation of the DRN originates from the 
locus coeruleus and varies with arousal states (Lechin et al, 2006; figure 1.4.). 
This excitation is mediated by the activation of the 1B adrenoceptor (Day et al, 
1997). However, the expression of the 2-adrenoceptor suggests that 
noradrenaline may also inhibit the serotonergic neurons of the DRN (Strazielle 
et al, 1999). The glutamatergic innervation of the DRN originates from the 
prefrontal cortex, hypothalamic nuclei, lateral habenula and the PAG. The 
release of glutamate activates AMPA and NMDA receptors in the DRN and 
therefore these afferents are excitatory in nature (Liu et al, 2002; Gartside et al, 
2007). However, these glutamatergic afferents, in particular those originating 
from the vmPFC and lateral habenula, can mediate the inhibition of the 
serotonergic neurons indirectly via excitation of the GABAergic interneurons of 
the DRN (Celada et al, 2002; Gartside et al, 2007; figure 1.4.). 
Although both raphé nuclei contain a small number of GABAergic interneurons, 
the majority of inhibitory afferents originate at distal sites (Adell et al., 2002). 
GABAergic afferents originate from the hypothalamus, the substantia nigra, the 
VTA and ventral PAG (Gervasoni et al, 2000; figure 1.4.). In addition, a 
combined study using retrograde tracing and glycine immunohistochemistry 
identified that the main glycinergic innervation to the DRN in rats originates from 
the ventral and ventrolateral PAG (Rampon et al, 1999; figure 1.4.).  
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Figure 1.4. –Schematic representation of the afferent projections which terminate in the 
dorsal raphe nucleus. The afferent innervations which terminate in the DRN originate from a 
diverse array of limbic and cortical centres previously implicated in the neuronal processes 
which underpin the generation of anxiety. Such centres include the prefrontal cortex, locus 
coeruleus, the amygdala, the periaqueductal grey, the hypothalamic nuclei and the septo-
hippocampal system. In addition, the afferent innervations originating from the median raphe 
nucleus, the lateral habenula and prefrontal cortex have been reported to indirectly inhibit the 
neuronal activity of the serotonergic neurons via the excitation of GABAergic interneurons. 
Adapted from Vertes and Linley (2008) and Lechin et al. (2006). 
CRF containing neurons terminate on both the serotonergic neurons and 
GABAergic interneurons of the DRN (Kirby et al, 2008; Waselus et al, 2005). 
The CRF1 receptor, which is the high affinity receptor for CRF, is expressed on 
both serotonergic and GABAergic neurons of the DRN. Conversely, the low 
affinity CRF2 receptor is exclusively expressed by the serotonergic neurons of 
the DRN. The effect of CRF in the DRN is bi-phasic, with low concentrations 
mediating the inhibition of serotonergic neurons and higher concentrations 
facilitating serotonergic transmission from the DRN (Lukkes et al, 2008). At low 
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concentrations, CRF facilitates the inhibition of the serotonergic neurons by the 
activation of CRF1 receptors expressed by the GABAergic interneurons (Kirby 
et al, 2008). However, at high concentrations CRF mediates the excitation of 
the serotonergic neurons via the activation of the CRF2 receptors (Kirby et al, 
2008). 
The DRN and MRN contain opioids such as dynorphin and enkephalin (Adell et 
al, 2002). Indeed, the attenuation of serotonin release from the midbrain raphé 
in response to morphine administration, which binds -opioid receptors, may 
result from disinhibition of GABAergic afferents or inhibition of excitatory inputs 
(Adell et al, 2002). The stimulation of serotonin release from the DRN induced 
by nicotine administration suggests there may be nicotinic acetylcholine 
receptors in the midbrain nuclei (Mihailescu et al, 1998). Cholinergic afferents 
from the brain stem originate from superior vestibular nucleus and terminate in 
the DRN via the medial longitudinal fasciculus (Jacobs and Azmitia, 1992). In 
addition, previous studies have reported that serotonergic release from the DRN 
and MRN may be regulated by histamine, nitric oxide, substance P, CRF and 
galanin may also modulate serotonergic activity (Adell et al, 2002). 
1.4.3. The efferent projections of the dorsal raphe nucleus 
With few exceptions, the DRN and the MRN generally project to distinct non-
overlapping sites in the forebrain. The MRN can be characterised as a 
midline/paramidline projection system (Vertes and Linley, 2008). The MRN 
innervates few laterally situated structures with the exception of modest 
innervations to the perirhinal and entorhinal cortices (Vertes, 1991). In contrast, 
the DRN projects to those regions and structures not innervated by the MRN. 
Despite the relatively small numbers of neurons contained within the DRN, the  
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Figure 1.5. –Schematic representation of the efferent serotonergic projections which 
originate in the dorsal raphe nucleus. The efferent serotonergic projections which originate in 
the DRN terminate in both limbic and cortical centres implicated in the neuronal processes 
which underpin the generation of anxiety. Such centres include the prefrontal cortex, locus 
coeruleus, the amygdala, the periaqueductal grey, the hypothalamic nuclei and the septo-
hippocampal system. Adapted from Vertes and Linley (2008). 
highly collateralised nature of these ascending projections leads to widespread 
innervations of the forebrain (Jacobs and Azmitia, 1992; figure 1.5.).  
The DRN innervates the forebrain via three projection pathways – the ventral, 
medial and dorsal ascending pathways (Michelsen et al, 2007). The dorsal 
ascending pathway originates in the medial and rostral DRN and innervates the 
striatum and globus pallidus (Michelsen et al, 2007; figure 1.5.). The substantia 
nigra is the main target of the medial ascending pathway (figure 1.5.). The 
projections of the medial ascending pathway originate in the rostral DRN 
(Michelsen et al, 2007). The most extensive innervations of the forebrain 
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originate from the ventral ascending pathway and terminate in numerous 
regions implicated in the mediation of anxiety (figure 1.5.). The pathway 
ascends ventrolaterally and then turns rostrally to enter the medial forebrain 
bundle (Michelsen et al, 2007). The ventral ascending pathway, which includes 
afferents from all three mesencephalic raphe nuclei, innervates thalamic and 
hypothalamic nuclei, the habenula, the septum, the amygdala, cortical centres 
and the hippocampus (Moore et al, 1978; Azmitia and Segal, 1978; figure 1.5.). 
Using the anterograde tracer Phaseolus vulgaris leuccoagglutinin, the terminal 
domains of the ascending projections have been further refined (Vertes and 
Kocsis, 1994; Vertes, 1991). In the hypothalamus, projections from the DRN 
terminate in the lateral and supramammillary nuclei (Vertes, 1991; figure 1.5.). 
The efferent projections to the amygdala are extensive and innervate the 
central, lateral, basolateral, basomedial nuclei and the amygdalo-piriform 
transition zone (Vertes, 1991; figure 1.5.). In addition, innervation of the septo-
hippocampal system was predominantly found in the medial lateral septum and 
was only moderate in the hippocampus (Vertes, 1991; figure 1.5.). Efferent 
projections to cortical nuclei include the anterior cingulate, prelimbic and 
infralimbic cortices of the prefrontal cortex and the entorhinal cortex (Vertes, 
1991; figure 1.5.). 
The DRN projects to the dopaminergic cell groups of the VTA and substantia 
nigra. In addition, the DRN innervates many of the terminal domains of the VTA 
and substantia nigra such as the dorsal and ventral striatum, the basal nuclei of 
the amygdala and medial prefrontal cortex (Vertes, 1991). Therefore the 
serotonergic projections from the DRN influence both the origins and terminal 
domains of the nigrostriatal and mesolimbic dopaminergic systems (Vertes and 
Linley, 2008). The dopaminergic neurons of the DRN terminate in the nucleus 
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accumbens, the lateral septum and to a lesser extent the caudate putamen 
(Stratford and Wirtshafter, 1990). 
In addition, the serotonergic projections from the DRN have also been found to 
innervate regions of the midbrain, pons and medulla. These include the locus 
coeruleus, the central linear nucleus, the median raphe, the raphe magnus and 
raphe obscurus (Vertes and Kocsis, 1994; figure 1.5.). Due to the expansive 
distribution of the efferent projections originating from the DRN it is unsurprising 
that the DRN has been implicated in range of neuronal processes such as 
arousal, feeding, emotion, motivation, thermoregulation and cognitive processes 
(Jacobs and Azmitia, 1992) 
1.4.4. Role of the dorsal raphe nucleus in anxiety 
Early work showed that the iontophoretic application of 5-HT into the DRN 
inhibits neuronal excitation of the serotonergic neurons (Wang and Aghajanian, 
1977). In agreement, Thiebot et al. (1984) reported that rats trained to press a 
lever for a food reward also received a foot shock with the presentation of the 
‘lights-off’ conditioned stimulus. However, no shock was administered in the 
‘light-on’ phase of the trial. 5,7-DHT lesions of the DRN induced a release of 
response suppression in the ‘lights off’ phase suggesting an anxiolytic-like 
effect. Similarly, the intra-DRN administration of GABA has been reported to 
release punished responding without reducing responding in the unpunished 
phase (Soubrie et al, 1981). In agreement, the systemic administration of 
clonazepam, chlordiazepoxide and midazolam depresses the firing of the 
serotonergic neurons of the DRN (Laurent et al, 1983). 
Pharmacological manipulation of GABAergic inhibition in the DRN has been 
reported in a range of behavioural tests of anxiety in rodents. In rats naïve to 
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the elevated plus-maze, the administration of midazolam increased the time 
spent exploring the open runways of the plus-maze and the duration of time 
spent in social interaction in the social interaction test (Gonzalez and File, 
1997). In the absence of any overt change in locomotor activity, these outcomes 
reflect an anxiolytic-like effect (Gonzalez and File, 1997). The intra-DRN 
administration of the benzodiazepine ligand flumazenil in rats previously 
exposed to the elevated plus-maze produced anxiolytic-like effects in both the 
social interaction test and elevated plus-maze (Gonzalez and File, 1997). The 
administration of the GABAA receptor agonist muscimol into the DRN increased 
social interaction and locomotor activity (Higgins et al, 1988). In agreement, 
muscimol was reported to increase punished responding in the Vogel-conflict 
task (Higgins et al, 1988). In mice, the intra-DRN administration of the 
benzodiazepine diazepam increased the latency of time to transition from the 
light to dark sections and the total time spent in the light compartment of the 
light-dark box (Costall et al, 1989). In the Geller-Seifer conflict task, the intra-
DRN administration of chlordiazepoxide is reported to produce anxiolytic-like 
effects when tested to extinction (Thiebot et al, 1980; Thiebot et al, 1982). The 
evidence suggests that an increase, either via activation or positive allotsteric 
modulation, of the GABAergic inhibition in the DRN induces anxiolytic-like 
effects in behavioural tests of anxiety.  
Using similar methods, the role of inhibitory 5-HT1A autoreceptors expressed in 
the DRN has been investigated. In the social interaction test, intra-DRN 
administration of the 5-HT1A agonists 8-OH DPAT, ipsapirone and buspirone 
were reported to be anxiolytic in the social interaction test (Higgins et al, 1988; 
Hogg et al, 1994). When investigated in the light dark box, the administration of 
buspirone into the DRN was reported to evoke anxiolytic-like effects in mice 
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(Costall et al, 1988) but not in rats (Carli et al, 1989). However, these reported 
species-dependent effects may be due to differences in the administered dose. 
When tested in the elevated plus-maze, the intra-DRN administration of 8-OH 
DPAT is reported to be anxiolytic in rats previously exposed to the elevated 
plus-maze but not those naïve to the apparatus (File and Gonzalez, 1996). The 
administration of 8-OH DPAT, ipsapirone, buspirone and gepirone into the DRN 
were all reported to induce anxiolytic-like effects in the Vogel-conflict task 
(Higgins et al, 1988; Higgins et al, 1992; Cervo et al, 2000). In agreement, the 
local administration of 8-OH DPAT into the DRN evoked anxiolytic-like effects in 
both the Geller-conflict and ultrasonic vocalisation tests (Schreiber and De Vry, 
1993; Remy et al, 1996). Therefore, intra-DRN administrations of 5-HT1A 
receptor agonists have been reported to increase anxiolytic-like behaviours in 
rodents. 
Using immunohistochemistry, the expression of immediate early gene c-fos has 
been reported to be increased in the DRN in response to a variant of aversive 
stimuli (Cullinan et al, 1995). In addition, electrophysiological evidence in the cat 
rostral DRN has identified that the activity of the neurons is influenced by a 
range of psychological, metabolic and physical stressors (Chaouloff et al, 1999). 
Therefore the effect of stress on the serotonergic neurons of the DRN may be to 
promote arousal (Jacobs and Fornal, 1991; Jacobs and Azmitia, 1992). In 
agreement the presentation of an aversive stimulus facilitates serotonin 
overflow in the terminal domains of the projections originating from the DRN 
(Rueter and Jacobs, 1996; Adell et al, 1997; Bland et al, 2003). However, 
Rueter and Jacobs (1996) reported an increase in serotonin overflow in the 
prefrontal cortex in response to non-aversive stimuli such as the presentation of 
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food. Therefore, an increase in serotonin overflow may reflect an increase in 
arousal which is an important response in the mediation of anxiety. 
1.4.5. Characterisation of the glycinergic inhibition of the serotonergic 
neurons of the dorsal raphe nucleus 
Historically, the strychnine-sensitive glycine receptor has been associated with 
the mediation of inhibition in the spinal cord, however, the ubiquitous expression 
of the glycine receptor subunits in the forebrain, in particular the  subunit, 
suggests the receptors may play a more complex role in behaviour than had 
previously been assumed (Malosio et al, 1991). In agreement, recent studies 
have implicated a role for the strychnine-sensitive glycine receptor in the 
hippocampus (Keck et al, 2008; Eichler et al, 2009), nucleus accumbens 
(Ericson et al, 2006; Chau et al, 2010), amygdala (McCool et al, 2003; McCool 
and Chappel, 2007) and VTA (Li et al, 2012). A recent immunohistochemical 
study investigating the expression of the strychnine-sensitive glycine receptor in 
the human brain has identified abundant expression in the DRN (Waldvogel et 
al, 2010). In addition, the presence of strychnine-sensitive glycine receptors in 
the rodent DRN was originally suggested by an electrophysiological 
investigation. Thus, the iontophoretic application of glycine to the DRN evoked a 
suppression of firing of the serotonergic neurons in the DRN which was 
reversed by strychnine in anaesthetised rats (Gallager and Aghajanian, 1976). 
In agreement, Malosio et al. (1991) identified the presence of RNA encoding the 
2 and beta subunits in the DRN of the adult rat brain. More recently, inhibitory 
neurotransmission has been characterised in slices of the mouse DRN (Maguire 
et al, 2013; figure 1.6.). In voltage-clamped serotonergic neurons, the majority 
of minature inhibitory post-synaptic currents were abolished by the antagonist  
40 

GABA
Glycine
GlyT1
TauT
GlyT2
Extrasynaptic ‘phasic’
inhibition predominantly
mediated by 
glycine receptors
Synaptic ‘phasic’
inhibition predominantly
mediated by
the GABAA receptors
INHIBITORY 
SYNAPSEGLIA
SEROTONERGIC NEURON
CB
A

Figure 1.6. – The inhibitory ionotropic GABAA and glycine receptors which inhibit the 
neuronal excitation of serotonergic neurons originating in the DRN. Maguire et al. (2013) 
identified that the majority of minature inhibitory post-synaptic currents were bicuculline-
sensitive, suggesting the expression of the ionotropic GABAA receptor (panel A). However, the 
application of bicuculline did not abolish synaptic inhibition. The application of the glycine 
receptor antagonist strychnine abolished the remainder of the synaptic inhibition identifying the 
expression of a small synaptic population of strychnine-sensitive glycine receptors. In addition, 
the application of strychnine induced a large outward shift in the baseline holding current which 
suggested the expression of a population of tonically active extrasynaptic glycine receptors 
(panel B). The application of low physiological concentrations of ethanol (30 mM) potentiated 
both the extrasynaptic (panel B) and synaptic (panel C) glycine-receptor mediated inhibition. 
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bicuculline, indicating the expression of synaptic GABAA receptors (Maguire et 
al, 2013; figure 1.6.). In addition, the application of strychnine elicited an 
outward shift in the baseline holding current suggesting the expression of a 
population of extrasynaptic strychnine-sensitive glycine receptors (Maguire et 
al, 2013; Farrant and Nusser, 2005; figure 1.6.). In agreement, 
immunohistochemical analysis demonstrated that the majority of strychnine-
sensitive glycine receptors did not co-localise with the inhibitory synaptic marker 
neuroligin2 (Maguire et al, 2013). In the presence of phenylephrine, which 
mimicked the excitatory innervations from the locus coeruleus, the application of 
glycine mediated a transient, strychnine-sensitive inhibition of neuronal 
excitation (Maguire et al, 2013). 
1.5. Strychnine-sensitive glycine receptors 
Historically, the strychnine-sensitive glycine receptor was originally purified and 
cloned from the rat spinal cord and was found to share significant homology 
with the nicotinic acetylcholine receptor (Pfeiffer et al, 1982; Grenningloh et al, 
1987). Therefore the strychnine-sensitive glycine receptor was identified as a 
member of the Cys-loop ligand gated ion channel family which includes the -
aminobutyric acid type A receptor (GABAA), the 5-hydroxytryptamine type 3 (5-
HT3) receptor, the nicotinic acetylcholine receptor (nACh) and the zinc-activated 
channel.  
Investigation of the homologous nicotinic acetylcholine receptor suggests the 
strychnine-sensitive glycine receptor consists of a pseudosymmetric pentameric 
arrangement of subunits around a central anion (Cl-)-conducting pore (Unwin, 
2003; Miyazawa et al, 2003). Each subunit consists of a large extracellular N-
terminal ligand binding domain, four transmembrane domains (TM1-TM4) a 
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short intracellular segment connecting TM1 and TM2, a short extracellular loop 
connecting TM2 and TM3, a large intracellular loop connecting TM3 and TM4 
and a short extracellular C-terminal domain (figure 1.7.).  
The structure of the ligand binding domain has been inferred from the ACh-
binding protein, a homologous protein derived from the freshwater snail Lymnea 
stagnalis (Brejc et al, 2001; Celie et al, 2004). The binding site is situated at the 
interface of the subunits and is comprised of three -sheets from one subunit 
and the three -sheets of the adjacent subunit. The activation of the receptor by 
glycine induces a conformational change, facilitating the movement of Cl- ions 
through the channel pore resulting in the hyperpolarisation of the membrane. 
The antagonist strychnine, however, binds to a distinct but overlapping binding 
site (O’Connor et al, 1996). 
1.5.1. The subunit composition of the strychnine-sensitive glycine 
receptors 
The subunit composition of the strychnine-sensitive glycine receptor exhibits 
significant diversity (Hernandes and Troncone, 2009). Functional receptors can 
be comprised solely of the  subunit (homomeric receptors) or may be 
comprised of both  and  subunits (heteromeric receptors; Lynch, 2009). The 
recombinant expression of the  subunit in the Xenopus laevis oocyte does not 
form functional receptors, suggesting the co-expression of the  subunit is 
necessary to form the functional receptor (Grenningloh et al, 1990a). The 
subunit arrangement of the heteromeric receptor remains contentious. Early 
investigations have suggested a 3:2 arrangement (Langosch et al, 1988), 
however, a subsequent study by Grudzinska et al. (2005) suggested a 2:3 
arrangement of the subunits. 
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Figure 1.7. – The proposed structure of the strychnine-sensitive glycine receptor and 
associated subunits. The structure of the strychnine sensitive glycine receptor, minus a single 
subunit to show the ion conducting channel, is shown in panel A. The receptor is comprised of 
five subunits arranged in a circular fashion to form the central chloride conducting channel. The 
extracellular domain contains the glycine binding site which is situated at the junction between 
adjacent subunits. Each subunit consists of four transmembrane domains and includes an 
extracellular N-terminal domain and a large intracellular loop (panel B). The latter of which 
interacts with intracellular signalling molecules to modulate receptor function. Figures derived 
from the models of Unwin (2003) and Miyazawa et al (2003).  
To date, four distinct  subunits (1-4) and one  subunit have been identified, 
which underpin the functional diversity of the receptor populations (Hernandes 
and Troncone, 2009). The incorporation of the  subunit in the heteromeric 
receptor reduces the conductance of the glycine receptor (Lynch, 2009). In 
addition, the incorporation of the  subunit has been proposed to mediate the 
location of the receptor. The  subunit co-localises with the scaffolding protein 
gephyrin, which serves to anchor the receptor to the post-synaptic density 
(Pfeiffer et al, 1982; Schmitt et al, 1987). However, single-quantum tracking 
suggests that the 1 receptor can migrate between synaptic, perisynaptic and 
extrasynaptic sites (Dahan et al, 2003; Muller et al, 2008). 
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The potential functional diversity of the receptors is further increased by reports 
of post-transcriptional modifications. For example, splice variants are reported 
for the 1 subunit (1ins variant) the 2 subunit (2A and 2B variants; Miller et 
al, 2004) and 3 subunit (3L and 3K; Nikolic et al, 1998). Similarly, Legendre 
et al. (2009) reported RNA editing of the glycine receptor results in high affinity 
glycine receptors due to a proline to leucine point mutation (2 P192L and 3 
P185L). RNA editing of GlyRs may have specific 
physiological/pathophysiological significance since a recent report indicates 
high affinity glycine receptors in the hippocampus may contribute to the 
pathology of temporal lobe epilepsy (Eichler et al, 2009). 
1.5.2. The physiological role of the strychnine-sensitive glycine receptor 
In common with the homologous GABAA receptor, the glycine receptor 
mediates inhibitory neurotransmission in the developed CNS and is highly 
expressed in the spinal cord, retina, brain stem and caudal brain regions 
(Frostholm and Rotter, 1985). However, the behavioural role of the strychnine-
sensitive glycine receptor has received limited investigation relative to other 
members of the cys-loop ligand gated ion channel superfamily. However, 
mutations of the strychnine-sensitive glycine receptor have been identified in 
the pathology of human startle syndrome (Legendre, 2001). 
The cloning of the receptor subunits has demonstrated the high degree of 
homology between the  subunits (> 90%; Grenningloh et al, 1990b) and to a 
lesser extent the  subunit (47%; Greninngloh et al, 1990a). Therefore, the 
composition and physiological role of native receptors has proved difficult due to 
the lack of pharmacological agents with the specificity to discriminate between 
the subunits (Lynch, 2009).  
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The strychnine-sensitive glycine receptor plays an important role in the 
mediation of neurodevelopment (Aguayo et al, 2004). During the embryonic and 
juvenile development, the intracellular concentration of Cl- is high (see below) 
and therefore the activation of the strychnine-sensitive glycine receptors and 
GABAA receptors mediate an efflux of Cl- mediating neuronal depolarization and 
excitation (Ito and Cherubini, 1991; Hernandes and Troncone, 2009). In 
addition, the depolarisation induced by the activation of these receptors 
mediates an influx of Ca2+ via voltage-gated Ca2+ channels which is thought to 
regulate downstream gene expression (Hernandes and Troncone, 2009). The 
2 subunit is predominantly expressed and is thought to be an important 
mediator of synaptogenesis (Hernandes and Troncone, 2009). However, during 
post-natal development the relative expression of the 1 and  subunits 
increases with a concurrent decrease in the expression of the 2 subunit 
expression (Malosio et al, 1991). This subunit transition coincides with the 
increased expression of the K+-Cl- co-transporter (KCC2) and a decrease of the 
Na+-K+-2Cl- co-transporter (NKCC1) which collectively regulate the intracellular 
chloride concentration (Blaesse et al, 2009). This developmental switch is 
thought to thought to be completed by postnatal day 14 (Malosio et al, 1991).   
1.5.3. The role of transporters in the mediation of the strychnine-sensitive 
glycine receptor 
The uptake of neurotransmitters in the CNS is mediated by a super-family of 
transporters which include the Na+ and Cl- transporters, the Na+ and K+ 
dependent transporters, the vesicular transporters and other amino acid 
transporters (Richerson and Wu, 2003; Jursky et al, 1994). The Na+ and Cl- 
dependent transporters encompass the the amino acid transporters, the GABA 
transporters, the monoamine transporters and the orphan transporters (Jursky 
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et al, 1994). The transporter is comprised of twelve transmembrane helices with 
six extracellular and five intracellular loops, with short intracellular N- and C-
terminals and a large extracellular loop located between helices VII and VIII 
(Jursky et al, 1994). The concentration of glycine in the extracellular fluid is 
mediated by the GLYT1 and GLYT2 Na+/Cl- -dependent transporters which are 
members of the amino acid transporter subdivision (Guastella et al, 1992; Liu et 
al, 1993). The GlyT1 and GlyT2 transporters share 50% homology. Five GlyT1 
isoforms (a-f) have been identified as well as the GlyT2a and GlyT2b variants 
(Hernandes and Troncone, 2009).  
However there are notable differences between the GlyT1 and GlyT2 
transporters. For example, the GlyT1 and GlyT2 transporters differ in their 
stoichiometry. The GlyT1 transporter requires two Na+ and one Cl- to co-
transport one glycine molecule. However, the GlyT2 transporter requires three 
Na+ and one Cl- to co-transport one glycine molecule (Roux and Supplisson, 
2000). In addition, the two transporter subtypes demonstrate distinct neuronal 
localisations. GLYT1 is expressed by glial cells, whereas GLYT2 is expressed 
exclusively by neurons (Jursky et al, 1994). However, these high-affinity 
transporters may serve a dual role in the mediation of the concentration of 
glycine in the extracellular space. In addition to uptake, these transporters may 
be reversed to and therefore mediate a paracrine release of glycine (Richerson 
and Wu, 2003). The reversal of the Na+/Cl- dependent transporters GlyT1 and 
GlyT2 may mediate this paracrine release in response to a depletion of the Na+ 
gradient (Legendre, 2001). The localisation of GlyT1 on glial cells, in contrast to 
the neuronal GlyT2, implies that GlyT1 may predominate in this release process 
(Legendre, 2001). 
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The GlyT1 and GlyT2 proteins show distinct regionally-selective expression in 
the CNS. The GlyT1 transporter is expressed ubiquitously throughout the CNS 
(Adams et al., 1995; Jursky et al., 1994). Although predominantly expressed on 
astrocytes, the GlyT1 transporter is expressed on glutamatergic neurons and 
regions of the brain abundant in NMDA receptor expression such as the 
neocortex and hippocampus (Cubelos et al., 2005). Conversely, the GlyT2 
transporter is localised to regions which are abundant in glycinergic innervation 
and express the strychnine-sensitive glycine receptor such as the spinal cord 
and brain stem (Jursky et al, 1994; Rampon et al., 1996).  
In addition, the transporter for taurine (section 1.5.4.) is member of the GABA 
transporter family. Similar to the GlyT transporter, the TauT transporter exists 
as both the TauT1 and TauT2 isoforms which are largely homologous (> 60%). 
The TauT1 transporter is predominantly expressed in retinal neurons and the 
cerebellum, whereas the mRNA encoding the TauT2 isoform has been 
identified in the brain stem, striatum, cerebellum and corpus callosum 
(Vinnakota et al., 1997). 
1.5.4. Agonists of the strychnine-sensitive glycine receptor 
The amino acid glycine was originally proposed as a neurotransmitter based on 
its association with interneurons in the spinal cord (Davidoff et al, 1967). The 
electrical stimulation of slices of the rat spinal cord evoked the release of 14C-
glycine (Hopkin and Neal, 1970). Subsequent experiments showed that the 
electrophoretic administration of glycine evoked a strychnine-sensitive inhibitory 
current in motorneurons (Curtis et al, 1967). When recombinantly expressed in 
the Xenopus oocyte, the homomeric 1 strychnine-sensitive glycine receptor 
was shown to be activated by glycine (Schmieden et al, 1992). In addition to 
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glycine, -alanine and taurine have been identified as endogenous agonists of 
the glycine receptor. Of these endogenous agonists, glycine is the most potent 
and taurine the least efficacious (reviewed by Lynch, 2009). Site directed 
mutagenesis studies have indentified the amino acids in the N-terminal domain 
(R65 and E157 of the alpha1 subunit and R86 and E180 of the beta subunit) 
which form the glycine binding pocket at the interface between subunits of the 
strychnine-sensitive glycine receptor (Grudzinska et al, 2005). 
Similarly, the amino acids 111 and 212 (Schmieden et al, 1992) and 58 and 59 
(Miller et al, 2004) were identified as critical determinants of the binding of -
alanine and taurine respectively. 
1.5.5. Antagonists of the strychnine-sensitive glycine receptor 
Strychnine is a natural alkaloid extract from the seeds of the Strychnos Nux-
vonica and is commonly used as a pesticide for small vertebrates (Makarovsky 
et al, 2008). Intoxication causes convulsions and muscle spasms which result in 
respiratory failure. The toxic effects of strychnine are attributed to the high 
affinity of strychnine for the glycine receptors expressed in the spinal cord 
(Young and Snyder, 1973). The presence of strychnine binding to the inhibitory 
glycine receptor abolishes the activation of the receptors in response to 
application of the endogenous agonist glycine (Houamed et al, 1984).  
The binding site of strychnine is distinct but overlaps with the glycine binding 
site to mediate the antagonistic effect. Site-directed mutagenesis studies have 
implicated amino acids 157 and 131 as critical determinants of strychnine 
binding (O’Connor et al, 1996). In addition, investigations of the heteromeric  
glycine receptor implicated the 180 residue in the binding of strychnine 
(Grudzinska et al, 2005). Although strychnine demonstrates a high affinity for all 
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strychnine-sensitive glycine receptors, it exhibits a higher affinity for the 
heteromeric receptor as opposed to the homomeric receptor (Pribilla et al, 
1992). Due to this specificity, strychnine remains an important tool in the study 
of strychnine-sensitive glycine receptors. However, it should be noted that at 
higher concentrations strychnine has also been reported to antagonise GABAA 
receptor function (Bowery and Smart, 2006). 
Picrotoxin, in addition to act as non-competitive antagonist of the GABAA 
receptor, blocks strychnine-sensitive glycine receptors although it exhibits a 
differential effect at homomeric vs. heteromeric receptors (Pribilla et al, 1992; 
Laube et al, 2002). This may be due to the relative affinities for the receptor of 
the two molecules which comprise picrotoxin – namely picrotin and picrotoxinin 
(Yang et al, 2007). Unlike strychnine, picrotoxin is a non-competitive antagonist 
which is thought to block the central ion conducting channel of the receptor 
through interactions with the pore lining residues. 
Additional antagonists of the strychnine-sensitive glycine receptors include 
cyanotriphenylborate (Rundstrom et al, 1994), a non-competitive open-channel 
blocker, and the GABAA receptor antagonists bicuculline and gabazine which 
competitively antagonise the receptor at higher concentrations than those that 
inhibit the GABAA receptor (Wang and Slaughter, 2005; Beato et al, 2007).  
1.5.6. Allosteric modulators of the strychnine-sensitive glycine receptor 
Although few compounds specifically act upon the strychnine-sensitive glycine 
receptor, however, a diverse range of molecules have been reported to 
modulate glycine receptor function albeit not exclusively. These include different 
cations such as zinc, cannabinoids, neuroactive steroids, tropeines, alcohols, 
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avermectins, butyrolactones and general anaesthetics (Yevenes and Zeilhofer, 
2011). 
Endocannabinoids and related molecules have been reported to modulate the 
strychnine-sensitive glycine receptors. In hippocampal neurons, the 
endogenous cannabinoids anandamide (AEA) and 2-arachidonyl-glycerol (2-
AG) reduced the amplitude of glycinergic mIPSCs in addition to the rise time, 
desensitisation and deactivation kinetics in a concentration-dependent manner 
(Lozovaya et al, 2005). These effects were insensitive to CB1 antagonists and 
remained despite the administration of the G protein inhibitor GDP--S 
(Lozovaya et al, 2005). In addition, potentiation of the recombinant expression 
of the 1 homomeric glycine receptor was reported in Xenopus laevis oocytes in 
response to AEA in a manner independent of the CB1 receptor (Hejazi et al, 
2006). Xiong et al. (2011) have implicated a serine residue in the TM3 region 
(S296 in 1 and S307 in 3) in the potentiating effects of 9-
tetrahydrocannabinol (the active ingredient of the Cannabis sativa plant) on the 
1 and 3 glycine receptors.  
Volatile anaesthetics such as isoflurane, enflurane, halothane and sevoflurane 
potentiate the inhibitory currents of recombinantly expressed homomeric 1 
glycine receptors in response to the administration of glycine (Downie et al, 
1996; Belelli et al, 1999; Krasowski and Harrison, 1999; Mascia et al, 1996). In 
addition, homomeric 2 glycine receptors are sensitive to isoflurane (Harrison et 
al, 1993). Due to the expression of glycine receptors in the spinal cord, the 
effects modulation of the glycine receptors has been proposed to mediate the 
immobility associated with anaesthesia by such agents (Rudolph and 
Antkowiak, 2004). The volatile anaesthetics have been proposed to act at a 
binding pocket comprised of the TM2 and TM3 domains in the 1 homomeric 
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receptor (Mihic et al, 1997). Amongst the intravenous general anaesthetics, 
propofol potentiates the activity of the strychnine-sensitive glycine receptor 
albeit at concentrations significantly higher than those acting upon GABAARs 
(Hales and Lambert, 1991; Pistis et al, 1997a).  
The avermectins are commonly used as anti-parasitic and insecticide agents 
and are derived from the Streptomyces avermitilis bacterium (Yevenes and 
Zeilhofer, 2011). Ivermectin, a member of the avermectins, has been shown to 
activate recombinant 1 homomeric and 1 heteromeric glycine receptors 
(Shan et al, 2001) with the A288 residue residing in the TM3 domain of the 1 
homomeric receptor being specifically implicated in such actions (Lynagh and 
Lynch, 2010).  
The endogenous neurosteroids are cholesterol based metabolites synthesised 
in the CNS. The 3 reduced neurosteroids include 5-pregnan-3-ol-20-one 
and 5-pregnan-3-ol-20-one and have been shown to facilitate inhibition 
mediated by the GABAA receptor. However, these neurosteroids have negligible 
effects on the strychnine-sensitive glycine receptor (Lambert et al, 2001; Pistis 
et al, 1997a; Weir et al, 2004). In contrast, a number of synthetically derived 
neurosteroids such as minaxolone, Org20599 and alphaxalone have been 
shown to potentiate the strychnine-sensitive glycine receptor (Ahrens et al, 
2008; Weir et al, 2004). However, this potentiation occurred at concentrations 
higher than those reported at the GABAA receptor (Weir et al, 2004). 
The tropeines are potent 5-HT3 antagonists and are most commonly used in 
conjucture with chemotherapy as an antiemetic (Yevenes and Zeilhofer, 2011). 
In cultured spinal neurons, the tropeines MDL-72222 and tropisetron potentiate 
glycine receptor-mediated currents at low nanomolar concentrations (Chesnoy-
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Marchais, 1996). However, at higher micromolar concentrations caused an 
inhibition. In addition, tropisetron potentiates 1 but inhibits 2 homomeric 
receptors and therefore demonstrating subunit-specificity in recombinant 
expression systems (Supplisson and Chesnoy-Marchais, 2000). In addition, the 
incorporation of the  subunit switched inhibition to potentiation in 2 containing 
receptors. Site-directed mutagenesis studies showed that mutation of the 1 
(N102) but not the  subunit (N125) abolished tropisetron mediated inhibition 
without altering potentiation. Therefore, the potentiating and inhibitory effects of 
tropisetron may be mediated by distinct sites on the strychnine-sensitive glycine 
receptor. 
The best characterised allosteric modulator of the strychnine-sensitive glycine 
receptor is the cation zinc. Zinc modulates the strychnine-sensitive glycine 
receptor in a bi-phasic manner. At low doses (< 10 M) potentiation 
predominates and is mediated by increasing the receptor affinity for glycine. In 
contrast, at higher doses zinc exerts an inhibition of the strychnine-sensitive 
glycine receptor (Bloomenthal et al, 1994; Laube et al, 2000). These bi-
directional effects are mediated at two distinct binding sites. The residues 
forming the binding site for the positive allosteric modulation have been 
identified as D80, E192 and E194 (Laube et al, 2000; Lynch et al, 1998). In 
contrast, H107, H109, T112 and T133 in the 1 glycine receptor have been 
implicated as residues critical to the binding site responsible for the inhibitory 
effect (Harvey et al, 1999; Laube et al, 2000; Miller et al, 2005). In addition, the 
1 homomeric glycine receptor shows increased sensitivity to the inhibitory 
effects of zinc than the 2 and 3 homomeric glycine receptors. The 
homozygous D80 transgenic mouse, a mutation shown to reduce the 
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potentiating effects of zinc in recombinant systems, demonstrated a progressive 
hyperekplexia-like phenotype (Yevenes and Zeilhofer, 2011). 
In addition, previous studies have identified interactions between ethanol and 
the function of the strychnine-sensitive glycine receptor. As this will form a 
significant basis for the present study, the physiological effects of ethanol and 
interactions with specific neurotransmitter systems and direct cellular targets will 
be discussed in depth (section 1.6.1. and 1.6.2. respectively).  
1.6. Ethanol 
Ethanol, the active substance of alcoholic beverages, is the most commonly 
used drug in the world due to its legal status, cultural significance and 
availability. Using a multicriteria decision analysis, Nutt et al. (2010) suggested 
that alcohol is the most harmful drug used in the UK based on factors 
influencing the cost to the individual and society in general. At low doses, the 
consumption of ethanol can induce the loss of fine motor control. However, at 
intermediate to high doses ethanol can elicit sedation, anxiolysis and 
anticonvulsant actions and anaesthesia (Little, 1991). The excessive 
consumption of ethanol can suppress respiratory function which, if untreated, 
can be fatal (Eckardt et al, 1998). Due to the dose-dependent nature of 
ethanol’s effects on the CNS, several definitions have been proposed as to 
what constitutes “moderate” ethanol consumption (Eckardt et al, 1998). 
However, the investigation of the effects of ethanol in humans is difficult due to 
the array of factors associated with the peripheral organs which determine the 
concentration of ethanol present in the CNS – the rate of absorption from the 
gastrointestinal tract, the volume of distribution of the body and the rate of 
metabolism. 
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In the fasted state, ethanol transitions through the empty stomach rapidly and is 
predominantly absorbed through the duodenum and jejunum. However, solid 
foods and hypertonic solutions slow gastric emptying and therefore ethanol is 
predominantly absorbed through the stomach which occurs at a slower rate 
than in the duodenum and jejunum (Cortot et al, 1986). Therefore, the site at 
which ethanol is primarily absorbed influences the concentration of ethanol 
entering the systemic circulation. In addition, the rate of ethanol absorption 
influences the rate of first pass metabolism. A reduced rate of ethanol 
absorption is associated with greater first pass metabolism (Eckardt et al, 
1998). The slowing of gastric emptying reduces the concentration of ethanol in 
the portal circulation, therefore, reducing the concentration exposed to the liver. 
In turn, this reduces the concentration of ethanol which enters the systemic 
circulation. 
In addition, the distribution of ethanol within the body varies with the 
vascularisation of the tissue due to the fact that ethanol distributes itself in total 
body water. At equilibrium, the distribution of ethanol between the intracellular 
and extracellular compartments is approximately equal. However, the 
establishment of this equilibrium is quicker in well vascularised tissues such as 
the brain, liver, lung and kidneys (Eckardt et al, 1998). 
Ethanol metabolism in the liver is predominantly mediated by alcohol 
dehydrogenase (ADH) enzymes, which converts ethanol to the metabolite 
acetaldehyde and is the rate-limiting step in ethanol metabolism. The ADH 
peptide is dimeric and contains two atoms of zinc per subunit. In humans, seven 
ADH genes and enzymes (ADH1-ADH7) have been identified and are 
catagorised in five groups based on their kinetics, electrophoretic mobility and 
sensitivity to pyrazole derivatives. Acetaldehyde is, in turn, metabolised by 
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aldehyde dehydrogenase (ALDH) enzymes to form acetate. Similarly, there are 
numerous isoforms of the tetrameric ALDH in the human liver. However, only 
the class I (ALDH1) and class II (ALDH2) isozymes are thought to mediate the 
oxidation of acetaldehyde. Therefore, genetic variation in the enzyme isoforms 
and their relative expression in the liver account for a component of the inter-
individual variation of ethanol’s pharmacological effects mediated in the CNS 
(Eckardt et al, 1998). In agreement, a study in monozygotic and dizygotic twins 
estimated that 62% of inter-individual variation in peak blood alcohol content 
and 49% of variability in the elimination rate of ethanol was due to genetic 
factors (Kopun and Propping, 1977). In addition, ethanol elimination rates are 
influenced by a number of factors including the individual’s history of alcohol 
consumption, smoking, diet, age, sex, weight and the time of day the alcohol is 
consumed. 
1.6.1. The pharmacology of ethanol 
Ethanol was originally proposed to alter the chemico-physical properties of 
neuronal membranes by a non-specific mechanism (McCreery and Hunt, 1978). 
As an amphipathic molecule, ethanol was hypothesised to perturb the physical 
properties of the lipid neuronal membrane and therefore alters the function of 
membrane bound proteins. However, this hypothesis was dismissed by 
evidence suggesting that the effect of ethanol on the fluidity of the membrane 
were negligible at physiological relevant concentrations (Eckardt et al, 1998). In 
the last 20 years or so significant progress has been made in identifying specific 
interactions between ethanol and endogenous neurotransmitter systems. In 
particular, investigations have focussed on the dopaminergic, GABAergic, 
glutamatergic and serotonergic and opioid systems in addition to the 
intracellular signalling pathways of the CNS. In more recent years, the inhibitory 
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glycinergic system has also gained significant weight in the mechanism of 
ethanol action as discussed in detail section (section 1.6.2.5.). As mentioned 
previously, the behavioural effects of ethanol are highly temporal and dose-
dependent and therefore the effects are mediated by the summation of these 
component interactions. Therefore, the effects of ethanol on the 
neurotransmitter systems associated with dependence will be discussed initially 
followed by a subsequent review of the evidence supporting direct interactions 
with cellular proteins. 
The mesolimbic dopamine system has been extensively investigated in the role 
of mediating the reinforcing effects of many substances including ethanol 
(Koob, 1992). In vivo recordings have demonstrated that the administration of 
low doses of ethanol induce an increase in the firing rate of mesolimbic 
dopaminergic neurons (Mereu et al, 1984; Gessa et al, 1985). In agreement, 
dopamine overflow in the nucleus accumbens is increased by the systemic 
administration of ethanol in rats (Imperato and Di Chiara, 1986). In addition, an 
ethanol induced increase in dopamine overflow in the caudate nucleus has 
been reported. However, this effect was induced by doses of ethanol higher 
then those reported to increase dopamine overflow in the nucleus accumbens 
(Imperato and Di Chiara, 1986). 
Previous studies have identified that the endogenous opioid system plays an 
important role in the reinforcing effects of ethanol (Froehlich and Li, 1994). In 
particular the opioid receptors mediate, in part, the ethanol induced stimulation 
of dopamine release. Using microdialysis, the systemic administration of 
naltrexone (at doses which blocks  and  opioid receptors) reversed the 
stimulation of dopamine overflow in the rat nucleus accumbens induced by 
locally applied ethanol (Benjamin et al, 1993). In addition, Acquas et al. (1993) 
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demonstrated that the local administration of the  receptor antagonist 
naltrindole suppressed the release of dopamine evoked by the systemic 
administration of ethanol. Recently, the Scottish Medicines Consortium has 
approved the use of the  opioid receptor antagonist nalmefene, a homologue 
of naltrexone, in the treatment of alcohol dependence 
(http://www.bbc.co.uk/news/uk-scotland-24431152; accessed 15/10/13). 
In addition, there is significant evidence supporting an interaction between the 
pharmacological effects of ethanol and the serotonergic system, however, this 
will be addressed in depth in section 1.6.3. 
1.6.2. The interactions between ethanol and cellular targets 
1.6.2.1. The GABAA Receptor  
The specific interaction of ethanol and the GABAA receptor was historically 
based upon the common behavioural outcomes of ethanol and GABAA receptor 
allosteric modulators, such as the benzodiazepines, which include anxiolysis, 
sedation, anticonvulsive and anaesthesia (Weiner and Valenzuela, 2006). In 
agreement, electrophysiological evidence from cultured hippocampal and 
cortical neurones suggest that ethanol is a positive allosteric modulator of the 
GABAA receptor at concentrations as low as 1 mM (Aguayo et al, 1990; 
Reynolds and Prasad, 1991). In addition, in vivo studies have shown that the 
systemic administration of ethanol potentiates the inhibitory effect of GABA on 
neuronal activity in the inferior collicular cortex (Simson et al, 1991a). However, 
the potentiating effects of ethanol are not ubiquitous throughout the CNS 
(Osmanovic and Shefner, 1990). Therefore, the potentiating effects of ethanol 
were thought to be mediated by subunit specific interactions which would 
account for the regionally specific effects reported. In agreement, Wafford et al. 
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(1991; 1992) identified that the long form of the 2 subunit (2L) was necessary 
for the potentiation of the GABAA receptor by ethanol. The 2L subunit contains 
an additional 8 amino acid sequence which mediated a protein kinase C 
phosphorylation site. In agreement, mutant mice lacking the brain-specific  
isoform of PKC show a reduced sensitivity to ethanol in vivo (Harris et al, 1995). 
More recent studies have focussed on the δ subunit-containing GABAA receptor 
which is expressed at extrasynaptic sites (Farrant and Nusser, 2005) and has 
been reported to be potentiated by low physiologically relevant concentrations 
of ethanol although this proposal remains highly controversial (Korpi et al, 
2007). 
1.6.2.2. The NMDA receptor 
Electrophysiological evidence suggests ethanol exerts an inhibitory effect on the 
excitatory NMDA receptor. Lovinger et al. (1989) demonstrated that the 
excitatory current evoked by the application of NMDA in voltage-clamped 
hippocampal cells was inhibited by ethanol in a concentration dependent 
manner. In agreement, the application of ethanol to cerebellar granule neurons 
reduced NMDA-mediated 45Ca2+ uptake and cGMP production (Hoffman et al, 
1989). The i.p. administration of ethanol inhibits the NMDA mediated neuronal 
activity in the rat medial septum (Simson et al, 1991b). Similar to the GABAA 
receptor, the effects of ethanol on the NMDA receptor are regionally-selective. 
However, subunit specificity for the NMDA receptor is not well defined. 
Generally, studies have reported that the GluN1/N2A and GluN1/N2B are 
slightly more sensitive to ethanol than GluN1 combined with GluN2C or GluN2D 
(Kuner et al, 1993; Möykkynen and Korpi, 2012). Similarly, the AMPA and 
kainate receptors have been reported to be inhibited by ethanol (Lovinger, 
1993; Wirkner et al, 2000; Läck et al, 2008). However, the mechanism of 
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ethanol mediated inhibition of the glutamate receptors remains to be determined 
(Möykkynen and Korpi, 2012). 
1.6.2.3. The nicotinic acetylcholine receptor 
An investigation of ethanol actions upon the nicotinic acetylcholine receptor was 
first proposed on the basis of the observed interaction between consumption of 
ethanol and cigarette smoking. In a study of moderate social drinkers (defined 
as 4-10 drinks/week), Mitchell et al. (1995) reported an association between 
increased cigarette smoking in the ascending limb of the blood alcohol curve. In 
mice, ethanol induced stimulation of dopamine overflow in the nucleus 
accumbens and locomotor activity were reduced by the administration of the 
nACh receptor antagonist mecamylamine (Blomqvist et al, 1996). In addition, 
mecamylamine has been shown to reduce voluntary ethanol intake in alcohol-
preferring rats (Blomqvist et al, 1996). 
1.6.2.4. The 5-HT3 receptor 
Low to moderate concentrations of ethanol have negligible effects on either the 
5-HT1A or 5-HT2 receptors (Eckardt et al, 1998). However, ethanol has been 
reported to interact with the ionotropic 5-HT3 receptor which is predominantly 
expressed in mesolimbic regions of the brain (Kilpatrick et al, 1987). 
Electrophysiological experiments have reported that ethanol potentiates the 
serotonin-induced activation of 5-HT3 receptors expressed in neuroblastoma 
cells and human embryonic kidney cells (Lovinger, 1991a; Lovinger and Zhou, 
1994). In addition, this effect was blocked by the addition of the 5-HT3 receptor 
antagonist tropisetron (ICS 205-930; Lovinger, 1991b). The subcutaneous 
administration of the 5-HT3 antagonist tropisetron reduced the increase in 
dopamine overflow in the nucleus accumbens induced by the i.p. administration 
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of ethanol (Carboni et al, 1989). In agreement, the antagonists of the 5-HT3 
receptor have been reported to reduce voluntary ethanol intake in alcohol-
preferring rats (Fadda et al, 1991; Kostowski et al, 1993). Therefore, these 
studies suggest an interaction between the dopaminergic and serotonergic 
systems contributes to the behavioural effects of ethanol.   
1.6.2.5. The strychnine-sensitive glycine receptor 
A number of recent studies have reported that the inhibitory glycinergic system 
plays a role in mediating the effects of ethanol. In Long-Evans rats, the 
administration of glycine into the VTA was found to reduce ethanol consumption 
in a strychnine-dependent manner (Li et al, 2012). In the nucleus accumbens 
(nAc), the administration of strychnine abolishes the ethanol induced increase in 
dopamine overflow (Molander and Soderpalm, 2005).  In agreement, the intra-
nAc administration of glycine (100 M by reverse dialysis) increased dopamine 
overflow in a subpopulation of ethanol preferring Wistar rats which reduced 
ethanol preference and intake (Molander et al, 2005). The acamprosate-
induced reduction of ethanol intake was found to be reversed by intra-nAc 
administration of strychnine (Chau et al, 2010). Collectively, this suggests that 
the strychnine-sensitive glycine receptors play a role in the interaction between 
ethanol and the dopaminergic system.  
In agreement with the studies described above, evidence from 
electrophysiological experiments consistently implicates ethanol as a positive 
allosteric modulator of the strychnine-sensitive glycine receptor at physiological 
concentrations thought to reflect mild intoxication. This potentiation originates 
from a decrease in the EC50 without a change in maximal currents (Aguayo et 
al, 1996; Mihic, 1999). Potentiation of the strychnine-sensitive glycine receptor 
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has been reported in the spinal cord, hippocampus, hypoglossal nucleus and 
ventral tegmental area (Aguayo et al, 1996; Eggers and Berger, 2004; Jiang 
and Ye, 2003). At concentrations below 100 mM, the homomeric 1 receptor is 
more sensitive to ethanol than the 2 receptor (Mascia et al, 1996; Perkins et al, 
2008; Yevenes et al, 2010). Site-directed mutagenesis studies have reported 
that S267 of the TM2 region and A288 of the TM3 region, thought to form a 
water filled cavity, abolish the potentiating effects of ethanol in the 1 
homomeric receptor (Mihic et al, 1997; Mascia et al, 2000; Ye et al, 1998). In 
addition, the ethanol modulation of the strychnine-sensitive glycine receptor 
may be mediated by an indirect action via a intracellular signalling pathways. 
For example, ethanol mediated potentiation of the native and recombinant 
strychnine-sensitive glycine receptors is attenuated by PKC inhibitors (Jiang 
and Ye, 2003; Mascia et al, 1998). The generation of the G-insensitive 1 
receptor attenuated the modulatory effects of ethanol; however, there was no 
effect on the potentiation induced by general anaesthetics (Yevenes et al, 
2008). Therefore both direct and indirect interactions with the glycine receptor 
are likely to mediate the positive allosteric modulation of ethanol.      
In addition, Maguire et al. (2013; figure 1.6.) have recently demonstrated that 
ethanol directly modifies the strychnine-sensitive glycine receptors of the DRN 
to facilitate the inhibition of the serotonergic neurons.  The application of a 
physiologically relevant concentration of ethanol (30 mM) induced a strychnine-
sensitive inward current (Maguire et al, 2013; figure 1.6.). Similarly, the pre-
application of glycine and subsequently ethanol induced a strychnine-sensitive 
inward current suggesting that ethanol potentiated the glycine receptor-
mediated inhibition of the serotonergic neurons (Maguire et al, 2013). To ensure 
the effects of ethanol were not due to osmotic pressures, the administration of a 
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mannitol-based hyper-osmotic solution had no effect on the baseline holding 
current (Maguire et al, 2013). In addition, ethanol had no effect on the frequency 
or amplitude of the glycine receptor-mediated mIPSC but prolonged the decay 
time (Maguire et al, 2013). Therefore the effects of ethanol are mediated by 
both the synaptic and extrasynaptic glycine receptors. 
1.6.3. The effects of ethanol on the serotonergic system 
Clinical evidence suggests that a proportion of alcohol-dependent individuals 
have lowered central serotonin (LeMarquand et al, 1994a). Therefore, Tabakoff 
and Hoffman (1991) suggested that ethanol facilitates serotonergic transmission 
and that alcoholics consume alcohol to self-medicate hypoactivity of 
serotonergic transmission. In agreement, the intra-ventricular administration of 
5,6-DHT in Sprague-Dawley rats increased ethanol consumption (Melchior and 
Myers, 1976). In addition, the majority of studies investigating tissue levels of 
serotonin and the metabolite 5-HIAA in animals suggest that the acute 
administration of ethanol decreases serotonin in the brain and increases 5-HIAA 
suggesting an increase in the turnover of serotonin (LeMarquand et al, 1994b). 
Langen et al. (2002) reported that the systemic administration of 1 g/kg of 
ethanol evoked a significant increase in serotonin overflow in the medial 
prefrontal cortex of Wistar-Harlan rats. Serotonergic neurons in the medial 
prefrontal cortex originate from the DRN (Azmitia and Segal, 1978) and 
therefore the results would support the hypothesis that ethanol facilitates 
serotonergic transmission. 
However, an increase in the turnover of serotonin in the brain is not necessarily 
due to an increase in the excitation of serotonergic neurons. For example, this 
may be mediated by an ethanol induced inhibition of the clearance of 5-HIAA 
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(Nutt and Glue, 1986). Although, such an effect would likely induce a global 
increase in brain 5-HIAA which is not the case as previous studies suggest the 
effects of ethanol on 5-HIAA are regionally selective (LeMarquand et al, 1994b). 
In addition, an alternative explanation for the increase in serotonin overflow 
reported by Langen et al. (2002) is that the serotonin transporter is inhibited by 
the administration of ethanol (Daws et al, 2006). However, the concentrations of 
ethanol used by Daws et al. (2006) to inhibit ethanol uptake were higher than 
those used by Langen et al. (2002). In addition, in vivo electrophysiological 
studies have shown that the systemic administration of ethanol in anaesthetised 
Sprague-Dawley rats induces a dose-dependent suppression of serotonergic 
neuronal excitation in the DRN (Chu et al, 1984; Pistis et al, 1997b). In 
agreement, the study of acute ethanol intake in healthy individuals suggests 
that ethanol lowers blood tryptophan, tryptophan in the cerebrospinal fluid, 
blood serotonin and increases platelet serotonin uptake (LeMarquand et al, 
1994a). Collectively these peripheral measures would suggest a decrease in 
central serotonin levels. 
Collectively, the majority of studies have reported that ethanol facilitates 
serotonergic transmission. The role of serotonin in the mediation of anxiety has 
been discussed previously and, in general, the evidence suggests that 
serotonin facilitates anxiety. Therefore, there is an apparent contradiction. If 
ethanol facilitates serotonergic transmission then ethanol should promote 
anxiety and not induce an anxiolytic effect.  
1.6.4. The anxiolytic effects of ethanol in humans 
The idea that the consumption of alcohol can reduce anxiety or responses to 
stress is based on reports and experiences that alcohol is associated with an 
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increased social interaction in humans. Extensive evidence suggests that 
ethanol and the anxiolytic benzodiazepines both potentiate responses at the 
GABAA receptor. Historically, the transition from moderate to excessive or 
pathological alcohol consumption was thought to be due to the positive affect 
and tension reducing effect evoked by alcohol and was refered to as the 
“tension-reduction hypothesis” (Pohorecky, 1981; Pohorecky, 1991). In 
agreement, most alcoholics report that relief of anxiety is an important reason 
for drinking (Edwards et al, 1972). However, the anxiolytic effect of ethanol is 
reported in the ascending limb of the blood alcohol concentration curve and is 
subsequently followed by a more prolonged period of anxiety and depression 
(Pohorecky, 1981). Studies of the anxiolytic effect of alcohol in humans have 
been difficult to interpret because of the factors stated previously and the role of 
expectancy (Eckardt et al, 1998). It has been reported that the anticipated 
effects of ethanol may have a greater influence than the pharmacological 
effects of ethanol. In addition, Wilson (1988) noted that the nature of the test 
administered is important due to the fact that ethanol may affect self-rating and 
autonomic measures of anxiety differently. 
Wilson et al. (1989) reported that a moderate dose of ethanol elicited a 
decrease in systolic blood pressure, but had no influence on either heart rate or 
or diastolic blood pressure in female social drinkers exposed to social stress. 
Conversely, Lipscomb et al. (1980) reported a dose-dependent decrease in 
heart rate in male social drinkers in response to social stress. Therefore, the 
effects of ethanol on the autonomic responses to anxiogenic stimuli are 
inconsistent in the literature. However, ethanol has been reported to reduce 
self-ratings of anxiety on Spielberger’s State Anxiety scale in female social 
drinkers with positive expectations of ethanol’s action, but not in others (De 
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Boer et al, 1994). However, Bond and Silveira (1993) found no effects of 
ethanol in a stressful competitive task. Similarly, Lister and File (1983) reported 
no effect of alcohol on students’ self-ratings of anxiety as measured on the 
Bond and Lader’s analogue scale but did report a reduction in anxiety on the 
Spielberger State Anxiety scale during testing under high and low stress 
conditions. 
The “self-medication” hypothesis proposed that the anxiolytic effect of ethanol 
facilitates the consumption of alcohol and therefore individuals with high anxiety 
will consume more alcohol than nonanxious individuals. The hypothesis is 
derived from the association of high alcohol intake in individuals diagnosed with 
an anxiety disorder. Chutuape and de Wit (1995) tried to address the “self-
medication hypothesis” by investigating whether anxiety upon consumption is 
reduced in individuals with anxiety disorders, and whether a decrease in anxiety 
is associated with increased preference for alcohol. The study found that 
alcohol decreased anxiety in the individuals with an anxiety disorder. However, 
the decrease in anxiety was not associated with an increased preference for 
alcohol. In addition, alcohol had minimal effects on the anxiety levels of the 
control group. 
In summary, the investigation of the putative anxiolytic effects of ethanol in 
humans is inconclusive to date. However, this is due to a multitude of factors 
that are difficult to control for. Therefore, it would be assumed that animal work 
would offer greater insight due to the increased control of potentially 
confounding factors and the multitude of behavioural tests which evoke an 
anxious state.    
1.6.5. The anxiolytic effects of ethanol in animals 
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In general, the concentration range which elicits anxiolytic effects in rats is lower 
in rats than it is in mice (Eckardt et al, 1998). In addition, the anxiolytic effects of 
ethanol reported in mice often occur in conjunction with a stimulation of 
locomotor activity and the two effects are difficult to dissociate experimentally 
(Eckardt et al, 1998). Conversely, the investigation of the anxiolytic effect of 
ethanol in rats is limited by the sedative and ataxic effects of ethanol at higher 
doses (Eckardt et al, 1998). In agreement, File (1980) reported that the 
systemic administration of 0.4 and 0.8 g/kg ethanol (i.p.) elicited anxiolytic 
effects in the social interaction test. However, the administration of 1.2 g/kg 
produced sedatory effects. Similarly, anxiolytic effects have been reported in the 
elevated plus maze following the administration of doses of ethanol ranging 
from 0.5 – 0.75 g/kg (i.p.; Criswell et al, 1994). Criswell et al. (1994) reported 
that the sedative component of ethanol’s effects were evident at 1 g/kg in the 
elevated plus-maze. Blanchard et al. (1990a) reported that the i.p. 
administration of 1.2 g/kg of ethanol increased transitions between the front and 
back of the cage and increased locomotor activity in response to exposure to a 
predator stressor characteristic of an anxiolytic effect. In the Geller-Seifter 
conflict task, 0.75 g/kg (i.p.) suppressed response inhibition but had no effect on 
unpunished responses (Koob et al, 1988). Similarly, doses of ethanol ranging 
from 0.5 – 2 g/kg were reported to be anxiolytic in a punished drinking conflict 
task; however, higher doses elicited sedative effects (Glowa et al, 1988). 
Attempts have been made to reverse the anxiolytic effects of ethanol. The 
administration of RO 15-4513, a partial agonist of the benzodiazepine binding 
site, reversed the anxiolytic-like effect of ethanol in the elevated plus-maze. 
However, RO 15-4513 reduced the total number of arm entries when given 
alone (Prunell et al, 1994b). In agreement, the administration of pregnenolone 
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and pregnenolone sulphate in mice reversed the anxiolytic effects of ethanol in 
the elevated plus-maze, however, the doses were anxiogenic when 
administered alone (Melchior and Ritzmann, 1994). 
In an attempt to address the “self-medication hypothesis”, the anxiety-like 
behaviours of animals which show a high preference for alcohol have been 
investigated. Stewart et al. (1993) reported that the alcohol preferring P line of 
rats had a higher level of anxiety in the elevated plus-maze and Geller-Seifter 
conflict task than the NP line. In agreement, similar results were reported for the 
Sardinian alcohol preferring line when compared to the non-preferring strain 
(Colombo et al, 1995). However, the alcohol-preferring AA line did not differ 
from the non-preferring ANA line in several tests of anxiety (Viglinskaya et al, 
1995; Tuominen et al, 1990). 
Collectively, the investigation of the effects of ethanol upon behaviour in rodents 
supports the hypothesis that ethanol elicits an anxiolytic-like effect in 
behavioural tests of anxiety. However, the dose-dependent effects of ethanol 
upon locomotor activity in both rats (sedatory) and mice (stimulation) appear to 
confound the investigation of the anxiolytic properties of the drug in behavioural 
tests. Therefore, the neuronal mechanisms which underpin the anxiolytic 
properties of ethanol remain to be determined. 
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2. Materials and Methods 
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2.1. Animals 
Male Sprague-Dawley rats (Harlan, UK) weighing 250-300 g (unless stated) at 
the beginning of the experiment were used throughout. Male rats were used in 
the present study as Nomikos and Spyraki (1988) demonstrated that behaviour 
in the elevated plus-maze and sensitivity to the anxiolytic effects of diazepam 
are influenced by the stage of the ovarian cycle in female rats.  
Upon arrival, animals were housed in cages of 4 and were habituated to the 
vivarium for 7 days prior to the start of the experiment. Those that received 
surgery were housed individually following the procedure to minimise the risk of 
post-operative infection. The vivarium was maintained at 21 ± 2 °C and 55 % 
humidity with a 12 hr light-dark cycle (lights on at 0600 hr and off at 1800 hr). 
Water and food were available ad libitum in the home cages. Behavioural 
testing was performed between 1300 hr and 1800 hr. All procedures were 
performed in accordance with the Animals (Scientific Procedures) Act, 1986 
(UK), under the auspices of Project Licences PIL 60/3575 and PIL 60/4289 and 
the personal license 60/12496.  
2.2. Stereotaxic surgery 
2.2.1. Background 
The word stereotaxis originates from the Greek words stereos which means 
‘3D’ and taxis which means ‘an orderly arrangement’. The term was initially 
coined by Horsely and Clarke (1908) to describe a novel method of accurately 
orientating a moveable object into a specific three dimensional location within 
the brain. Initially pioneered in primates, the stereotaxic instrument of Horsely 
and Clarke (1908) was later adapted for rodents and allows for the implantation 
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of guide cannulae, electrodes and microdialysis probes into discreet brain 
nuclei. In rodents, the stereotaxic instrument or “frame” consists of a base plate, 
an incisor bar, an anaesthetic nose cone, two ear bars and a manipulator which 
can be orientated in the anterior-posterior, medial-lateral and dorsal-ventral 
planes (figure 2.1.). The head of the animal is affixed to the frame by two 
tapered ear bars which fit into the external auditory meati and the incisor bar 
which rests behind the upper incisors (Cooley and Vanderwolf, 2005). The head 
is clamped to the incisor bar by sliding the anaesthetic nose cone over the 
snout.  
The stereotaxic surgical technique is based upon the definite and predictable 
locations of target nuclei relative to the surrounding skull. When affixed to the 
frame, the skull of the animal remains in a definitive spatial relation to the frame 
itself. A direct line from one auditory meatus to the other, referred to as the 
interaural line, was the basic reference point in the Horsely-Clarke method 
(1908). The three dimensional location, or co-ordinates, of the target nucleus 
within the brain can be determined relative to the central point of the interaural 
line (referred to as stereotaxic zero; figure 2.1).  The co-ordinates of the target 
nucleus can be determined from a stereotaxic atlas, such as Paxinos and 
Watson (1998) or König and Klippel (1963). However, an alternative method 
was proposed by Hess (1957), who used the anatomical features of the skull as 
the stereotaxic zero point. Therefore, the modern technique is the 
amalgamation of both the Hess and Horsely-Clarke methods. Bregma is defined 
as the intersection of the coronal suture of the skull with the sagittal suture 
whereas lambda is the intersection of the lambdoidal suture and the sagittal 
suture (figure 2.1.; Cooley and Vanderwolf, 2005). The use of bregma as the 
reference point is advantageous as the variability of sex, strain and weight is 
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reported to be minimised by the use bregma as opposed to the interaural line 
(Whishaw et al, 1977; Paxinos et al, 1985). 
2.2.2. Protocol 
Stereotaxic coordinates were verified histologically in cadavers before each set 
of experimental cannulations. The animals were anaesthetised by inhalation of 
5% isoflurane (Baxter International Inc., UK) in medical oxygen and were 
positioned in a stereotaxic frame (dual lab stereotaxic instrument; Stoelting 
Ltd.). In addition, the non-steroidal anti-inflammatory carprofen (Rimadyl; Pfizer, 
UK), a COX-2 inhibitor, was administered subcutaneously to provide analgesia 
(5 mg/kg; 1 ml/kg). The body temperature of the animal was maintained at 35 
°C by a thermostatically controlled heat pad (Harvard homeostatic blanket; 
Harvard Apparatus, UK).  
The hair was removed from the scalp and chlorhexidine gluconate solution 
(Hydrex Pink; Ecolab Ltd., UK) applied to reduce the likelihood of infection.  An 
incision was made along the midline of the scalp to expose the skull and the 
incisor bar adjusted to ensure that bregma and lambda were level in the dorsal-
ventral plane (within ± 0.2 mm). 
For cannulation of the DRN, an 8 mm-long stainless steel guide cannula (26 ga; 
Cooper’s Needle Works Ltd., Birmingham, UK;  section 2.3.2) was mounted on 
the stereotaxic manipulator at an angle of 26° relative to the vertical plane. 
Conventionally, the location of the target site is determined from a single 
reference point (Whishaw et al, 1977). However, in the present study the 
distribution of the cannulae targeted at the DRN was variable in the anterior-
posterior plane when initially measured from bregma alone. In agreement, 
Paxinos et al. (1985) suggested that the interaural line may serve as more 
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Figure 2.1. – The stereotaxic frame and the reference points for stereotaxic coordinates. 
The frame itself (panel A and panel B) consists of a base plate, two ear bars, an incisor bar, 
the anaesthetic nose cone and a manipulator arm. The head of the animal is held in a fixed 
position relative to the frame via the ear bars, incisor bar and anaesthetic nose cone. The latter 
of which provides the anaesthetic required to maintain anaesthesia throughout the procedure. 
The guide cannula, which is implanted into the brain, is affixed to the manipulator. Therefore, 
the cannula can be manoeuvred in the anterior-posterior, the lateral and dorsal-ventral planes to 
the target site. The location of the target site can be determined relative to either stereotaxic 
zero (panel C), bregma or lambda (panel D). Panel D adapted from Paxinos and Watson 
(1998). 
reliable reference point for caudal structures. Therefore, the anterior-posterior 
co-ordinate for the DRN was determined as a ratio of the measured distance 
between bregma and lambda. In accordance with the stereotaxic atlas of 
Paxinos and Watson (1998), the target site within the DRN is located 7.8 mm 
posterior to bregma and 1.2 mm anterior to lambda. In the medial-lateral axis, 
the cannula was positioned 2.9 mm from the midline. The reference point in the 
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dorsal-ventral axis was taken from the surface of the dura. Three indentations 
were made in the surface of the skull to accommodate screws (0-80 x 1/8; 
Bilaney Consultants, UK) implanted in the cranial bones surrounding the target 
site. An incision in the dura was made using a hypodermic needle and the 
cannula was lowered 4.1 mm from the surface of the dura.  
For cannulation of the lateral ventricle, an 8 mm-long stainless steel guide 
cannula (26 ga; Cooper’s Needle Works Ltd., Birmingham, UK; section 2.3.2) 
was mounted on the stereotaxic manipulator in the vertical plane (i.e. an angle 
of 0°). The cannula was implanted, as above, and was positioned -0.9 mm 
posterior from bregma, +1.3 mm lateral to the midline and -2.0 mm below the 
surface of the dura.  
Dental cement (Poly-F Plus Cement; Dentsply, Germany) was built-up to 
encompass the cannulae and screws in a cement cap and secure the cannulae 
in position. The patency of the guide cannulae were maintained by the insertion 
of stainless-steel stylets (34 ga; Cooper’s Needle Works Ltd., Birmingham, UK; 
section 2.3.2). Upon termination of the anaesthetic, the animals were returned 
to the home cage which, in turn, was placed within a heated chamber to aid 
recovery (27°C; Scanbar A/S, Denmark). Animals were allowed to recover for 
10 days prior to the microinjection of substances. The animals were weighed 
and the stylets replaced daily to accustom the animals to handling and maintain 
the patency of the cannulae. 
2.3. Intracerebral Microinjection 
2.3.1. Background 
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The systemic administration of substances is useful in assessing the effects of a 
compound on the animal as a whole. However, the substance may not readily 
cross the blood-brain barrier or may have deleterious consequences when 
administered systemically. Therefore, investigation of the effects of such 
compounds in the brain necessitates their administration centrally. In addition, 
central administration can be used investigate the effects of a substance on 
discreet nuclei and, within limits, inferences can be made to the effects of the 
compound on neuronal targets in vivo if the pharmacology of the substance has 
been previously established (e.g. receptor activation, blockade or allosteric 
modulation). 
Historically, Hashimoto (1915; reviewed by Greenshaw, 1986) originally 
proposed a basic cannula system for the administration of substances into the 
diencephalon of unanesthetized rabbits. However, the modern technique is 
based upon the more refined approach of Euler and Holmgren (1956). Guide 
cannulae are implanted stereotaxically under anaesthesia and are fitted with a 
stylet to maintain patency. After recovery, the stylet is replaced by a narrower 
cannula (the microinjection needle) which projects a pre-determined length 
beyond the tip of the guide cannula into the region of interest. A set volume of 
solution is slowly administered, via the microinjection needle, into the region of 
interest using a motorised perfusion pump.    
2.3.2. Protocol  
Guide cannulae were constructed from 26 ga. stainless steel tubing cut to 8 mm 
lengths (figure 2.2). The guide cannula was tapered at the ventral end, which is 
stereotaxically implanted into the brain. However, the smooth stainless steel 
tubing does not provide a reliable adhesive surface for the dental cement. 
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Therefore, any downward pressure could potentially displace the cannula from 
its location and damage the target site. To prevent this, shallow grooves were 
cut into the dorsal half of the cannula to provide an adhesive surface for the 
dental cement to anchor to (figure 2.2).  
A stylet was constructed for each guide cannula from 34 ga. stainless steel 
tubing (figure 2.2.). Each stylet was positioned within the guide cannula and 
protruded 0.1 mm from the ventral tip. The remainder of the stylet, which 
projects from dorsal tip of guide cannula, is bent to a 45° angle to prevent the 
stylet protruding further. The lumen of the stainless steel tubing was occluded at 
both ends. This ensured that, when positioned in the guide cannula, the stylet 
reduced the necrosis caused by exposure of the cerebral tissue to the open air. 
The guide cannulae and stylets were autoclaved prior to surgery to minimise the 
risk of infection.  
The main cannula of the microinjection needle was constructed from a 36 ga. 
stainless steel tube cut to a length of 20 mm (Cooper’s Needle Works Ltd., 
Birmingham, UK; figure 2.2.). A stainless steel collar (25 ga.; 3 mm; figure 2.2.) 
was then positioned 10 mm or 9.5 mm from the tip of the main cannula for 
administration into the DRN and lateral ventricle respectively. This collar serves 
as a barrier to ensure the needle projects the designed length from the guide 
cannula tip to the target site. A coil of stainless steel wire (2 mm long coil, 0.2 
mm diameter; Advent Research Materials, UK) was positioned above the first 
collar to act as an adhesive surface to connect all of the components of the 
microinjection needle (figure 2.2.). In addition, a second collar (23 ga.; 3 mm; 
figure 2.2.) with a tapered end was positioned above the coil of stainless steel 
which was used to connect the needle to the perfusion system. Superglue 
(Loctite Super Glue Precision; Henkel Loctite) was used to bind the three 
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external components to the main cannula of the microinjection needle. The 
depth with which the microinjection needle protrudes beyond the tip of the guide 
cannula was selected (2 mm for the DRN and 1.5 mm for the lateral ventricle) to 
minimise the backward diffusion of administered substances into the space 
between the guide cannula and microinjection needle (Greenshaw, 1986). 
However, it should be noted that backward diffusion of substances along the 
outer wall of the microinjection needle is unavoidable as this route offers the 
least resistance to the solution upon administration into the neuronal tissue. 
The delivery of the experimental solution was mediated by a motorised 
perfusion pump (Pump 22; Harvard Apparatus, UK) which controlled the 
plunger of the microinjection syringe (2.5 ml; CMA/Microdialysis Type 1, 
Exmire). The portex tubing (internal diameter 0.58 mm, external diameter 0.98 
mm; Smiths Medical International Ltd., UK; figure 2.2.), which connected the 
microinjection syringe and the microinjection needle, was divided into a long 
and a short section which were connected via a stainless steel junction (23 ga.; 
5 mm; figure 2.2.). The long section of portex tubing connected the 
microinjection syringe to the junction and was filled with aCSF solution. The 
short section of portex tubing was filled with the experimental solution (i.e. 
vehicle or drug treatment) and was attached to the junction and the 
microinjection needle. In addition, a small air bubble was incorporated into the 
short section of portex tubing to separate the experimental solution from the 
aCSF solution (figure 2.2.). The incorporation of the air bubble served to reduce 
the volume of the experimental solution required and indicated the movement of 
the experimental solution through the portex tubing.   
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Figure 2.2. – The guide cannula, stylet, microinjection needle and the perfusion system. 
The guide cannula is constructed from an 8 mm long, 26 ga. stainless steel tube and is 
surgically implanted into the animal. Post-surgery, a 34 ga. stainless steel stylet is inserted into 
the guide cannula to maintain patency and prevent tissue necrosis (panel A and panel B). The 
administration of the experimental solution is mediated by an aCSF-filled microinjection syringe 
which is driven by a motorised perfusion pump. The former is connected to the microinjection 
needle via portex tubing (panel C). The portex tubing is divided into a short and long section, 
which are connected via a stainless steel junction (5 mm, 23 ga.). The shorter section of portex 
tubing is filled with the experimental solution, while the longer section is filled with aCSF 
solution. A small air bubble is incorporated into the short section of portex tubing which serves 
to separate the solutions. On the test day, the stylet is replaced by the 34 ga. microinjection 
needle which projects beyond the tip of the guide cannula into the target site and the 
experimental solution is administered.    
 
On the test day, animals were removed from the home cage and gently 
wrapped in a cloth. The stylet was removed from the guide cannula and 
replaced with the microinjection needle. The experimental substances were 
administered at a rate of 250 nl/min to minimise the damage at the target site 
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caused by displacement. The total volume administered was 1 l and 500 nl for 
the lateral ventricle and DRN respectively. The microinjection needle remained 
in place for a further 2 min following the termination of administration to allow for 
the diffusion of substances from the needle tip. The microinjection needle was 
removed and replaced with the stylet. Immediately following the drug 
administration to the target site, animals were removed from the cloth and 
tested in the appropriate behavioural apparatus. 
2.4. Optimisation of the Intracerebral Microinjection Technique 
During the first 12 months of the thesis, considerable effort was made to 
optimise the surgical, microinjection and histological protocols used in the 
present study in an attempt to minimise the number of animals used throughout. 
Prior to the initiation of experimental studies, 16 cadavers were used to optimise 
the stereotaxic coordinates. Initial coordinates were based upon Figure 51 of 
the stereotaxic atlas of Paxinos and Watson (1998). As described in section 
2.2.2., the location of the DRN was determined relative to both bregma and 
lambda. Following the cannulation of a further 10 cadavers it was noted that the 
use of bregma as a point of reference alone resulted in a high degree of 
variance in the location of the cannula in the anterior-posterior plane. As the 
dorsal-ventral position of the DRN varies through the anterior-posterior axis, this 
variance resulted in a number of misplaced cannulations. Furthermore, the 
guide cannula was implanted at an angle of 26°. The angle was selected as 
initial cannulations were implanted at an angle of 10°, however, these were 
frequently found to occlude the cerebral aqueduct.   
The surgical protocol adopted in the present study was predominantly based 
upon the protocol described by Cooley and Vanderwolf (2005) and remained 
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consistent throughout. However, alterations were made to improve the recovery 
of the animals. Following the implantation of the cannulae, the skin was 
replaced over the dental cement and sutured in place. However, sutures were 
affixed using either a horizontal or vertical mattress to ensure that the knot of 
the suture was located away from the incision. This greatly decreased the 
propensity of the animals removing the sutures. 
The microinjection technique was initially based upon the protocol used to 
administer substances into the DRN reported by File and Gonzalez (1996). 
However, in a study of 43 rats it was  found that the use of a 21 ga. guide 
cannula and associated 30 ga. microinjection needle resulted in an adverse 
‘startle-like’ reaction which appeared to be due to the mechanical disruption of 
the target site upon insertion of the microinjection needle into the cannula. 
Therefore, the microinjection needle and cannula were refined to 34 ga. and 26 
ga. respectively and this reduced the incidence of the adverse reaction to the 
insertion of the microinjection needle. 
In addition, the length of the guide cannulae were modified in order to minimise 
the incidence of the animals removing the stainless steel stylet used to maintain 
the patency of the guide cannula. Initially, the guide cannulae were 12 mm in 
length and therefore 8 mm of the cannula protruded from the surface of the 
skull. However, in the aforementioned study of  43 animals the stainless steel 
stylet was removed with a regular frequency and led to a number of the 
cannulae becoming blocked. Attempting to address this issue, commercially 
manufactured guide cannulae (Bilaney Consultants, UK) were purchased which 
were fitted with a screw on dust cap. However, an additional 8 animals were 
able to remove these dust caps with regularity thereby exposing the cerebral 
tissue at the base of the cannula. This issue was ultimately rectified by reducing 
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the length of the guide cannula to 8 mm which resulted in 4 mm of the guide 
protruding from the surface of the skull. This ensured that there was a sufficient 
surface area for the dental cement to adhere to; however, the guide cannulae 
protruded a minimal distance from the surface of the cement cap. Furthermore, 
the construction of the dental cement cap also was integral to the resolution of 
this problem. As the guide cannula no longer protruded far from the surface of 
the skull, the cement was built up to encircle the guide cannula rendering the 
cannula and stylet inaccessible to the paws of the animal while ensuring that 
the cannula was accessable to the experimentor. 
2.5. Drugs 
2.5.1. Vehicle solutions 
For ICV and intra-DRN administrations, experimental substances were 
dissolved in an aCSF vehicle (containing, in mM, 126 NaCl, 26 NaHCO3, 10 
MgSO4, 10 Glucose, 2.5 KCl, 1.25 NaH2PO4 and 0.5 CaCl2; pH 7.4). When 
bubbled with carbogen (95% oxygen; 5 % carbon dioxide), the aCSF vehicle 
serves as a buffer to control for changes in pH. The aCSF solution was filtered 
prior to the addition of the drug using a syringe driven filter (0.2 m; Millex 
Syringe Driven Filter Unit). For intraperitoneal administration, experimental 
substances were dissolved in 0.9 % NaCl solution.   
2.5.2. Strychnine 
The glycine receptor antagonist strychnine hydrochloride (1 g/500 nl; Sigma 
Aldrich, UK) was dissolved in aCSF and administered into the DRN over 2 min. 
Previously, the effects of intra-DRN administration of strychnine have not been 
investigated. However, the effects of varying concentrations of centrally 
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administered strychnine have been investigated in the amygdala (167 pg; 
McCool and Chappel, 2007), the ventral tegmental area (3 ng; Li et al, 2012), 
the periaqueductal grey (334.4 ng – 668.8 ng; Palazzo et al, 2009), the caudal 
pontine reticular formation (1.67 g – 3.34 g; Koch and Friauf, 1995) and the 
nucleus accumbens (5 g; Chau et al, 2010).  
2.5.3. Chlordiazepoxide 
In rats, the anxiolytic effects of systemically administered chlordiazepoxide have 
been investigated extensively in the elevated plus-maze (Criswell et al, 1994; 
Garcia et al, 2011; Pellow et al, 1985; Moy et al, 1997). In the present study, 
chlordiazepoxide (2.5 mg/kg and 5 mg/kg; chlordiazepoxide hydrochloride; 
Sigma Aldrich, UK) was dissolved in saline solution and administered intra-
peritoneum at 3 ml/kg body weight, 20 min prior to behavioural testing. 
Therefore, the doses of chlordiazepoxide administered were within the range 
previously reported to elicit an anxiolytic-like effect in the elevated plus-maze 
(1.5 – 7.5 mg/kg; Garcia et al, 2011; Pellow et al, 1985).   
2.5.4. Glycine 
In the present study, 1 ng, 11 ng and 112 ng of glycine (glycine sodium salt; 
Sigma-Aldrich, UK) were administered into the DRN (500 nl) over 2 min. Yang 
et al. (1992) reported that the administration of 10 g glycine into the DRN 
elicited a decrease in heart rate and mean arterial blood pressure in 
anaesthetised rats. However, previous studies have administered lower doses 
of glycine into the hypothalamic paraventricular nucleus (375 ng – 3.75 g; 
Krowicki and Kapusta, 2011) and the periaqueductal grey (3 g - 6 g, Schmitt 
et al, 1995; 375 ng – 1.5 g, Palazzo et al, 2009). Recently, Li et al. (2012) 
reported a strychnine-sensitive reduction in ethanol consumption in rats 
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administered low doses of glycine into the ventral tegmental area (37.5 pg – 
1.87 ng). Therefore, lower doses were administered in the present study 
comparable to Li et al. (2012) as opposed to the higher dose reported by Yang 
et al. (2002) with consideration of the potential non-specific effects such as 
increased osmotic pressure. 
2.5.5. Ethanol 
In the present study, the behavioural effects of ethanol (Ethanol Absolute 
AnalaR Normapur; VWR International) administered systemically and centrally 
were investigated. For intra-peritoneum administration, ethanol (0.5 g/kg, 0.75 
g/kg, 1.0 g/kg and 1.5 g/kg) was dissolved in saline and administered 6 ml/kg 
body weight, 20 min prior to behavioural testing. For ICV and intra-DRN 
administration, ethanol was dissolved in aCSF solution. 128 g of ethanol (1 l) 
was administered into the lateral ventricle over 4 min. In addition, 4 g, 8 g 
and 16 g of ethanol (500 nl) were administered into the DRN over 2 min.   
2.6. Open field and locomotor activity box 
2.6.1. Background 
The origin of the open field is attributed to Hall (1934) who reported the number 
of defecations as an index of ‘timidity’. The open field is a novel environment 
consisting of an open area enclosed by walls to prevent escape (figure 2.3.). In 
rats, approach-avoidance conflict is generated by the drive to explore the novel 
environment and the innate fear of the open central space. Therefore, animals 
preferentially explore the open field in close proximity to the outer walls as 
opposed to the centre of the arena (Walsh and Cummings, 1976). Validation of 
the open field as a measure of anxiety-like behaviours has been reported using 
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benzodiazepines such as chlordiazepoxide (Sanger and Zivkovic, 1988; Britton 
and Britton, 1981; Horvath et al, 1992) and diazepam (McNamara and Skelton, 
1992; Schmitt and Hiemke, 1998; Rex et al, 1996). However, the lack of 
standardisation in the protocols used for the open field is a limitation. For 
example, the dimensions of the maze itself can vary considerably from wall 
height, size of arena, shape (circular, square or rectangular), illumination, 
colour, texture and the starting position of the animal (centre versus corner; 
Walsh and Cummings, 1976; Stanford, 2007).    
2.6.2. Behavioural Measures 
Classically, the number of defecations and locomotor activity of the animal were 
considered measures of emotionality in the open field (Walsh and Cummings, 
1976). However, correlation studies have shown that the two measures appear 
unrelated (Pare et al, 1964). Since then numerous measures, including 
spatiotemporal indices, have been adopted to the protocol. The majority of the 
30 or so measures that have been employed are some measure of locomotor 
activity (Walsh and Cummings, 1976). The most commonly used indices of 
anxiolytic-like behaviours in the open field are the time spent exploring the 
central zone, the ratio of central: total locomotion and the latency to enter the 
central area (Prut and Belzung, 2003). An increase in exploration of the central 
area in the absence of an overt change in general locomotor activity is 
interpreted as an anxiolytic-like effect. Locomotor activity, as measured by the 
number of line crossings, is typically used to investigate putative stimulatory or 
sedatory effects (Prut and Belzung, 2003). Therefore, in the open field it may be 
difficult to dissociate between the locomotor and anxiety properties of a 
substance (Stanford, 2007). In the present study, the percentage of the trial 
time spent in the central zone and the number of transitions into the central 
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zone are considered measures of anxiety-like behaviours. Freezing or time 
immobile is commonly used as an index of anxiety-like behaviour and is thought 
to reflect a high anxiety state (Walsh and Cummings, 1976). However, this 
measure can be confounded by periods of sleep which can result from 
habituation to the environment (Prut and Belzung, 2003).  
 
Figure 2.3. – The open field and locomotor activity box. The open field (panel A) is a clear 
perspex box with a 100 cm squared base and 50 cm high walls. The base of the open field was 
subdivided into 10 cm squares. The total number of line crossings was considered a measure of 
the general locomotor activity of the animals. The percentage of the trial time spent exploring 
the innermost 60 cm squared area, termed the central zone, is considered a measure of 
anxiety-like behaviour. In addition, the number of transitions from the peripheral area into the 
central zone was used as an index of anxiety. The locomotor activity box (panel B) consisted of 
a 45 cm square base lined with two sets of parallel photobeams (2.54 cm apart) located on 
adjacent walls. The walls themselves were 30 cm high. The total number of ambulatory counts 
was determined by the Activity Monitor software and is considered a measure of general 
activity. In addition, the percentage of the trial time spent exploring the central zone of the arena 
was considered a measure of anxiety-like behaviour. The central zone was defined as the 
innermost 11.5 photobeams on either wall (29.21 cm square).    
2.6.3. Protocol 
On the test day, the rats were moved to the testing room between 0900 hr -
1000 hr to habituate. The open field (figure 2.3.) was positioned directly beneath 
a ceiling-mounted digital camera and the light level in the room was measured 
at 30 lux. All behavioural testing was performed between 1300 hr - 1800 h. 
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Following the administration of the experimental solutions, the animals were 
placed at the centre of the open field as previous studies have shown that 
animals placed in close proximity to a wall favour the exploration of the area in 
which they were originally situated (Satinder, 1969). Behaviour was recorded on 
a digital camera for 15 min and scored as 3 x 5 min time bins. At the end of the 
trial the animals were removed from the open field apparatus and killed by 
cervical dislocation.  
Similarly, animals were placed in the centre of the locomotor activity box (figure 
2.3.) for 20 mins. Behaviour in the locomotor activity box was scored by the 
Activity Monitor software, which tracked the location of the animals via the 
breaking of photobeams and registered the number of ambulatory counts and 
the duration of time spent in the central zone. At the completion of the trial, the 
animals were removed from the locomotor activity box and returned to the home 
cage.  
2.7. Elevated plus-maze 
2.7.1. Background 
Handley and Mithani (1984) developed the elevated plus-maze based upon the 
observations of Montgomery (1955), who reported that rats exposed to a three 
armed maze explored the enclosed arms and avoided the open arms. The 
elevated plus-maze (figure 2.4.) consists of four arms which are elevated from 
the floor. Two arms, which are situated opposite one another, are walled. The 
remaining two are open. In the elevated plus-maze conflict is generated by the 
desire to explore and the innate fear of the elevated open runways (Handley et 
al, 1993). When exposed to the elevated plus-maze animals preferentially 
explore the enclosed runways as opposed to the open runways. A range of 
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anxiolytic compounds, such as the benzodiazepines and barbiturates, were 
found to increase exploration of the open runways, whereas anxiogenic 
compounds increase avoidance of the aversive environment (Pellow et al, 
1985). Pellow et al. (1985) reported that plasma corticosterone was elevated in 
animals confined to the open and enclosed runways of the elevated plus-maze 
when compared to those remaining in the home cage. In addition, the restriction 
of animals to the open runways was found to increase plasma corticosterone 
above those confined to the enclosed runways (Pellow et al, 1985). Increased 
expression of Fos protein has been reported in areas of the brain associated 
with defensive behaviours such as the amygdala, hippocampus, medial 
hypothalamic area and the periaqueductal grey in response to exposure to the 
elevated plus-maze (Silveira et al, 1993).  
2.7.2. Behavioural Measures 
Classically, spatiotemporal measures such as the number and percentage of 
total entries made into the open runways and the percentage of the total time 
spent exploring the open runways have been reported for the elevated plus-
maze. A factor analysis found that these indices load heavily on a single factor 
interpreted as anxiety and are therefore reported in the present study (Cruz et 
al, 1994). In a similar manner to the open field, measures of anxiety-like 
behaviour in the elevated plus-maze are dependent on the motor activity of the 
animals. In agreement, the number of entries into the open runways loads on a 
second factor in addition to the anxiety factor, which is thought to reflect the 
motor activity of the animals (Cruz et al, 1994). Therefore, the number of open 
arm entries is predominantly a measure of anxiety but is influenced by the 
general motor activity of the animals. The number of closed arm entries, as 
opposed to the total number of arm entries, was reported in the present study 
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Figure 2.4. – The elevated plus-maze. The plus-maze is a symmetrical maze consisting of four 
wooden arms elevated 70 cm from the floor. Each arm is 40 cm long and 15 cm wide. Two 
runways, situated opposite one another, are enclosed with walls 30 cm high. The two remaining 
arms remain open. 
 
as a measure of locomotor activity. The number of closed arm entries loads 
heavily on the locomotor activity factor in the factor analysis but does not load 
on the anxiety factor (Cruz et al, 1994). Conversely, the total number of arm 
entries loads on both the motor and anxiety factors and is therefore a 
contaminated measure of motility. Additional ethological measures of anxiety-
like behaviours, such as risk assessment and avoidance behaviours, in the 
plus-maze have been proposed (Carobrez and Bertoglio, 2005). However, in 
rats these measures do not load highly onto the anxiety factor in a factor 
analysis and were therefore not investigated in the current study (Cruz et al, 
1994). 
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2.7.3. Protocol 
On the test day, the rats were moved to the testing room between 0900 hr -
1000 hr.  The light level at the centre of the elevated plus-maze was measured 
at 30 lux. The animals were tested in the elevated plus-maze between 1300 hr - 
1800 hr. Following the administration of the experimental solution the rat was 
placed in the centre area of the elevated plus-maze facing an open runway. 
Pellow et al. (1985) have previously reported that rats placed facing an open 
runway at the beginning of the trial do not show a bias for either the open or 
enclosed runways when making the initial arm entry. The behaviour was 
recorded for 15 minutes using a digital camera and was scored as 3 x 5 min 
time bins (unless stated). The entry of an animal into an arm of the elevated 
plus-maze was scored if all four paws were moved into the confines of the arm. 
Following behavioural testing, the animal was removed from the maze and 
killed by cervical dislocation (unless specified).  
2.8. Elevated open platforms 
2.8.1. Background   
Previously, the open field and elevated plus-maze have been discussed as 
behavioural tests which investigate behaviour in response to acute stress. 
However, there are instances where an aversive stimulus cannot be escaped 
from or avoided and therefore the animal must adapt physiologically to cope 
with the aversive stimulus. Previous studies suggest that the acute and 
repeated exposure to an inescapable stressor results in regionally-selective 
physiological adaptations in the brain which are thought to mediate the process 
of habituation (Amat et al, 2005; Christianson et al, 2009; Graeff et al, 2004). 
The process of habituation has been investigated previously in the laboratory 
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using repeated exposure to an inescapable elevated open platform stressor 
(Storey et al, 2006; Robertson et al, 2005; figure 2.5.). Acute exposure (1 hr) to 
the elevated open platform increases plasma corticosterone levels (Storey et al, 
2006). However, the plasma corticosterone of animals repeatedly exposed to 
the platforms over the course of 20 days (1 hr daily) was not significantly 
different from unstressed controls suggesting the habituation of the endocrine 
response to the stressor (Storey et al, 2006).  
The processes of habituation to the elevated open platform stressor may be 
mediated by regionally-selective alterations in serotonergic transmission. Acute 
exposure to an inescapable stressor evokes an increase in serotonin overflow 
and tissue levels of the serotonin metabolite 5-HIAA in the frontal cortex (Bland 
et al, 2003; Storey et al, 2006). However, the repeated exposure to the elevated 
open platform (1 hr daily, 10 days) abolishes this increase in serotonin overflow 
and 5-HIAA levels in the frontal cortex (Storey et al, 2006). Therefore, acute 
exposure to the inescapable stressor elicits an increase in serotonin turnover 
and release of 5-HT in the frontal cortex. Azmitia and Segal (1978) reported that 
the serotonergic innervation of the prefrontal cortex originates from the DRN as 
opposed to the MRN. Therefore, acute exposure to the elevated open platform 
stressor may increase the neuronal excitation of the serotonergic neurons of the 
DRN. Previous studies have reported an increase in serotonin overflow in the 
vmPFC of rats acutely exposed to inescapable shocks (Bland et al, 2003; Amat 
et al, 2005). However, the repeated exposure to the inescapable stressor may 
suppress the firing of the serotonergic neurons originating from the DRN in 
response to the stressor.  
Serotonin overflow and tissue 5-HIAA levels in the dorsal hippocampus were 
increased in animals repeatedly (10 days, 1 hr daily), but not acutely (1 hr), 
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exposed to the elevated open platform (Storey et al, 2006). In addition, 
Robertson et al. (2005) reported an increase in the expression of 
mineralocorticoid (MR) and glucocorticoid (GR) receptors in the hippocampus in 
response to the repeated exposure to the stressor. However, this upregulation 
of MR and GR was abolished by the selective lesioning of the projections from 
the MRN to the dorsal hippocampus. Collectively, the results support the dual 
role of serotonin proposed by Graeff et al. (1996) who suggested that 
serotonergic projections from the MRN to the hippocampus facilitate resistance 
to chronic stress by disconnecting aversive events from the neurological 
process which underpin appetitive and social behaviours. 
In addition to physiological adaptations, repeated exposure to the elevated open 
platform stressor results in an anxiolytic-like effect when animals are 
subsequently challenged in the elevated plus-maze 24 hrs after the final 
exposure to the platforms. Repeated exposure (10 days) to the elevated open 
platform stressor significantly increased the number of open arm entries, the 
percentage of total entries made into the open runways and the time spent 
exploring the open runways (Storey et al, 2006). Previous studies have shown 
that plasma corticosterone is increased in response to acute exposure to the 
elevated plus-maze (Pellow et al, 1985). However, in animals repeatedly pre-
exposed to the elevated open platform stressor for 10 days this increase in 
plasma corticosterone in response to the elevated plus-maze was enhanced 
above the levels of animals acutely exposed to the elevated plus-maze alone 
(Storey et al, 2006).  
2.8.2. Protocol    
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Animals in the home cage were transported through to the testing room 
between 0900 hr – 1000 hr. The lighting in the room was approximately 30 lux 
(as measured from the centre of the platform).  Between 0900 hr and 1200 hr, 
animals were removed from the home cage and placed in the centre of the 
elevated open platform for 1 hr. The animals were removed from the platform 
and returned to the home cage. Animals were pre-exposed to the elevated open 
platform for 1 hr daily for 10 consecutive days. On the 11th day, animals were 
tested on the elevated plus-maze as described above. 
 
Figure 2.5. – The elevated open platform. The elevated platform consisted of a square 
podium (41 cm squared) with surrounding walls (2.5 cm high) to minimise the incidence of 
animals falling from the platform. The podium was attached to the central column, which raised 
the podium to a height of 1 m. The podium itself was covered with a square sheet of diamond 
textured perspex to increase grip for the animals.   
 
2.9. Histological identification of the microinjection site 
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Animals were removed from the behavioural apparatus upon completion of the 
trial and were killed humanely by cervical dislocation. 2% Chicago sky blue dye 
(500 nl over 2 min; Sigma-Aldrich, UK; Chau et al, 2010), dissolved in the aCSF 
vehicle, was administered into the DRN via the indwelling cannula to visualise 
the site of the injection for histological analysis. The brain was dissected from 
the skull and stored in a 0.2 M phosphate buffered 4% formalin solution for two 
days. The brain was then transferred to a 0.2 M phosphate buffered 30% 
surcrose solution for three days prior to sectioning of the tissue.  
However, animals which were administered substances into the lateral ventricle 
were killed humanely by transcardial perfusion. The administration of Chicago 
sky blue dye was insufficient to identify the location of microinjection sites 
targeted at the lateral ventricle. Animals were administered Euthital (sodium 
pentobarbitone; Pfizer, UK) at 2 ml/kg body weight. Upon sedation, the animals 
received a microinjection of 2% Chicago sky blue dye (1 l and 500 nl over 2 
min for ICV and DRN respectively) via the indwelling cannula. Upon completion 
of the administration, the microinjection needle was replaced with an elongated 
stylet. These stylets extended 1.5 mm and 2 mm beyond the tip of the guide 
cannula to mimic the length of the injector during fixation. The onset of the 
terminal anaesthesia was confirmed by the absence of the appendage 
withdrawal reflex in response to a pinch of the tip of the tail and the skin 
between adjacent toes. The heart was subsequently exposed and a needle was 
inserted into the left ventricle and clamped using haemostats. Following an 
incision into the right atrium, ice cold heparinised saline (3 ml heparin/ 100 ml 
saline; Leo Laboratories, UK) was perfused into the cadaver via the needle. The 
saline solution was replaced with 0.2 M phosphate buffered 4% formalin 
solution (12 ml/min). Upon fixation of the cadaver, the brain was dissected from 
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the skull and stored in 0.2 M phosphate buffered 4% fixative solution for a 
period of 3 days and was replaced by the 0.2 M phosphate buffered 30% 
sucrose solution as described previously.  
The brains were removed from the 0.2 M phosphate buffered 30% sucrose 
solution and frozen at -50°C. The brains were cut into 32 m sections at -20°C 
using a cryostat (Clinicut 60 Cryostat, Bright Instruments Co Ltd., UK) and 
mounted on gelatinised microscope slides. To visualise the topography of the 
brain, the sections were stained with the Nissl stain Cresyl Violet and viewed 
under the microscope (Axioskop 2; Carl Zeiss Ltd., UK; figure 2.6.). Animals 
with injection sites located out with the target site, as defined by Paxinos and 
Watson (1998), were removed from the analysis as determined by an  
 
Figure 2.6. – Examples of injection sites located within the lateral ventricle and DRN. 
Upon completion of behavioural testing, animals were killed humanely by cervical dislocation or 
transcardial perfusion. Microinjection sites were visualised by the administration of Chicago sky 
blue dye via the indwelling cannula. The tissue was dissected from the skull and fixed in a 4% 
formalin solution. The brain was cut to 32 m coronal sections and mounted on gelatinised 
microscope slides. To visualise the topography of the brain, sections were stained using cresyl 
violet and were examined under the microscope. Microinjection sites located within the lateral 
ventricle (panel A) and the DRN (panel B) were included in the statistical analysis. However, 
animals were excluded if the microinjection was located out with the target site. Confirmation of 
the injection site was verified by an experimenter blind to the treatment and behavioural history 
of the animals.    
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experimenter blind to the treatment administered and the behavioural history of 
the animal. 
2.10. Statistical Analysis 
Behavioural measures were analysed using repeated measures analysis of 
variance with time as the within-subjects factor and the treatment(s) as the 
between subjects factor. Greenhouse-Geisser correction factor applied to data 
which did not adhere to Mauchly’s test of sphericity. Post hoc analysis of the 
between-subject factors was performed by Games-Howell test. Post hoc 
analysis of interactions of the between and within-subjects factors were 
performed using independent samples t-tests. 
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3. Do the strychnine-sensitive 
glycine receptors expressed by the 
serotonergic neurons of the DRN 
influence anxiety-like behaviours? 
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3.1. The effect of intra-DRN administration of strychnine on the 
exploration of the open field. 
3.1.1. Rationale 
Collectively, the administration of substances which suppress the neuronal 
excitation of the serotonergic neurons in the DRN are reported to induce 
anxiolytic-like effects in both conditioned and unconditioned behavioural tests of 
anxiety (section 1.4.4.). In the present study, the selective glycine receptor 
antagonist strychnine was administered into the DRN to suppress, as opposed 
to facilitate, the neuronal inhibition of the serotonergic neurons. Prior studies in 
the laboratory have reported that the neuronal excitation of the serotonergic 
neurons of the DRN is suppressed by a tonically active strychnine-sensitive 
glycinergic inhibition (Maguire et al, 2013; section 1.4.5.). Therefore, the 
antagonism of the glycinergic inhibition was hypothesised to increase anxiety-
like behaviours and this was investigated in the open field.  
3.1.2. Methods 
Male Sprague-Dawley rats weighing 250-300 g at the beginning of the 
experiment were implanted with guide cannulae targeted at the DRN (see 
section 2.2 and 2.3). The animals were left for 10 days in the home cage to 
recover. On day 11 post-surgery, animals were transported to the testing room. 
Under gentle retraint, the stylet was replaced with a 36 ga. needle protruding 2 
mm beyond the tip of the cannula into the DRN. The rats were administered 1 
g strychnine hydrochloride (n=7) or the aCSF vehicle (500 nl; n=9) over 2 min 
by means of the needle inserted through the guide cannula. The needle was left 
in place for a further 2 min to allow for diffusion of the solution from the tip of the 
needle. The animals were then immediately placed at the centre of a perspex 
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open field (see section 2.6).  Activity in the open field was recorded on a digital 
camera for 15 min and scored as 3 x 5 min time bins (number of line crossings, 
time in the central zone and transitions into the central zone; figure 3.1.).  Upon 
completion of the behavioural study the rats were killed humanly by cervical 
dislocation and the injection site was verified histologically in fixed sections of 
the DRN by an observer blind to the treatment the rats had received (figure 
3.1.). The experiment was performed with a single group of 20 animals. Animals 
were tested over 5 days, with 4 animals tested in the elevated plus-maze on 
each day. Of the 20 animals which began the experiment, 1 animal could not be 
administered the experimental solution due to the blockade of the guide 
cannula. In addition, 3 animals were removed from the study as the histological 
investigation identified the administrations were located outwith the DRN. The 
behaviour was analysed by a repeated measures ANOVA with treatment on the 
test day (strychnine or aCSF) as the between-subjects factor and time as the 
within-subjects factor (0-5 min, 5-10 min and 10-15 min time bins). Greenhouse-
Geisser correction factor applied to data which did not adhere to Mauchly’s test 
of sphericity. 
3.1.3. Results 
The blockade of the strychnine-sensitive glycine receptors, achieved via the 
intra-DRN administration of the antagonist strychnine into the DRN, had no 
significant effect upon the total number of line crossings suggesting the 
antagonism of the glycine receptors did not elicit an overt change in locomotor 
activity. Contrary to the hypothesised anxiogenic-like effect, neither the 
percentage of the total time spent exploring the central zone nor the number of 
transitions into the central zone were significantly influenced by the intra-DRN 
administration of strychnine. Therefore, this suggests the antagonism of the 
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glycine receptors of the DRN did not significantly influence anxiety-like 
behaviours in the open field. However, both the number of line crossings and 
the percentage of the trial time spent in the central zone varied significantly 
between the time bins suggesting the behaviour of the animals in the open field 
changed over the course of the trial time.  
Repeated measures ANOVA showed that strychnine had no significant effects 
on the total number of line crossings (F(1,14) = 0.48; n.s.; figure 3.2.), the 
percentage of the total time spent exploring the central zone (F(1,14)=2.337; 
n.s.; figure 3.2.) or the number of transitions into the central zone 
(F(1,14)=0.708; n.s.; figure 3.3.).  
The total number of line crossings (Greenhouse-Geisser correction applied; 
F(1.207, 16.894)=26.968; p<0.001) and the percentage of the total time spent 
exploring the central zone (F(2,28)=44.121; p<0.001) were significantly different 
over the course of the time bins. However, the number of transitions from the 
periphery to the central zone (Greenhouse-Geisser correction applied; F(1.259, 
17.625)=2.613; n.s.) did not significantly differ across the time bins.  
There was no significant interaction between the administration of strychnine 
and the time bins on the total number of line crossings (time x treatment; 
Greenhouse-Geisser correction applied; F(1.207, 16.894)=1.235; n.s.; figure 
3.2.), the percentage of the total time spent in the central zone (time x 
treatment; F(2,28)=0.462; n.s.; figure 3.2.) or on the number of transitions from 
the periphery into the central zone. (time x treatment; Greenhouse-Geisser 
correction applied; F(1.259, 17.625)=0.680; n.s.; figure 3.3.). 
3.1.4. Discussion 
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Previous studies have reported that the administration of 8-OH DPAT into the 
DRN mediates an anxiolytic-like effect in the social interaction test (Hogg et al, 
1994; Higgins et al, 1988) and elevated plus-maze (File and Gonzales, 1996). 
Therefore, it was hypothesised that the administration of strychnine into the 
DRN would facilitate the neuronal excitation of the serotonergic neurons, via the 
blockade of the strychnine-sensitive glycine receptors, and this would elicit an 
anxiogenic-like effect in animals exposed to the open field. However, Higgins 
and Elliott (1991) reported the intra-DRN administration of the 5-HT1A receptor 
ligands 8-OH DPAT and gepirone produced a hypoactive state in the open field. 
The findings of Higgins and Elliott (1991) would suggest that the suppression of 
the serotonergic neurons of the DRN mediates an anxiogenic-like effect and 
therefore the administration of strychnine would elicit an anxiolytic-like effect in 
the open field. The administration of 8-OH DPAT reduced the number of line 
crossings, the number of rearings and the percentage of the trial time spent in 
the central zone (Higgins and Elliott, 1991). In addition, there was an increased 
incidence of a flattened body posture (Higgins and Elliott, 1991). However, the 
doses of 8-OH DPAT (500 ng and 2.5 g) administered by Higgins and Elliott 
(1991) were higher than had previously been reported to elicit anxiolytic-like 
effects in the social interaction test (20 - 100 ng; Hogg et al, 1994; Higgins et al, 
1988) and elevated plus-maze (100 - 200 ng in maze experienced animals; File 
and Gonzales, 1996).Therefore, the effects reported by Higgins and Elliott 
(1991) may be mediated by a non-specific mechanism.  
Contrary to the original hypothesis, blockade of the strychnine-sensitive glycine 
receptors of the DRN via the administration of the antagonist strychnine did not 
induce an anxiogenic-like phenotype in the open field but had no significant 
influence on either anxiety-like behaviours or locomotor activity. In the present 
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Figure 3.1. – Experimental design and a representative schematic showing the 
distribution of microinjection sites targeted at the DRN. Panel A shows the experimental 
design, where the number of days denotes the number of days post-surgery. Panel B is a 
diagramatic representation of the DRN and surrounding area adapted from the coronal sections 
of Paxinos and Watson (1998). Numerical values indicate the posterior distance from Bregma. 
Following behavioural testing and cervical dislocation, 2% Chicago sky blue dye was 
administered into the DRN. The brain was removed and fixed in a 4% formalin solution for 48 hr 
and then transferred to a 30% sucrose solution for 72 hr. Coronal sections (36 m) containing 
the DRN were mounted on gelatinised slides and stained using cresyl violet to visualise the 
topography of the brain. Filled circles show examples of cannulations which resulted in the 
successful administration of substances into the DRN and were included in the study. Open 
circles depict the location of injection sites excluded from the study either due to the 
administration of substances outside of the DRN or by the occlusion of the cerebral aqueduct. 
Histological assessment of the cannulations was performed by an observer blind to the 
treatment administered and behavioural history of the animal.  
 
study, the lack of measurable behavioural outcomes in response to the intra-
DRN administration of strychnine may be due to the nature of the treatment. 
Strychnine is a competitive antagonist of the strychnine-sensitive glycine 
receptor and occupies a site overlapping the agonist binding site (O’Connor et 
al, 1996; Grudzinska et al, 2005). Therefore, behavioural outcomes are 
dependent upon the extracellular concentration of the endogenous agonist  
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Figure 3.2. – The effect of intra-DRN administration of strychnine on the total number of 
line crossings and the percentage of the total time spent in the central zone of the open 
field. On day 11 post-surgery, animals were administered 1 µg strychnine hydrochloride (n=7) 
or the aCSF vehicle (500 nl; n=9) into the DRN via the indwelling cannulae prior to a 15 min 
exposure to the open field. The number of line crossings was not significantly influenced by the 
administration of strychnine (panel A). The percentage of the total time spent exploring the 
central zone of the open field was not significantly influenced by the administration of strychnine 
into the DRN (panel B). Data are presented as the mean ± S.E.M. 
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Figure 3.3. – The effect of intra-DRN administration of strychnine on the number of 
transitions from the periphery into the central zone of the open field. On day 11 post-
surgery, animals were administered 1 µg strychnine hydrochloride (n=7) or the aCSF vehicle 
(500 nl; n=9) into the DRN via the indwelling cannulae immediately prior to a 15 min exposure to 
the open field. The number entries made into the central zone of the open field was not 
significantly influenced by the administration of strychnine into the DRN. Data are presented as 
the mean ± S.E.M. 
 
within the DRN during the testing period. The low percentage of the total time 
spent and number of transitions into the central zone in both aCSF and 
strychnine treated animals would suggest a high basal state of anxiety upon 
exposure to the open field. As previously discussed (section 1.3.1), the 
behavioural expression of a high anxiety state is associated with increased 
serotonergic transmission. Therefore, it may be that under such conditions the 
concentration of the endogenous agonist which acts upon the strychnine-
sensitive glycine receptors may be low and this may contribute to the lack of the 
hypothesised anxiogenic-like effects of the intra-DRN administration of 
strychnine.  
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Therefore, the behavioural effects of strychnine may be masked by the high 
basal levels of anxiety in the animals. A number of factors associated with the 
experimental protocol may have influenced the basal anxiety state of the 
animals (section 5). However, Hale et al. (2008) reported a mild, but statistically 
significant, regionally-selective increase in c-Fos expression in the serotonergic 
neurons of the DRN in animals exposed to the open field. Therefore, it is 
unlikely that exposure to the open field is the sole mediator of the high basal 
state of anxiety observed. 
3.2. The effect of systemic administration of chlordiazepoxide on the 
exploration of the open and closed arms of the elevated plus-maze. 
3.2.1. Rationale 
To investigate the putative effects of strychnine-sensitive glycine receptors in 
the DRN, the elevated plus-maze test of anxiety was used in conjuncture with 
the open field. The benzodiazepine chlordiazepoxide has been used as part of 
a battery of anxiolytic compounds, with a known therapeutic value in humans, to 
demonstrate the validity of the elevated plus-maze as a test of anxiety-like 
behaviour in rats (Pellow et al, 1985). In order to validate the elevated plus-
maze methodology used in the present study, the effects of intra-peritoneal (i.p.) 
administration of chlordiazepoxide on the exploration of the elevated plus-maze 
was investigated prior to assessing the putative role of the strychnine-sensitive 
glycine receptors in the DRN.   
3.2.2. Methods 
Male Sprague-Dawley rats (250-300 g) were housed in cages of four 
throughout. Animals received daily i.p. injections of saline (1 ml/kg) for 7 
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consecutive days in the testing room to habituate to the injection procedure. On 
day 8, animals were transported to the testing room and received an i.p. 
injection of either 2.5 mg/kg (n=7) or 5 mg/kg chlordiazepoxide (n=8) or the 
saline vehicle (3 ml/kg; n=10) 20 minutes prior to exposure to the elevated plus-
maze. Animals were placed in the centre of the elevated plus-maze facing an 
open runway (see section 2.7). Behaviour in the elevated plus-maze recorded 
on a digital camera for 15 mins and scored as 3 x 5 min time bins (number of 
open arm entries, percentage of total entries made into the open runways, 
percentage of total time spent in the open runways and the number of entries 
into the closed arms; figures 3.4. and 3.5.). The experiment was performed 
using an original batch of 12 animals and a subsequent batch of 16 animals. 
Animals were tested over 7 days, with 4 animals tested in the elevated plus-
maze on each day. Of the 28 animals which began the experiment, 3 animals 
were removed from the final analysis after identification as statistical outliers 
(defined as greater than double the standard deviation from the mean). Data 
were analysed by repeated measures ANOVA (dose of chlordiazepoxide as the 
between-subjects factor and time as the within-subjects factor). Post-hoc 
analysis of the between-subject factor was performed using the Games-Howell 
test. Independent samples t-tests are reported for the investigation of the 
interactions between the within and between subject factors.   
3.2.3. Results 
The effect of systemically administering the GABAA receptor allosteric 
modulator chlordiazepoxide upon the the number and percentage of entries 
made into the open runways and the percentage of the trial time spent in the 
open runways of the elevated plus-maze varied significantly over the course of 
the time bins. When compared against the saline control, both the 2.5 mg/kg 
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and 5 mg/kg doses of chlordiazepoxide significantly increased all three indices 
of anxiety-like behaviour in the initial 0-5 min time bin characteristic of an 
anxiolytic-like effect. However, the 5 mg/kg dose of chlordiazepoxide 
significantly decreased the indices of anxiety in the final 10-15 min time bin. In 
addition, the 5 mg/kg dose of chlordiazepoxide significantly decreased the 
number of enclosed arm entries during the 15 min trial which suggest a 
suppression of locomotor activity. 
Repeated measures ANOVA showed that chlordiazepoxide significantly 
influenced the number of open arm entries (F(2,22)=16.549; p<0.001; figure 
3.4.), the percentage of total entries made into the open runways (F(2,22) = 
7.053; p<0.01; figure 3.4.), the percentage of the total time spent exploring the 
open arms (F(2,22) = 9.769; p<0.01; figure 3.5.) and the number of closed arm 
entries (F(2,22) = 11.964; p<0.001; figure 3.5.). Post hoc analysis of the main 
effects of the treatment showed that 2.5 mg/kg (p<0.01), but not 5 mg/kg (n.s.), 
chlordiazepoxide significantly increased the number of entries into the open 
runways (figure 3.4.), the percentage of total entries made into the open arms 
(p<0.05; figure 3.4.) and the percentage of the total time spent exploring the 
open runways of the maze (p<0.05; figure 3.5.) during the 15 min trial. 
Conversely, the 5 mg/kg (p<0.01), but not the 2.5 mg/kg (n.s.), dose of 
chlordiazepoxide significantly reduced the number of entries made into the 
enclosed runways of the elevated plus-maze (figure 3.5.). 
The number of open arm entries (F(2,44)=40.344; p<0.001), the percentage of 
the total arm entries made into the open runways (F(2,44) = 11.564; p<0.001), 
the percentage of the total time spent in exploring the open arms (F(2,44) = 
18.550; p<0.001) and the number of enclosed arm entries (F(2,44) = 61.709; 
p<0.001) varied significantly over the time bins of the trial. 
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The effect of chlordiazepoxide varied over the time bins and influenced the 
number of open arm entries (time x treatment; F(4,44)=5.717; p<0.01; figure 
3.4.), the percentage of the total entries made into the open runways (time x 
treatment; F(4,44) = 7.192; p<0.001; figure 3.4.) and the percentage of the total 
time spent exploring the open runways (time x treatment; F(4,44) = 5.556; 
p<0.01; figure 3.5.). However, the effect of chlordiazepoxide on the enclosed 
arm entries did not vary over the course of the time bins (time x treatment; 
F(4,44) = 0.413; n.s.; figure 3.5.). 
Post hoc analysis showed that in the 0-5 min time bin, the administration of 2.5 
mg/kg chlordiazepoxide significantly increased the number of open arm entries 
(t (15) = -5.312, p<0.001; figure 3.4.), the percentage of the total arm entries 
made into the open runways (t (15) = -3.130, p<0.01; figure 3.4.) and the 
percentage of the total time spent in the open runways (t (15) = -3.211, p<0.01; 
figure 3.5.). In the 5-10 min time bin, 2.5 mg/kg chlordiazepoxide significantly 
increased the number of open arm entries (t (15) = -2.246, p<0.05; figure 3.4.) 
and the percentage of time spent exploring the open runways (t (15) = -2.478, 
p<0.05; figure 3.5.), but had no significant effect on the percentage of the total 
entries made into the open runways (t (15) = -1.845, n.s.; figure 3.4.). In the 10-
15 min time bin, the administration of 2.5 mg/kg chlordiazepoxide had no 
significant effects on the number of open arm entries (t (15) = -0.466, n.s.; 
figure 3.4.), the percentage of the total arm entries made into the open runways 
(t (15) = -0.361, n.s.; figure 3.4.) or the percentage of the total time spent in the 
open arms (t (15) = -0.299, n.s.; figure 3.5.). 
The administration of 5 mg/kg significantly increased the number of open arm 
entries (t (16) = -2.322, p<0.05; figure 3.4.), the percentage of the total entries 
made into the open runways (t (16) = -3.701, p<0.01; figure 3.4.) and the  
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Figure 3.4. – The effect of systemic administration of chlordiazepoxide on the number 
and percentage of the total entries made into the open arms of the elevated plus-maze. 
Animals were administered the saline vehicle (n=10), 2.5 mg/kg (n=7) or 5 mg/kg (n=8) 
chlordiazepoxide i.p. 20 min prior to testing (3 ml/kg). Behaviour on the elevated plus-maze was 
scored for 15 min (3 x 5 min time bins). Panel A shows the total number of entries made into 
the open runways of the elevated plus-maze; panel B expresses these open arm entries as a 
percentage of the total number of entries made into the open and closed arms of the elevated 
plus-maze. p<0.05, *; p<0.01, **; p<0.001, *** versus saline control. Data are presented as the 
mean ± S.E.M. 
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Figure 3.5. – The effect of systemic administration of chlordiazepoxide on the percentage 
of the total time spent in the open arms and the number of closed arm entries in the 
elevated plus-maze. Animals were administered the saline vehicle (n=10), 2.5 mg/kg (n=7) or 5 
mg/kg (n=8) chlordiazepoxide i.p. 20 min prior to testing (3 ml/kg). Behaviour on the elevated 
plus-maze was scored for 15 min (3 x 5 min time bins). Panel A shows the percentage of the 
trial time spent exploring the open runways of the elevated plus-maze. Panel B expresses the 
total number of entries made into the enclosed runways of the elevated plus-maze. p<0.05, *; 
p<0.01, **; p<0.001, *** versus saline control. Data are presented as mean ± S.E.M. 
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percentage of time spent exploring the open arms (t (16) = -2.660, p<0.05; 
figure 3.5.) in the 0-5 min time bin. However in the 5-10 min time bin, the 
administration of 5 mg/kg chlordiazepoxide did not significantly increase the 
number of open arm entries (t (16) = -2.322, p<0.05; figure 3.4.), the percentage 
of the total entries made into the open runways (t (16) = 1.408, n.s.; figure 3.4.) 
or the percentage of the total time spent in the open runways (t (16) = 1.596, 
n.s.; figure 3.5.). In the 10-15 min time bin, the administration of 5 mg/kg 
chlordiazepoxide significantly reduced the number of entries into the open arms 
(t (10.585) = 4.773, p<0.01; figure 3.4.), the percentage of the total entries 
made into the open runways (t (16) = 4.680, p<0.001; figure 3.4.) and the 
percentage of the trial time spent exploring the open runways (t (10.143) = 
5.862, p<0.001; figure 3.5.). 
3.2.4. Discussion 
Chlordiazepoxide, originally referred to as methaminodiazepoxide, was found to 
have efficacy as an anxiolytic in clinical trials and was therefore marketed under 
the trade name Librium in 1960 (Lopez-Munoz et al, 2011). Benzodiazepines 
are positive allosteric modulators of the GABAA receptor and this is thought to 
be the mechanism for their anxiolytic effects. Benzodiazepine sensitivity is 
conveyed by a conserved histidine residue in the N-terminal domain (H101 in 
the rat 1 subunit) of the 1, 2, 3 and 5 subunit containing receptors (Dunn 
et al, 1999; Wieland et al, 1992). However, expression of an arginine at the 
homologous site of the 6 conveys insensitivity to diazepam (Wieland et al, 
1992). In agreement, Smith et al. (2012) reported that the anxiolytic effects of 
diazepam were abolished in the 2H101R transgenic mouse. 
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In agreement with previous studies (Criswell et al, 1994; Garcia et al, 2011; 
Pellow et al, 1985; Moy et al, 1997), the systemic administration of 
chlordiazepoxide in rats significantly increased the three indices of anxiety-like 
behaviour in the elevated plus-maze confirming an anxiolytic-like effect. The  
total number of and percentage of the total arm entries made into the open 
runways, in addition to the percentage of the trial time spent exploring them, 
were significantly increased in the initial 5 min of exposure to the plus-maze 
when the approach-avoidance conflict generated by the novel environment 
peaks (Montgomery, 1955; Pellow et al, 1985). However, the 5 mg/kg dose of 
chlordiazepoxide significantly decreased the number of entries into the 
enclosed arms and demonstrates the sedative component of chlordiazepoxide 
at the higher dose which masks the anxiolytic-like effects. Thus, 
chlordiazepoxide evoked the anticipated effects on rat behaviour in the elevated 
plus-maze, data that indicate that the procedure adopted for these studies 
seems to be a valid measure of anxiety. 
3.3. The effect of intra-DRN administration of strychnine on the 
exploration of the open and closed arms of the elevated plus-maze in 
animals pre-exposed to an elevated open platform. 
3.3.1. Rationale 
As previously discussed, the anticipated anxiogenic-like effects of strychnine 
administered into the DRN may have been masked by the high basal state of 
anxiety observed in animals exposed to the open field. Previous studies in the 
laboratory have identified that animals repeatedly exposed to an inescapable 
elevated open platform stressor show an anxiolytic-like phenotype when 
subsequently tested in the elevated plus-maze (Storey et al, 2006). Although 
acutely aversive, the repeated exposure to the platform mediates physiological 
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adaptations in the CNS which appear to reduce the aversive nature of the 
inescapable platform stressor over a period of 10 days (section 2.8.1.; Storey at 
al, 2006; Robertson et al, 2005). The aversive components of the elevated open 
platform and the elevated plus-maze are similar in nature (i.e. an elevated open 
space). The anxiolytic-like effect of pre-exposure to the platforms is thought to 
be a consequence of the habituation to an elevated open environment. 
Therefore, the pre-exposure to the elevated open platforms serves as a 
behavioural manipulation to reduce the basal levels of the anxiety in the 
elevated plus-maze. In the lateral amygdala, the anxiolytic-like effect of 
administration of strychnine or taurine was dependent on the “basal anxiety-
state” of the animals in this test (McCool and Chappell, 2007). Therefore in the 
present study, the effect of intra-DRN administration of strychnine was 
investigated in animals pre-exposed and naïve to the platform stressor prior to 
testing in the elevated plus-maze. 
3.3.2. Method 
Male Sprague-Dawley rats weighing 250-325 g at the beginning of the 
experiment were implanted with guide cannulae targeted at the DRN (see 
section 2.2 and 2.3). The rats were then divided into two groups. One group (n 
= 16) was exposed to an inescapable elevated open platform stress (Storey et 
al, 2006; Robertson et al, 2005) for 1 hr per day for 10 days; the second (n = 
20) remained in their home cages throughout. On day 11 post-surgery, animals 
were transported to the testing room. Under gentle retraint, the stylet was 
replaced with a 36 ga. needle protruding 2 mm beyond the tip of the cannula 
into the DRN. Each rat received a microinjection of either strychnine 
hydrochloride (1 µg), or the aCSF vehicle (500 nl) delivered over 2 min. The 
needle was left in place for a further 2 min to allow for the diffusion of the 
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solution from the tip of the neddle. Immediately after the microinjection, the 
animals were placed at the centre of the elevated plus maze facing an open 
arm (see section 2.7). Behaviour in the elevated plus-maze was recorded on a 
digital camera for 15 min and scored as 3 x 5 min time bins (number of open 
arm entries, percentage of total entries made into the open runways, 
percentage of total time spent in the open runways and the number of entries 
into the closed arms; figure 3.6.). Upon completion of the behavioural study the 
rats were killed humanly by cervical dislocation and the injection site was 
verified histologically in fixed sections of the DRN by an observer blind to the 
treatment the rats had received (figure 3.6.). The experiment was performed in 
groups of 20, 8, 3, 12, 16 and 8 animals. Animals were tested over 17 days, 
with 4 animals tested in the elevated plus-maze on each day. Of the 67 animals 
which began the study, 3 animals did not recover upon the termination of 
anaesthesia. In addition, a further 2 animals were removed prior to behavioural 
testing as one animal developed a post-operative infection and a second animal 
damaged the cement cap post-surgery. On the testing day, an additional 7 
animals could not be administered the experimental solution due to the blocking 
of the guide cannula. Furthermore, 15 animals were removed from the study as 
the histological investigation identified administrations outwith the DRN. An 
additional 4 animals were removed from the final analysis as they were 
identified as statistical outliers (i.e. greater than double the standard deviation 
from the mean). The behaviour was analysed by a repeated measures ANOVA 
using pre-treatment (stress or home cage) and treatment (aCSF or strychnine) 
as the between-subjects factors analysed and time as the within-subjects factor. 
Post-hoc independent samples t-tests are reported for the investigation of 
interactions between the within and between subject factors. 
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3.3.3. Results 
The number of closed arm entries, a measure of locomotor activity, was 
significantly increased in the initial 0-5 min time bin by the pre-exposure of the 
animals to the elevated open platforms. Exposure to the elevated open 
platforms significantly increased both the number and percentage of entries into 
the open runways and the percentage of the trial time spent in the open 
runways when compared to the home cage control suggesting an anxiolytic-like 
effect. Furthermore, the effect of pre-exposure to the platforms on the 
percentage of the trial time spent in the open runways varied between the time 
bins suggesting that animals exposed to the platforms habituated to the 
elevated plus-maze differently from animals remaining in the home cage during 
the trial. Additionally, the intra-DRN administration of strychnine partially 
reversed the platform-induced increase in the percentage of the trial time spent 
in the open runways. However, the administration of strychnine had no 
significant influence on the number of closed arm entries nor the number and 
percentage of entries made into the open runways. Therefore, in animals pre-
exposed to the elevated platforms the administration of strychnine decreases 
the latency of escape from the open runways of the elevated plus-maze. 
Repeated measures ANOVA showed that prior exposure to the elevated open 
platform significantly increased the number of open arm entries 
(F(1,32)=49.033; p<0.001; figure 3.7.), the percentage of the total arm entries 
made into the open runways (F(1,32) = 33.679; p<0.001; figure 3.7.), the 
percentage of the total time spent in the open runways (F(1,32) = 65.917; 
p<0.001; figure 3.8.) and the number of the closed arm entries (F(1,32) = 6.009; 
p<0.05; figure 3.8.). The intra-DRN administration of strychnine significantly 
reduced the percentage of the total time spent in the open arms (F(1,32) = 
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9.027; p<0.01; figure 3.8.). However, there was no significant effect of 
strychnine on the number of open arm entries (F(1,32)=2.105; n.s.; figure 3.7.), 
the percentage of entries made into the open arms (F(1,32) = 2.436; n.s.; figure 
3.7.) or the number of closed arm entries (F(1,32) = 0.010; n.s.; figure 3.8.). A 
significant interaction between the repeated exposure to the elevated platforms 
and the administration on the strychnine influenced the percentage of the total 
time spent exploring the open runways (pretreatment x treatment; F(1,32) = 
10.774; p<0.01; figure 3.8.). However, there was no such interaction influencing 
the number of open arm entries (pretreatment x treatment; F(1,32)=2.105; n.s.; 
figure 3.7.), the percentage of total entries made into the open runways 
(pretreatment x treatment; F(1,32) = 0.647; n.s.; figure 3.7.) or on the number of 
closed arm entries (pretreatment x treatment; F(1,32) = 0.301; n.s.; figure 3.8.). 
Post hoc analysis showed in rats repeatedly exposed to the elevated open 
platform stressor (t (14) = 3.381; p<0.001; figure 3.8.), but not those remaining 
in the home cage (t (18) = -0.285; n.s.; figure 3.8.), the intra-DRN administration 
of strychnine significantly reduced the percentage of the trial time spent 
exploring the open runways.  
The number of open arm entries (F(2,64)=4.904; p<0.05), the percentage of the 
total entries made into the open runways (F(2,64) = 4.426; p<0.05), the 
percentage of the total time spent exploring the open runways (F(2,64) = 
5.841;p<0.01) and the number of closed arm entries (F(2,64) = 14.106; 
p<0.001) varied significantly across the time bins.  
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Figure 3.6. – Experimental design and a representative schematic showing the 
distribution of microinjection sites targeted at the DRN. Panel A shows the experimental 
design, where the number of days denotes the number of days post-surgery. Panel B is a 
diagramatic representation of the DRN and surrounding area adapted from the coronal sections 
of Paxinos and Watson (1998). Numerical values indicate the posterior distance from Bregma. 
Following behavioural testing and cervical dislocation, 2% Chicago sky blue dye was 
administered into the DRN. The brain was removed and fixed in a 4% formalin solution for 48 hr 
and then transferred to a 30% sucrose solution for 72 hr. Coronal sections (36 m) containing 
the DRN were mounted on gelatinised slides and stained using cresyl violet to visualise the 
topography of the brain. Filled circles show examples of cannulations which resulted in the 
successful administration of substances into the DRN and were included in the study. Open 
circles depict the location of injection sites excluded from the study either due to the 
administration of substances outside of the DRN or by the occlusion of the cerebral aqueduct. 
Histological assessment of the cannulations was performed by an observer blind to the 
behavioural and treatment history of the animal. 
 
The effect of pre-exposure to the elevated open platform on the percentage of 
the total time spent in the open runways (time x pretreatment; F(2,64) = 3.952; 
p<0.05) and the number of closed arm entries (time x pretreatment; F(2,64) = 
6.526; p<0.01) was significantly different between the time bins. However, the 
effect of the platform stress on the number (time x pretreatment; F(2,64)=2.309; 
n.s.) or the percentage of total entries made into the open runways (time x  
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Figure 3.7. – The effect of intra-DRN administration of strychnine on the number and 
percentage of total arm entries made into the open arms of the elevated plus-maze in 
animals repeatedly exposed to an elevated open platform stressor. Animals were exposed 
to an elevated open platform stressor (n=16) for 1h daily over 10 consecutive days or remained 
in the home cage throughout (n=20). On day 11 post-surgery, animals were administered 1 µg 
strychnine hydrochloride (n=20) or the aCSF vehicle (500 nl; n=16) into the DRN via the 
indwelling cannulae prior to a 15 min exposure to the elevated plus-maze. Animals repeatedly 
exposed to the elevated open platform, but not those remaining in the home cage, showed an 
increase in both the number (panel A) and percentage of total arm entries made into the open 
runways during the 15 min trial (panel B). p<0.001, *** versus home cage control. Data are 
presented as mean ± S.E.M.  
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Figure 3.8. – The effect of intra-DRN administration of strychnine on the percentage of 
the total time spent exploring the open runways and the number of entries into the 
enclosed arms of the elevated plus-maze in animals repeatedly exposed to an elevated 
open platform stressor. Animals were exposed to an elevated open platform stressor (n=16) 
for 1h daily over 10 consecutive days or remained in the home cage throughout (n=20). On day 
11 post-surgery, animals were administered 1 µg strychnine hydrochloride (n=20) or the aCSF 
vehicle (500 nl; n=16) into the DRN via the indwelling cannulae prior to a 15 min exposure to the 
elevated plus-maze. Animals repeatedly exposed to the elevated open platform showed a 
significant increase in the time spent in the open runways during the 0-5 min, 5-10 min and 10-
15 min time bins. Intra-DRN administration of strychnine selectively reversed the increase in the 
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percentage of time spent in the open runways of animals exposed to the elevated platforms 
(panel A). The number of closed arm entries in the initial 0-5 min time bin was significantly 
increased in animals repeatedly exposed to the elevated open platform (panel B). p<0.01, ** 
versus home cage control; p<0.01,## versus aCSF control. Data are presented as mean ± 
S.E.M. 
 
pretreatment; F(2,64) = 1.933; n.s.) did not significantly differ between the time 
bins. The number of open arm entries (time x treatment; F(2,64)=0.253; n.s.), 
the percentage of the total entries made into the open arms (time x treatment; 
F(2,64) = 0.93; n.s.), the percentage of the trial time spent exploring the open 
runways (time x treatment; F(2,64) = 0.126; n.s.) and the number of entries into 
the enclosed arms (time x treatment; F(2,64) = 0.760; n.s.) were not significantly 
influenced by an interaction between the administration of strychnine and the 
time bins. The number of open arm entries (time x pretreatment x treatment; 
F(2,64)=1.771; n.s.), the percentage of the total arm entries made into the open 
runways (time x pretreatment x treatment; F(2,64) = 0.555; n.s.), the time spent 
exploring the open runways (time x pretreatment x treatment; F(2,64) = 0.128; 
n.s.) and the number of entries into the enclosed runways (time x pretreatment 
x treatment; F(2,64) = 1.543; n.s.) were not significantly influenced by an 
interaction between the pre-exposure to the platforms and the administration of 
strychnine over the time bins. 
Post-hoc analysis showed that the elevated open platforms significantly 
increased the percentage of the trial time spent in the open arms during the 0-5 
min (t (20.985) = -3.250, p<0.01; figure 3.8.), the 5-10 min (t (20.985) = -4.523, 
p<0.001; figure 3.8.) and 10-15 min time bins (t (18.865) = -4.949, p<0.001; 
figure 3.8.). In addition, pre-exposure to the elevated open platforms 
significantly increased the number of closed arm entries in the 0-5 min time bin 
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(t (34) = -3.134, p<0.01; figure 3.8.), but had no significant effects on the 5-10 
min bin (t (34) = -0.297, n.s.; figure 3.8.) or the final 5 minute bin (t (34) = -
1.506, n.s.; figure 3.8.).  
3.3.4. Discussion 
In agreement with the findings in the open field, animals naïve to the elevated 
open platform stressor showed high basal levels of anxiety when tested in the 
elevated plus-maze. In addition, the intra-DRN administration of strychnine did 
not have any significant effects on the indices of anxiety or the locomotor 
activity of these animals. Therefore, as was observed in the open field, the 
effects of strychnine in the elevated plus-maze may be masked in elevated 
open platform-naïve animals. 
In agreement with previous findings in the laboratory, repeated exposure to the 
inescapable elevated open platform stressor reduced anxiety-like behaviours in 
animals tested on the elevated plus-maze characteristic of an anxiolytic-like 
effect (Storey et al, 2006; Robertson et al, 2005). In animals exposed to the 
elevated open platform stressor, but not those remaining in the home cage, the 
intra-DRN administration of strychnine decreased the latency of escape from 
the open runways of the elevated plus-maze suggesting the reversal of a 
selective component of the anxiolytic-like effects induced by the exposure to the 
elevated open platforms. This partial reversal of the anxiolytic-like effect of the 
platforms was independent of any changes in the locomotor activity of the 
animals and therefore cannot be attributed to a stimulation of motor activity. 
Gonzalez and File (1997) have reported that the intra-DRN administration of the 
benzodiazepine midazolam in plus-maze naive rats increased the percentage of 
time spent in the open runways. Therefore, the latency of escape from the 
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aversive environment may, in part, be mediated by the serotonergic neurons in 
the DRN. 
Graeff et al. (1996) anticipated that drugs which increase the firing of 
serotonergic neurons in the DRN would facilitate inhibitory avoidance of the 
open runways (i.e. remain in the closed runways) and impair one-way escape 
from the aversive environment (i.e. escape from the open arms) in an elevated 
t-maze. Inhibitory avoidance is measured by placing the animal in the closed 
arm of the t-maze and measuring the latency to exit the arm. This is considered 
a measure of learned fear and is thought to be mediated by serotonergic 
transmission to the amygdala and frontal cortex which mediate active escape or 
avoidance behaviours in response to perceived or distal threats (Graeff et al, 
1996). Similarly, the one-way escape is measured by placing the animal in the 
open ‘aversive’ arm and measuring the latency to escape to the enclosed arm. 
This is considered a measure of innate fear, and is mediated by the 
serotonergic projections to the periaqueductal grey which inhibit fight/flight 
responses to immediate or proximal threats (Graeff et al, 1996). In agreement, 
Graeff et al. (1996) reported the presumed excitation of the serotonergic 
neurons elicited by the intra-DRN administration of a subtoxic dose of kainic 
acid significantly increased inhibitory avoidance of the open runways and 
increased the latency of one-way escape from the open runways. The 
administration of 8-OH DPAT into the DRN was found to decrease inhibitory 
avoidance but had no effect on one-way escape (Graeff et al, 1996). Therefore, 
previous studies in the t-maze would appear to contradict the findings of the 
present study. An increase in the escape from the open runways of the t-maze 
is characteristic of an increase in panic-like behaviours, which are thought to be 
mediated by the inhibition, as opposed to the facilitation, of the excitation of the 
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serotonergic neurons projecting from the DRN to the periaqueductal grey 
(Graeff and Rawlins, 1980).  
However, it is important to note that in the modified t-maze the animal is placed 
within the confines of the aversive environment, forcing confrontation with the 
stressor, whereas in the elevated plus-maze the animal is placed in the centre 
of the maze and thus explores the aversive open runways voluntarily. In 
addition, the open runways of the elevated plus-maze are considered aversive 
due to the perception of a potential threat. Conversely, in the t-maze the 
experimenter may serve as a proximal threat when measuring one-way escape. 
Therefore, the latency to escape from the open runways of the elevated plus-
maze and the t-maze may be mediated by distinct neuronal substrates (section 
1.1.5.). The increased escape from the open runways, observed with the intra-
DRN administration of strychnine in animals pre-exposed to the elevated 
platforms, may be interpreted as an increase in learned active avoidance 
behaviours, as opposed to an increase in panic-like behaviours, in response to 
the perceived threat posed by the open runways of the plus-maze. 
When confronted with a stressor, the animal responds with either active or 
passive coping mechanisms which are dependent on the nature of the stressor 
(Blanchard et al, 2011). The absence of behavioural escape from the elevated 
open platform stressor induces physiological coping mechanisms which are, in 
part, mediated by alterations in the serotonergic system (section 2.8.1.). Using 
in vivo microdialysis, Bland et al. (2003) reported a prolonged increase in 
serotonin overflow in the vmPFC of animals acutely exposed to inescapable 
stress. However, Storey et al. (2006) reported that repeated exposure to the 
inescapable platform stressor abolishes the increase in serotonin overflow in 
the frontal cortex and facilitates serotonin overflow in the dorsal hippocampus. 
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Therefore, previous studies have identified that the habituation to the 
inescapable platform stressor results in the inhibition of the serotonergic 
neurons of the DRN and facilitates the excitation of the serotonergic neurons of 
the MRN. The present study suggests that the inhibition of the serotonergic 
neurons of the DRN in response to the habituated stressor may be mediated by 
the activation of the strychnine-sensitive glycine receptors. However, this 
interpretation should considered parsimoniously as platform naïve animals 
show a significantly lower number of open arm entries when compared with 
animals pre-exposed to the elevated open platform. Therefore the number of 
entries into the open runways, which is independent of the administration of 
strychnine in both the animals pre-exposed to the elevated open platform and 
those naïve to the stressor, may mask an effect of strychnine on the time spent 
in the open runways in the platform-naïve animals.  
3.4. The effect of intra-DRN administration of glycine on the exploration of 
the open and closed arms of the elevated plus-maze. 
3.4.1. Rationale 
Investigations in the open field and elevated plus-maze suggested that intra-
DRN administration of strychnine increases anxiety-like behaviours in the 
animals with a low basal state of anxiety. Therefore the hypothesis was that 
activation, as opposed to the blockade, of the receptors would induce an 
anxiolytic-like effect in animals with a high basal state of anxiety in a test of 
anxiety. A study was performed to investigate the putative anxiolytic-like effects 
of intra-DRN administration of the agonist glycine in the elevated plus-maze test 
of anxiety. 
3.4.2. Method 
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Male Sprague-Dawley rats weighing 250-300 g at the beginning of the 
experiment were implanted with guide cannulae targeted at the DRN (see 
section 2.2 and 2.3). The rats were left for 10 days in the home cage to recover 
from the surgery. On day 11 post-surgery, animals were transported to the 
testing room. Under gentle retraint, the stylet was replaced with a 36 ga. needle 
protruding 2 mm beyond the tip of the cannula into the DRN.  The rats were 
administered the aCSF vehicle (500 nl; n=4), 1 ng (n=3), 11 ng (n=4) or 112 ng 
glycine (n=3) over 2 mins by means of the needle inserted through the guide 
cannula. The needle was left in place for a further 2 min to allow for diffusion of 
the solution from the tip of the needle. The animals were then immediately 
placed at the centre of the elevated plus-maze facing an open arm (see section 
2.7). Behaviour in the elevated plus-maze was recorded on a digital camera for 
15 min and scored as 3 x 5 min time bins (number of open arm entries, 
percentage of total entries made into the open runways, percentage of total time 
spent in the open runways and the number of entries into the closed arms; 
figure 3.9.). Upon completion of the behavioural study the rats were killed 
humanly by cervical dislocation and the injection site was verified histologically 
in fixed sections of the DRN by an observer blind to the treatment the rats had 
received (figure 3.9.). The experiment was performed using a single batch of 16 
animals. Animals were tested over 4 days, with 4 animals tested in the elevated 
plus-maze on each day. Of the 16 animals which began the study, 2 animals 
could not be administered the experimental solution due to the blockage of the 
guide cannula. The behaviour was analysed by a repeated measures ANOVA 
using treatment (glycine or aCSF) as the independent factor analysed and time 
as the within-subjects factor. Greenhouse-Geisser correction factor applied to 
data which did not adhere to Mauchly’s test of sphericity. 
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3.4.3. Results 
In vitro, the application of exogenous glycine reduces the neuronal excitation of 
the serotonergic neurons of the DRN via the activation of the strychnine-
sensitive glycine receptors (Maguire et al, 2013). Therefore, the intra-DRN 
administration of glycine in vivo was hypothesised to induce an anxiolytic-like 
phenotype in animals exposed to the elevated plus-maze. However, the intra-
DRN administration of glycine had no significant effect on either the indices of 
anxiety (number and percentage of total arm entries made into the open runway 
and the percentage of the trial time spent in the open runways) or locomotor 
activity (the number of enclosed arm entries). 
The intra-DRN administration of glycine did not significantly influence the 
number of open arm entries (F(3,10)=1.286; n.s.; figure 3.10.), the percentage 
of the total arm entries made into the open runways (F(3,10)=1.830; n.s.; figure 
3.10.), the percentage of the total time spent in the open arms (F(3,10)=1.934; 
n.s. figure 3.11.) or the number of closed arm entries (F(3,10)=2.680; n.s.; 
figure 3.11.). 
The number of open arm entries (F(2,20)=6.254; p<0.01) and the number of 
closed arm entries (F(2,20)=13.657; p<0.001) differed significantly between the 
time bins. However, the percentage of the total arm entries made into the open 
runways (F(2,20)=2.839; n.s.) and the percentage of the total time spent 
exploring the open runways (F(2,20)=2.752; n.s.) were not significantly different 
between the time bins.  
There was no significant interaction between the administration of glycine and 
the time bins on the number of open arm entries (time x treatment; 
F(6,20)=0.491; n.s.; figure 3.10.), the percentage of entries made into the open 
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Figure 3.9. – Experimental design and a representative schematic showing the 
distribution of microinjection sites targeted at the DRN. Panel A shows the experimental 
design, where the number of days denotes the number of days post-surgery. Panel B is a 
diagramatic representation of the DRN and surrounding area adapted from the coronal sections 
of Paxinos and Watson (1998). Numerical values indicate the posterior distance from Bregma. 
Following behavioural testing and cervical dislocation, 2% Chicago sky blue dye was 
administered into the DRN. The brain was removed and fixed in a 4% formalin solution for 48 hr 
and then transferred to a 30% sucrose solution for 72 hr. Coronal sections (36 m) containing 
the DRN were mounted on gelatinised slides and stained using cresyl violet to visualise the 
topography of the brain. Filled circles show examples of cannulations which resulted in the 
successful administration of substances into the DRN and were included in the study. Open 
circles depict the location of injection sites excluded from the study either due to the 
administration of substances outside of the DRN or by the occlusion of the cerebral aqueduct. 
Histological assessment of the cannulations was performed by an observer blind to the 
treatment and behavioural history of the animals. 
 
runways (time x treatment; F(6,20)=0.268; n.s.; figure 3.10.), the percentage of 
time spent exploring the open runways (time x treatment; F(6,20)=0.632; n.s.; 
figure 3.11.) and the number of closed arm entries (time x treatment; 
F(6,20)=0.749; n.s.; figure 3.11.). 
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Figure 3.10. – The effect of intra-DRN administration of glycine on the number and 
percentage of the total entries made into the open runways of the elevated plus-maze. 
Following surgery, animals remained in the home cage for 10 days to recover. On day 11 post-
surgery, animals were administered 1 ng (n=3), 11 ng (n=4) or 112 ng glycine (n=3) or the 
aCSF vehicle (500 nl; n=4) into the DRN via indwelling cannulae prior to a 15 min exposure to 
the elevated plus-maze. Panel A shows that the administration of glycine did not significantly 
influence the number of entries made into the open runways of the elevated plus-maze. Panel 
B shows that the intra-DRN administration of glycine had no significant influence on the 
percentage of the total entries made into the open runways. Data are presented as the mean ± 
S.E.M. 
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Figure 3.11. – The effect of intra-DRN administration of glycine on the time spent 
exploring the open runways and the number of entries into the closed arms of the 
elevated plus-maze. Following surgery, animals remained in the home cage for 10 days to 
recover. On day 11 post-surgery, animals were administered 1 ng (n=3), 11 ng (n=4) or 112 ng 
glycine (n=3) or the aCSF vehicle (500 nl; n=4) into the DRN via indwelling cannulae prior to a 
15 min exposure to the elevated plus-maze. Panel A shows that the percentage of the total time 
spent exploring the open runways of the elevated plus-maze was not significantly influenced by 
the administration of glycine into the DRN. Panel B shows that the number of entries made into 
the enclosed arms of the maze was not significantly influenced by the administration of glycine. 
Data are presented as the mean ± S.E.M. 
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3.4.4. Discussion 
Statistically, the results suggest that the local administration of glycine into the 
DRN has no effect on the indices of anxiety-related behaviours (number of open 
arm entries, percentage of the total entries made into the open arm or the 
percentage of the total time spent in the open runways) or locomotor activity 
(number of enclosed arm entries) as measured in the elevated plus-maze. 
Based upon the data generated at present, a power analysis suggests that a 
sample size of 6 animals in each group would be required to validate these 
findings and therefore the present study is underpowered.  
However, the administration of 1 ng glycine is trending towards an anxiogenic-
like effect, as opposed to the anxiolytic-like effect as was hypothesised. It is 
anticipated that the administration of glycine into the DRN would activate the 
strychnine-sensitive glycine receptors therefore depressing the neuronal 
excitation of the serotonergic neurons and induce an anxiolytic-like effect in the 
elevated plus-maze. However, a potential anxiogenic-like effect may potentially 
be mediated if the intra-DRN administration of 1 ng glycine facilitates the 
NMDA-mediated excitation of the serotonergic neurons of the DRN (Johnson 
and Ascher, 1987; Kleckner and Dingledine, 1988). In agreement, the 
administration of the GlyT1 inhibitors Org-24461 and NFPS was reported to 
increase the excitation of the serotonergic neurons in the DRN (Papp et al, 
2008). However, Keck et al. (2008) demonstrated that the activation of 
extrasynaptic strychnine-sensitive glycine receptors in the hippocampus results 
in an increased conductance which results in an inhibitory ‘shunt’ of excitatory 
innervations.  
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Furthermore, the experimental findings of the present study may be confounded 
due to the uptake of the exogenous glycine mediated by the GlyT1 and GlyT2 
transporters (section 1.5.3). Therefore, the administration of higher doses of 
glycine may be required to elicit a behavioural response. In agreement, Schmitt 
et al. (1995) demonstrated that the administration 3 g - 6 g glycine into the 
PAG induces anxiogenic-like effects in the elevated plus-maze. However, the 
administration of higher doses may exert non-specific osmotic effects upon the 
neuronal tissue of the target site (Greenshaw, 1986). Therefore, an alternative 
approach which may be included in the study would be to co-administer glycine 
in conjecture with an inhibitor of glycine transporters such as sarcosine and 
ALX5407. 
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4. Are components of the 
anxiolytic properties of ethanol 
mediated by the potentiation of 
the strychnine-sensitive glycine 
receptors in the DRN? 
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4.1. The effect of systemic administration of ethanol on the exploration of 
the open and closed arms of the elevated plus-maze. 
4.1.1. Rationale 
Previous studies have shown that the systemic administration of ethanol 
significantly reduces anxiety-like behaviours in the elevated plus-maze (Criswell 
et al, 1994; Moy et al, 1997; Prunell et al, 1994a; Prunell et al, 1994b; Langen et 
al, 2002). In addition, the anxiolytic properties of systemically administered 
ethanol have also been reported in the social interaction test (File et al, 1976), 
the Geller-Seifter test (Aston-Jones et al, 1984) and the open field (Da Silva et 
al, 2005). Therefore, the present study aimed to investigate the reported 
anxiolytic-like effects of ethanol administered (i.p.) in rats exposed to the 
elevated plus-maze.  
4.1.2. Method 
Male Sprague-Dawley rats (250-300g) were housed in cages of four throughout. 
Animals received daily i.p. injections of saline (1 ml/kg) for 7 consecutive days 
in the testing room in order to habituate to the injection procedure. On day 8, 
animals received an i.p. injection of 0.5 g/kg (n=4), 0.75 g/kg (n=4), 1 g/kg (n=8) 
or 1.5 g/kg ethanol (n=8) or the saline vehicle (6 ml/kg; n=8) 20 minutes prior to 
exposure to the elevated plus-maze. Animals were placed in the centre of the 
maze facing an open runway (see section 2.7). Behaviour was recorded for 15 
mins using a digital camera and scored as 3 x 5 min time bins (number of open 
arm entries, percentage of total entries made into the open runways, 
percentage of total time spent in the open runways and the number of entries 
into the closed arms; figure 4.1. and figure 4.2).  The experiment was performed 
using two batches of 16 animals. Animals were tested over 8 days, with 4 
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animals tested in the elevated plus-maze on each day. Of the 32 animals which 
began the study, one animal was identified as a statistical outlier (i.e. double the 
standard deviation from the mean) and a further animal was excluded as the 
administration may have been into the bladder and not the peritoneum. Data 
were analysed by repeated measures ANOVA with dose of ethanol as the 
between-subjects factor and time as the within-subjects factor. Post-hoc 
analysis of the between-subject factor was performed using the Games-Howell 
test. Greenhouse-Geisser correction factor applied to data which did not adhere 
to Mauchly’s test of sphericity.  
4.1.3. Results 
The i.p. administration of ethanol had no significant influence on any of the 
three indices of anxiety in the elevated plus-maze. However, the administration 
of ethanol did significantly influence the number of closed arm entries 
suggesting a change in locomotor activity. When compared to the saline control 
group, none of the selected doses of ethanol used in the present study 
significantly influenced the locomotor activity of the animals.  
Repeated measures ANOVA showed that the administration of ethanol 
significantly influenced the number of closed arm entries (F(4, 27)=3.474; 
p<0.05; figure 4.2.). However, ethanol had no significant effects on the number 
of open arm entries (F(4, 27)=1.123; n.s.; figure 4.1.), the percentage of the 
total arm entries made into the open runways (F(4, 27) = 0.779; n.s.; figure 4.1.) 
or the percentage of the total time spent in the open arms (F(4, 27) = 0.963; 
n.s.; figure 4.2.). However, post hoc analysis of the main effect of ethanol 
administration on the number of entries into the enclosed arms showed that  
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Figure 4.1. – The effect of systemic administration of ethanol on the number and 
percentage of entries made into the open arms of the elevated plus-maze. Animals were 
habituated to the injection procedure by administering saline (1 ml/kg daily) for 8 consecutive 
days in the testing room. On the test day, animals were administered the saline vehicle (n=8), 
0.5 g/kg (n=4), 0.75 g/kg (n=4), 1 g/kg (n=8) or 1.5 g/kg (n=8) ethanol i.p. 20 min prior to testing 
(6 ml/kg). Behaviour on the elevated plus-maze was scored for 15 min (3 x 5 min time bins). 
Panel A shows the number of entries made into the open runways of the elevated plus-maze; 
Panel B expresses these as a percentage of the total number of arm entries. Data are 
presented as mean ± S.E.M. 
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Figure 4.2. – The effect of systemic administration of ethanol on the percentage of the 
total time spent in the open runways and the number of entries made into the enclosed 
runways of the elevated plus-maze. Animals were habituated to the injection procedure by 
administering saline (1 ml/kg daily) for 8 consecutive days in the testing room. On the test day, 
animals were administered the saline vehicle (n=8), 0.5 g/kg (n=4), 0.75 g/kg (n=4), 1 g/kg (n=8) 
or 1.5 g/kg (n=8) ethanol i.p. 20 min prior to testing (6 ml/kg). Behaviour on the elevated plus-
maze was scored for 15 min (3 x 5 min time bins). The percentage of the total time spent in the 
open runways of the elevated plus-maze is shown in panel A. The number of entries made into 
the enclosed runways is shown in panel B and was significantly influenced by the 
administration of ethanol. However, none of the doses of ethanol significantly differed from the 
saline control and therefore the effects of ethanol on the number of enclosed arm entries are bi-
phasic in nature. Data are presented as mean ± S.E.M. 
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none of the doses of ethanol administered in the present study were 
significantly different from the saline control. 
The number of open arm entries (Greenhouse-Geisser correction applied; 
F(1.499, 40.485)=30.544; p<0.001), the percentage of total arm entries made 
into the open runways (F(2, 54) = 14.672; p<0.001), the percentage of the total 
time spent in the open runways (F(2, 54) = 21.243; p<0.001) and the number of 
entries into the enclosed runways (Greenhouse-Geisser correction applied; 
F(1.385, 37.384)=72.930; p<0.001) were significantly different over the course 
of the time bins. 
There was no significant interaction the administration of ethanol and the time 
bins on the number of open arm entries (time x treatment; Greenhouse-Geisser 
correction applied; F(5.998, 40.485)=1.539; n.s.; figure 4.1.), the percentage of 
entries made into the open runways (time x treatment; F(8, 54) = 1.231; n.s.; 
figure 4.1.), the percentage of the total time spent exploring the open arms (time 
x treatment; F(8, 54) = 1.113; n.s.; figure 4.2.) or the number of entries into the 
enclosed runways (time x treatment; Greenhouse-Geisser correction applied; 
F(5.538, 37.384)=0.536; n.s.; figure 4.2.). 
4.1.4. Discussion 
Previous studies have reported anxiolytic-like effects in the elevated plus-maze 
in rats following the intra-peritoneal administration of ethanol (Criswell et al, 
1994; Moy et al, 1997). Similarly, Prunell et al. (1994a, 1994b) reported 
anxiolytic-like effects in the elevated plus-maze in response to the 
administration of ethanol per os in rats. However, the investigation of the 
anxiolytic properties of ethanol in rats is reported to be limited by the sedative 
and ataxic effects of ethanol at higher doses (Eckardt et al, 1998). In 
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agreement, the data of the present study do not suggest the significant 
anxiolytic-like effects previously reported in Sprague-Dawley rats systemically 
administered ethanol (Criswell et al, 1994; Moy et al, 1997; Prunell et al, 1994a; 
Prunell et al, 1994b). However, the bi-phasic effects of ethanol on the number of 
enclosed arm entries suggest that, in part, the sedative properties of ethanol 
may mask the anxiolytic-like effects in the study. In agreement, File (1980) 
reported the administration 1.2 g/kg ethanol produces sedatory effects in the 
social interaction test. Similarly, Criswell et al. (1994) reported sedatory effects 
were evident at 1 g/kg in the elevated plus-maze. 
Linakis and Cunningham (1979) reported that the administration of ethanol into 
the peritoneum acts upon the mucosal membrane to cause a dose-dependent 
irritant effect. In addition, the rate of absorption of the drug follows a bi-phasic 
trend with increasing concentrations of ethanol via this route of administration 
(Linakis and Cunningham, 1979). Criswell et al. (1994) administered a fixed 
concentration of ethanol, varying the volume administered by the weight of the 
animal (ml/kg) to achieve the desired dose in an attempt to account for these 
potentially confounding factors. Such an approach could have been adopted in 
the present study. However, additional saline groups would be incorporated into 
the study to control for the varying volumes of solution administered. 
Alternatively, LASA guidelines suggest that rats may be administered up to 10 
ml/kg via the i.p. administration route 
(http://www.dilab.com/pdf/lasa_administration.pdf; accessed 27/9/13). 
Therefore, the concentration of the ethanol administered in the present study 
could have been further diluted to minimise the aversive component of the 
administration.   
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4.2. The effect of intracerebroventricular administration of ethanol on the 
exploration of the open and closed arms of the elevated plus-maze. 
4.2.1. Rationale 
Correa et al. (2003a) previously reported that the i.p. administration of ethanol 
in rats suppresses locomotor activity at high doses (2 g/kg). Conversely, the 
ICV administration (32 g - 128 g) of ethanol increased locomotor activity in 
both the open field and motor activity cages (Correa et al, 2003a; 2003b). In 
addition, the ICV administration of 128 g of ethanol increased locomotor 
activity in the central zone of the open field which may reflect an anxiolytic-like 
effect (Correa et al, 2003b). In addition, Correa et al. (2003b) identified that the 
central administration of the two major metabolites of ethanol, namely 
acetaldehyde and acetate, influenced both anxiety-like behaviours and 
locomotor activity in the open field. Therefore, the bi-phasic effect of 
administering ethanol on locomotor activity and the lack of anxiolytic-like effect 
reported previously in the elevated plus-maze in response to the systemic 
administration of ethanol (see section 4.1.) may reflect the cumulative effects of 
acetaldehyde, acetate and ethanol. Therefore, the effects of centrally 
administered ethanol in the elevated plus-maze were investigated in the present 
study to attempt to dissociate the effects of ethanol in the elevated plus-maze 
specifically. 
4.2.2. Method 
Male Sprague-Dawley rats weighing 250-300 g at the beginning of the 
experiment were implanted with guide cannulae targeted at the lateral ventricle 
(see section 2.2 and 2.3). The rats were left for 10 days in the home cage to 
recover from the surgery. On day 11 post-surgery, animals were transported to 
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the testing room. Under gentle retraint, the stylet was replaced with a 30 ga. 
needle protruding 1.5 mm beyond the tip of the cannula into the lateral ventricle. 
On day 11 post-surgery, animals were administered 128.8 g ethanol (n=4) or 
the aCSF vehicle (1 l; n=4) over 2 min by means of the needle inserted 
through the guide cannula. The needle was left in place for a further 2 min to 
allow for diffusion of the solution from the tip of the injector. Animals were 
placed in the centre of the elevated plus-maze facing an open runway (see 
section 2.7). Behaviour was recorded for 15 mins on a digital camera and 
scored as 3 x 5 min time bins (number of open arm entries, percentage of total 
entries made into the open runways, percentage of total time spent in the open 
runways and the number of entries into the closed arms; figure 4.3.). Upon 
completion of the behavioural study the rats were killed humanly by cervical 
dislocation and the injection site was verified histologically in fixed sections of 
the lateral ventricle by an observer blind to the treatment the rats had received 
(figure 4.3.). The experiment was performed in a single batch of 12 animals. 
Animals were tested over 3 days, with 4 animals tested in the elevated plus-
maze on each day. Of the 12 animals which began the experiment, 2 animals 
could not be administered the experimental solution due to the blocking of the 
guide cannulae. An additional 2 animals were removed from the study as the 
histological investigation identified the administrations were located outwith the 
lateral ventricle.  Data were analysed by repeated measures ANOVA with the 
administration of ethanol as the between-subjects factor and time as the within-
subjects factor. Independent samples t-tests are reported for the investigation of 
the interactions between the within and between subject factors. 
4.2.3. Results 
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The administration of ethanol into the lateral ventricle significantly increased the 
percentage of the trial time spent in the open runways of the elevated plus-
maze. However, the administration of ethanol did not have a significant 
influence on either the number or percentage of entries made into the open 
runways. Previously, the administration of strychnine into the DRN reversed the 
platform-induced increase in the duration of time spent in the open runways of 
the elevated plus-maze. Therefore, the ethanol induced increase in the duration 
of the trial time spent in the open runways may be mediated, in part, by the 
potentiation of the glycine receptor-mediated inhibition of the serotonergic 
neurons of the DRN. Furthermore, the administration of ethanol into the lateral 
ventricle did not increase the number of enclosed arm entries made in the 
elevated plus-maze. Therefore, this suggests the effect of ethanol on the 
duration of the trial time spent in the open runways was independent of an overt 
change in the locomotor activity of the animals.  
Repeated measures ANOVA showed that the administration of ethanol 
significantly increased the percentage of the total time spent in the open 
runways (F(1,6) = 8.178; p<0.05; figure 4.5.). There was no significant effect of 
ethanol on the number of open arm entries (F(1, 6)=5.672; n.s.; figure 4.4.), the 
percentage of total entries made into the open runways (F(1,6) = 3.976; n.s.; 
figure 4.4.) and the number of closed arm entries (F(1,6) = 0.038; n.s.; figure 
4.5.). 
The percentage of total entries made into the open runways (F(2,12) = 7.167; 
p<0.05), the percentage of the total time spent exploring the open runways 
(F(2,12) = 5.001; p<0.05) and the number of enclosed arm entries (F(2,12) = 
22.544; p<0.001) were significantly different between the time bins. However,  
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Figure 4.3. – Experimental design and a representative schematic showing the 
distribution of microinjection sites targeted at the lateral ventricle. Panel A shows the 
experimental design, where the number of days denotes the number of days post-surgery. 
Panel B is a diagramatic representation of the lateral ventricle and surrounding area adapted 
from the coronal sections of Paxinos and Watson (1998; bottom panel). Numerical values 
indicate the posterior distance from Bregma. Following behavioural testing and subsequent 
schedule 1 procedure, 2% Chicago sky blue dye was administered into the lateral ventricle 
using the same injector used for administration of the testing solution. The brain was removed 
and fixed in 4% formalin for 48 hr and then transferred to a 30% sucrose solution for 72 hr. 
Coronal sections (36 m) containing the lateral ventricle were mounted on gelatinised slides 
and stained using cresyl violet to visualise the topography of the brain. Filled circles show 
examples of cannulations which resulted in the successful administration of substances into the 
lateral ventricle and were included in the study. Open circles depict the location of injection sites 
excluded from the study due to the administration of substances outside of the lateral ventricle. 
Histological assessment of the cannulations was performed by an observer blind to the 
treatment and behavioural history of the animals. 
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Figure 4.4. – The effect of intracerebroventricular administration of ethanol on the 
number and percentage of the total entries made into the open runways of the elevated 
plus-maze. Following surgery, animals remained in the home cage for 10 days to recover. On 
the 11th day following surgery, animals were administered 128.8 µg ethanol (n=4) or the aCSF 
vehicle (1 l; n=4) into the lateral ventricle via indwelling cannulae prior to a 15 min exposure to 
the open field. Panel A shows the total number of entries made into the open runways of the 
elevated plus-maze; Panel B expresses these open arm entries as a percentage of the total 
number of entries made into the open and closed arms of the elevated plus-maze. Data are 
presented as the mean ± S.E.M. 
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Figure 4.5. – The effect of intracerebroventricular administration of ethanol on the 
percentage of time spent exploring the open runways and the number of closed arm 
entries in the elevated plus-maze. Following surgery, animals remained in the home cage for 
10 days to recover. On the 11th day following surgery, animals were administered 128.8 µg 
ethanol (n=4) or the aCSF vehicle (1 l; n=4) into the lateral ventricle via indwelling cannulae 
prior to a 15 min exposure to the open field. Panel A shows the percentage of the total time 
spent exploring the open runways of the elevated plus-maze was increased by the ICV 
administration of ethanol. Panel B expresses the number of entries made into the enclosed 
runways. p<0.05, * versus aCSF control. Data are presented as the mean ± S.E.M. 
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the number of open arm entries (F(2, 12)=2.969; n.s.) was not significantly 
different between the time bins. 
There was no significant influence of an interaction between the administration 
of ethanol and the time bins on the number of open arm entries (time x 
treatment; F(2, 12)=0.092; n.s.; figure 4.4.), the percentage of the total arm 
entries made into the open arms (time x treatment; F(2,12) = 0.34; n.s.; figure 
4.4.), the percentage of the total time spent in the open runways (time x 
treatment; F(2,12) = 0.352; n.s.; figure 4.5.) and the number of closed arm 
entries (time x treatment; F(2,12) = 0.397; n.s.; figure 4.5.). 
4.2.4. Discussion 
The data in the elevated plus-maze suggest that the administration of ethanol 
into the lateral ventricle induced a significant increase in the time spent in the 
open runways, suggesting an anxiolytic-like effect. In addition, both the number 
and percentage of the entries made into the open runways approached 
significance. A power analysis of the data generated in the study suggested that 
group sizes of 5 animals would be required to avoid a type II statistical error. If 
these trends were to achieve significance, the ICV administration of ethanol 
would mimic the anxiolytic-like effects previously reported in the elevated plus-
maze in response to systemic administration (Criswell et al, 1994; Prunell et al, 
1994a; Prunell et al, 1994b). Contrary to the findings of Correa et al. (2003a; 
2003b), the pilot study seems to suggest that the administration of ethanol into 
the lateral ventricle did not significantly influence the locomotor activity of the 
animals. However, the absence of an overt change in locomotor activity 
suggests that the ICV administration of ethanol may serve as an alternative 
route of administration to study the anxiolytic properties of ethanol in the 
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absence of the confounding sedatory properties that have previously been 
reported in rats (Eckardt et al, 1998). 
4.3. The effect of intra-DRN administration of strychnine and 
intracerebroventricular administration of ethanol on the exploration of the 
elevated plus-maze and locomotor activity box. 
4.3.1. Rationale 
Previous data suggest that the ICV administration of ethanol elicits an 
anxiolytic-like effect in the elevated plus-maze (see section 4.2). Previous 
studies in the laboratory have identified that the strychnine-sensitive glycine 
receptors in the DRN are potentiated by low, physiological concentrations of 
ethanol (30 mM; Maguire et al, 2013). Classically, the suppression of the 
serotonergic neurons of the DRN has been identified as a component of the 
anxiolytic properties of the benzodiazepines (Pratt et al, 1979; Laurent et al, 
1983; Gonzalez and File, 1997). Therefore, it was hypothesised that a 
component of the anxiolytic properties of ethanol in the elevated plus-maze may 
be mediated by the potentiation of the strychnine-sensitive glycine receptors. 
The hypothesis was investigated by administering strychnine and ethanol into 
the DRN and lateral ventricle respectively. Behaviour was accessed in the 
elevated plus-maze and locomotor activity box. The investigation of behaviours 
in the locomotor activity box was incorporated into the study to investigate the 
effects of the intra-DRN administration in animals exposed to less aversive 
environment when compared to the open field and elevated plus-maze tests of 
anxiety.  
4.3.2. Method 
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Male Sprague-Dawley rats weighing 250-300 g at the beginning of the 
experiment were implanted with guide cannulae targeted at the lateral ventricle 
and DRN (see section 2.2 and 2.3). The animals were left for 10 days in the 
home cage to recover. On day 11 post-surgery, animals were transported to the 
testing room. Under gentle restraint, a stylet was replaced with a 36 ga. needle 
protruding 1.5 mm beyond the tip of the cannula into the lateral ventricle. 
Animals were administered 128.8 g ethanol (n=15) or the aCSF vehicle (1 l; 
n=14) into the lateral ventricle by means of the needle inserted via the guide 
cannula over 4 min. 2 min into the administration of the solutions into the lateral 
ventricle, a second needle was introduced into the DRN protruding 2 mm from 
the tip of the guide cannula. Animals were administered 1 g strychnine 
hydrochloride (n=15) or the aCSF vehicle (500 nl; n=14) over the remaining 2 
min by means of the needle inserted via the guide cannula. Both needles 
remained in place for a further 2 min to allow for diffusion of the solutions from 
the tips of the two needles. The needles were then removed and replaced by 
the stylets. Animals were placed at the centre of an elevated plus maze facing 
an open arm (see section 2.7). Behaviour was recorded on a digital camera for 
20 min and scored as 4 x 5 min time bins (number of open arm entries, 
percentage of total entries made into the open runways, percentage of total time 
spent in the open runways and the number of entries into the closed arms). 
Behaviour in the elevated plus-maze was investigated over a 20 min period as 
opposed to the 15 min trial used previously. Data investigating the effects of the 
i.c.v. administration of ethanol (figure 4.4. and figure 4.5) demonstrated a 
putative increasing trend in all three anxiety measures over the course of the 
three time bins which may be a putative anxiolytic-like effect of ethanol. 
Therefore, the trial time was increased by an additional 5 min to investigate this 
146 

putative trend and determine the effects of administering ethanol into the lateral 
ventricle.  The animals were returned to the home cage for 3 days. On day 15 
post-surgery, the animals were administered the same combination of 
treatments as described above (ethanol or aCSF into the lateral ventricle; 
strychnine or aCSF into the DRN). Immediately after the microinjection, the 
animals were placed in the centre of a locomotor activity box (see section 2.6). 
The behaviour was recorded for 20 mins and scored as 4 x 5 min time bins 
(percentage time in the central zone and the number of ambulatory counts). The 
locomotor activity box was a 45 cm squared box comprising two rows of 
photobeams located on adjacent walls (figure 2.3.). The central zone was 
defined as the innermost 11.5 photobeams on adjacent walls (29.21 cm square) 
and the ambulatory counts were registered as the breaking of the photobeams 
positioned parallel to the floor of the apparatus. On day 17 post-surgery, 
animals were administered a lethal dose of Euthatal (sodium pentobarbital; 
i.p.).Upon sedation, the animals were administered 2% Chicago sky blue dye 
(500 nl) over 2 mins using the needles used to administered the solutions on 
the testing days. Upon anaesthesia, the animals were perfused transcardially 
with 4% formalin. The injection site was verified histologically in fixed sections of 
the lateral ventricle and DRN by an observer blind to the treatment the rats had 
received (figure 4.6.). The experiment was performed in four batches, each 
consisting of 16 animals. Animals were tested over 16 days, with 4 animals 
tested in the elevated plus-maze on each day. Of the 64 animals which began 
the experiment, 1 animal did not recover upon the termination of the 
anaesthesia and a further animal damaged the cement cap post-surgery. In 
addition, 5 animals could not be administered the experimental solution due to 
the blocking of the guide cannula and a further animals was removed as it fell 
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from an open runway of the plus-maze. An additional 22 animals were removed 
from the study as the histological investigation identified the administrations 
were located outwith the lateral ventricle (5 outwith the lateral ventricle alone, 6 
outwith the DRN alone and 11 outwith both the DRN and lateral ventricle). 
Statistical analysis of the data identified 4 animals which were identified as 
outliers in the final analysis (i.e. greater than double the standard deviation from 
the mean). Behaviour was analysed by a repeated measures ANOVA using 
treatment administered into the lateral ventricle (ethanol or aCSF) and 
treatment administered into the DRN (strychnine or aCSF) as the between-
subjects factors analysed and time as the within-subjects factor. Post-hoc 
independent samples t-tests are reported for the investigation of interactions 
between the within and between subject factors. Greenhouse-Geisser 
correction factor applied to data which did not adhere to Mauchly’s test of 
sphericity. 
4.3.3. Results 
As was identified in previous experiments, the i.c.v. administration of ethanol 
increased the percentage of the trial time spent in the open runways of the 
elevated plus-maze suggesting an anxiolytic-like effect. In addition, the 
administration of ethanol increased the number of entries into the open runways 
of the elevated plus-maze. However, ethanol did not elicit a similar anxiolytic-
like effect in the locomotor activity box as measured by the percentage of the 
trial time spent exploring the central zone. Conversely, the administration of 
strychnine into the DRN did not significantly influence the anxiety-like 
behaviours in the elevated plus-maze. However, the administration of 
strychnine selectively reduced the number of entries into the enclosed runways 
of the elevated plus-maze and the number of ambulatory counts in the  
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Figure 4.6. – Representative schematic showing the distribution of microinjection sites 
targeted at the DRN and lateral ventricle. Panel A shows the experimental design, where the 
number of days denotes the number of days post-surgery. Diagramatic representation of the 
DRN (panel B), the lateral ventricle (panel C) and surrounding areas adapted from the coronal 
sections of Paxinos and Watson (1998). Numerical values indicate the posterior distance from 
Bregma. Following behavioural testing, 2% Chicago sky blue dye was administered into the 
DRN and lateral ventricle using the same needles used for administration of the testing 
solutions. The animals were administered a lethal injection of Euthatal (sodium pentobarbital, 
200mg/ml) and were fixed by transcardial perfusion of 4% formalin. The brain was removed and 
remained in fixative for 48 hr and then transferred to a 30% sucrose solution for 72 hr. Coronal 
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sections (36 m) containing the DRN and lateral ventricle were mounted on gelatinised slides 
and stained using cresyl violet to visualise the topography of the brain. Filled circles show 
examples of cannulations which resulted in the successful administration of substances into the 
DRN and lateral ventricle and were included in the study. Open circles depict the location of 
injection sites excluded from the study either due to the administration of substances outside of 
the DRN and lateral ventricle. Histological assessment of the cannulations was performed by an 
observer blind to the treatment and behavioural history of the animals. 
 
locomotor activity box in animals administered aCSF into the lateral ventricle 
suggesting a suppression of locomotor activity. In the locomotor activity, the 
administration of strychnine into the DRN reduced the percentage of the trial 
time spent exploring the central zone suggesting a putative anxiogenic-like 
effect.  
In the elevated plus-maze, there was a main effect of the ICV administration of 
ethanol on the number of open arm entries (F(1,25)=5.933; p<0.05; figure 4.7.), 
the percentage of the total time spent exploring the open arms (F(1,25)=6.886; 
p<0.05; figure 4.8.) and the number of closed arm entries (F(1,25)=5.140; 
p<0.05; figure 4.8.). However, there was no main effect of ethanol on the 
percentage of the total arm entries made into the open runways of the elevated 
plus-maze (F(1,25)=2.194; n.s.; figure 4.7.). In the locomotor activity box, the 
ICV administration of ethanol did not significantly influence the percentage of 
the total time spent in the central zone (F(1,25)=0.033; n.s.; figure 4.9.) or the 
total number of ambulatory counts (F(1,25)=0.095; n.s.; figure 4.9.).  
The administration of strychnine into the DRN did not significantly influence the 
number of open arm entries (F(1,25)=0.212; n.s.; figure 4.7.), the percentage of 
the total entries made into the open runways (F(1,25)=0.781; n.s.; figure 4.7.), 
the percentage of the total time spent in the open runways (F(1,25)=0.374; n.s.;  
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Figure 4.7. – The effect of intracerebroventricular administration of ethanol and intra-DRN 
administration of strychnine on the number and percentage of the total entries made into 
the open runways of the elevated plus-maze. On the 11th day post-surgery, animals were 
administered 128.8 g ethanol (n=15) or the aCSF vehicle (n=14; 1 l) into the lateral ventricle 
in addition to the administration of 1 g strychnine hydrochloride (n=15) or the aCSF vehicle 
(n=14; 500nl) into the DRN via two indwelling cannulae prior to a 20 min exposure to the 
elevated plus-maze. Panel A shows the number of open arm entries, which was increased by 
the administration of ethanol (p<0.05). Panel B expresses the open arm entries as a 
percentage of the total number of entries. p<0.05, * versus aCSF-lateral ventricle control. Data 
are presented as mean ± S.E.M. 
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Figure 4.8. – The effect of intracerebroventricular administration of ethanol and intra-DRN 
administration of strychnine on the percentage of time spent in the open runways and 
the number of entries into the enclosed arms of the elevated plus-maze. On the 11th day 
post-surgery, animals were administered 128.8 g ethanol (n=15) or the aCSF vehicle (n=14; 1 
l) into the lateral ventricle in addition to the administration of 1 g strychnine hydrochloride 
(n=15) or the aCSF vehicle (n=14; 500nl) into the DRN via two indwelling cannulae prior to a 20 
min exposure to the elevated plus-maze. Panel A shows the percentage of the total time spent 
exploring the open runways of the elevated plus-maze, which was increased by the 
administration of ethanol (p<0.05). Panel B shows the number of entries into the enclosed 
runways was significantly reduced by the administration of strychnine in rats that were 
administered aCSF, but not ethanol, into the lateral ventricle (p<0.01). p<0.05, * versus aCSF-
lateral ventricle control; p<0.01, ## versus aCSF-DRN control.  Data are presented as mean ± 
S.E.M. 
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Figure 4.9. – The effect of intracerebroventricular administration of ethanol and intra-DRN 
administration of strychnine the percentage of time spent exploring the central zone and 
number of ambulatory counts made in the locomotor activity box. On the 15th day post-
surgery, animals were administered 128.8 g ethanol (n=15) or the aCSF vehicle (n=14; 1 l) 
into the lateral ventricle in addition to the administration of 1 g strychnine hydrochloride (n=15) 
or the aCSF vehicle (n=14; 500nl) into the DRN via two indwelling cannulae prior to a 20 min 
exposure to locomotor activity box. Panel A shows the percentage of the total time spent 
exploring the central zone of the locomotor activity box, which was significantly reduced in the 
0-5 min time bin by the administration of strychnine (p<0.01). Panel B shows the number of 
ambulatory counts in the locomotor activity box, which was reduced in the 0-5 min time bin by 
the administration of strychnine in rats which were administered aCSF, but not ethanol, into the 
lateral ventricle (p<0.01).  p<0.01, ** versus aCSF-DRN control. Data are presented as mean ± 
S.E.M. 
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figure 4.8.) or the number of closed arm entries (F(1,25)=1.606; n.s.; figure 4.8.) 
in the elevated plus-maze. Similarly, there were no significant effects of 
strychnine on the percentage of the total time spent in the central zone 
(F(1,25)=1.876; n.s.; figure 4.9.) or on the total ambulatory counts 
(F(1,25)=2.028; n.s.; figure 4.9.) in the locomotor activity box. 
There was no significant interaction between the administration of ethanol and 
the administration of strychnine on the number of open arm entries (ethanol x 
strychnine; F(1,32)=1.389; n.s.; figure 4.7.), the percentage of the total arm 
entries made into the open runways (ethanol x strychnine; F(1,25)=0.245; n.s.; 
figure 4.7.) and the percentage of the total time spent in the open arms (ethanol 
x strychnine; F(1,25)=0.821; n.s.; figure 4.8.) of the elevated plus-maze. 
However, there was a significant interaction between the administration of 
ethanol and the administration of strychnine on the number of closed arm 
entries (ethanol x strychnine; F(1,25)=5.792; p<0.05; figure 4.8.) in the elevated 
plus-maze. In the locomotor activity box, there was no significant interaction 
between the administration of ethanol and the administration of strychnine on 
the percentage of the total time spent in the central zone (ethanol x strychnine; 
F(1,25)=0.015; n.s.; figure 4.9.) or the number of ambulatory counts (ethanol x 
strychnine; F(1,25)=0.509; n.s.; figure 4.9.). Post hoc analysis of the effect of 
the interaction between the administration of ethanol and the administration of 
strychnine on the number of entries into the enclosed arms of the elevated plus-
maze found that the administration of strychnine into the DRN significantly 
reduced the number of closed arm entries in rats administered aCSF (t(12) = 
3.645, p<0.01), but not ethanol (t(13) = -0.676, n.s.), into the lateral ventricle. 
The number of open arm entries (F(3,75)=42.767; p<0.001), the percentage of 
the total arm entries made into the open runways (F(3,75)=16.537; p<0.001), 
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the percentage of the total time spent in the open runways (F(3,75)=13.986; 
p<0.001) and the number of closed arm entries (Greenhouse-Geisser 
correction; F(2.148, 53.699) = 30.267; p<0.001) were significantly different 
between the time bins in the elevated plus-maze. Similarly, the percentage of 
the total time spent in the central zone (F(3,75)=51.548; p<0.001) and the total 
number of ambulatory counts (F(3,75)=101.073; p<0.001) varied significantly 
over the time bins. 
The number of open arm entries (time x ethanol; F(3, 75)=1.491; n.s.; figure 
4.7.), the percentage of the total arm entries made into the open runways (time 
x ethanol; F(3, 75)=0.893; n.s.; figure 4.7.), the percentage of the total time 
spent in the open arms (time x ethanol; F(3,75)=0.693; n.s.; figure 4.8.) and the 
number of closed arm entries (time x ethanol; Greenhouse-Geisser correction; 
F(2.148, 53.699) = 0.884; n.s.; figure 4.8.) were not significantly influenced by 
an interaction between the administration of ethanol and the time bins in the 
elevated plus-maze. In the locomotor activity box, there was no significant 
interaction between the administration of ethanol and the time bins on the 
percentage of the total time spent in the central zone (time x ethanol; 
F(3,75)=1.503; n.s.; figure 4.9.) or the number of ambulatory counts (time x 
ethanol; F(3,75)=0.879; n.s.; figure 4.9.). 
Similarly, there was no significant interaction between the administration of 
strychnine into the DRN and the time bins on the number of open arm entries 
(time x strychnine; F(3,75)=1.624; n.s.; figure 4.7.), the percentage of the total 
arm entries made into the open runways (time x strychnine; F(3,75)=1.515; n.s.; 
figure 4.7.), the percentage of the total time spent exploring the open runways 
(time x strychnine; F(3,75)=1.613; n.s.; figure 4.8.) and the number of closed 
arm entries (time x strychnine; Greenhouse-Geisser correction; F(2.148, 
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53.699) = 1.937; n.s.; figure 4.8.). In the locomotor activity box, there was a 
significant interaction between the administration of strychnine and the time bins 
on the percentage of the total time spent in the central zone (time x strychnine; 
F(3,75)=4.777; p<0.01; figure 4.9.). However, the number of ambulatory counts 
was not significantly influenced by an interaction between the administration of 
strychnine and the time bins (time x strychnine; F(3,75)=1.688; n.s.; figure 4.9.). 
Post hoc analysis showed that strychnine administered into the DRN 
significantly reduced the time spent in the central zone, when compared to the 
aCSF control, during the 0-5 min time bin (t(27)=3.282; p<0.01; figure 4.9.). 
However, there was no significant effect of intra-DRN administration of 
strychnine on the percentage of time spent in the central zone in the 5-10 min 
(t(27)=0.788; n.s.), 10-15 min (t(27)=0.948; n.s.) or 15-20 min time bins (t(27)=-
0.900; n.s.). 
In addition, there were no significant interaction between the administration of 
ethanol, the administration of strychnine and the time bins on the number of 
open arm entries (time x ethanol x strychnine; F(3,75)=0.805; n.s.; figure 4.7.), 
the percentage of the total arm entries made into the open runways (time x 
ethanol x strychnine; F(3,75)=1.713; n.s.; figure 4.7.), the percentage of the 
total time spent in the open runways (time x ethanol x strychnine; 
F(3,75)=0.577; n.s.; figure 4.8.) and the number of closed arm entries (time x 
ethanol x strychnine; Greenhouse-Geisser correction; F(2.148, 53.699) = 0.987; 
n.s.; figure 4.8.). However, there was a significant interaction between the 
administration of ethanol, the administration of strychnine and the time bins on 
the number of ambulatory counts (time x ethanol x strychnine; F(3,75)=2.770; 
p<0.05; figure 4.9.) but not the percentage of the total time spent in the central 
zone of the locomotor activity box (time x ethanol x strychnine; F(3,75)=1.206; 
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n.s.; figure 4.9.). Post hoc analysis showed that in animals administered the 
aCSF control into the lateral ventricle, the intra-DRN administration of 
strychnine significantly reduced the number of ambulatory counts in the initial 0-
5 min period (t(12)=3.578; p<0.01; figure 4.9.), but had no significant effect on 
the 5-10 min (t(12)=1.090; n.s.), 10-15 min (t(12)=0.851; n.s.) or 15-20 min time 
bins (t(12)=-0.871; n.s.). However, in animals administered ethanol into the 
lateral ventricle, the intra-DRN administration of strychnine had no significant 
effects on the number of ambulatory counts in the 0-5 min (t(13)=0.734; n.s.), 5-
10 min (t(13)=0.901; n.s.), 10-15 min (t(13)=0.814; n.s.) or 15-20 min time bins 
(t(13)=0.300; n.s.).  
4.3.4. Discussion 
In agreement with the study and Correa et al. (2003b), the ICV administration of 
ethanol induced an anxiolytic-like effect as characterised in the present study by 
the increase in the duration of time spent exploring and increase in entries to 
the open runways of the elevated plus-maze. Surprisingly, the ICV 
administration of ethanol did not increase the percentage of the total entries 
made into the open arms in the elevated plus-maze. However, this may have 
been due to the decrease in the number of closed arm entries, which is a 
denominator in the calculation of the percentage of total entries made into the 
open runways, observed in animals administered strychnine into the DRN and 
aCSF into the lateral ventricle. This contrasts with the findings of the previous 
study in the elevated plus-maze, which investigated animals naïve and 
repeatedly exposed to an elevated platform stressor, where the administration 
of strychnine elicited no overt effects on locomotor activity in either group. This 
supports the hypothesis that some of the properties of strychnine administered 
into the DRN were masked in prior experiments by the high basal level of 
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anxiety in the animals. The mechanism responsible for the unveiling of this 
locomotor effect can only speculated upon. However, they may be attributed to 
an improvement in the microinjection procedure, surgical technique or post-
operative care.  
Interestingly, the strychnine-mediated reduction in locomotor activity observed 
in the animals administered aCSF into the lateral ventricle was not apparent in 
animals administered ethanol in the elevated plus-maze. One potential 
explanation for this may be effects of ethanol at a distal site, such the 
dopaminergic system. As previously discussed (section 1.4.3.), the efferent 
projections which originate from the DRN influence both the origins and terminal 
domains of the nigrostriatal and mesolimbic dopaminergic systems (Vertes, 
1991; Vertes and Linley, 2007; Stratford and Wirtshafter. 1990). However, due 
to order in which the substances were administered, the ICV administration of 
ethanol may elicit effects within the dopaminergic system which the subsequent 
strychnine-mediated facilitation of serotonergic transmission is incapable of 
inhibiting. For example, Arizzi-LaFrance et al. (2006) have previously reported 
that the direct administration of 16 – 128 g of ethanol into the substantia nigra 
pars reticulate mediates a stimulation of locomotor activity in rats exposed to a 
locomotor activity box. In addition, the administration of low doses of ethanol 
has previously been reported to increase the firing rate of mesolimbic 
dopaminergic neurons (Mereu et al, 1984; Gessa et al, 1985). 
In the locomotor activity box, the administration of ethanol had no effect on the 
ambulatory counts or the percentage of the trial time spent in the central zone. 
These findings contradict those of Correa et al. (2003a; 2003b), who reported 
that the ICV administration of ethanol elicits a stimulation of locomotor activity 
and an increase in the number of line crossings in the central zone of an open 
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field. This may have been due to the dimensions of the locomotor activity box 
itself, which was smaller than open field used by Correa et al. (2003b; 113 cm 
squared),  as the animals administered aCSF and EtOH in the lateral ventricle 
(in the absence of strychnine) explore the central zone approximately 45% of 
the duration of the 0-5 min time bin. Therefore, the apparatus may not be 
sufficiently aversive to elicit an anxiolytic-like effect. 
Conversely, the intra-DRN administration of strychnine reduces the percentage 
of the trial time spent exploring the central zone in the initial 0-5 min time bin 
suggesting an anxiogenic-like effect. However, this interpretation must be 
considered cautiously as the ambulatory counts are also reduced in the initial 0-
5 min time in animals administered strychnine into the DRN and aCSF into the 
lateral ventricle. As was observed in the elevated plus-maze, the administration 
of ethanol prevented, in part, the decrease in locomotor activity induced by the 
intra-DRN administration of strychnine in the 0-5 min time bin. However, the ICV 
administration of ethanol did not reverse the strychnine-mediated decrease in 
the duration of the 0-5 min time bin spent exploring the central zone. Therefore, 
it may be that the strychnine-sensitive glycine receptors expressed in the DRN 
may mediate distinct anxiolytic and stimulatory roles.  
The stimulatory and inhibitory effects of serotonin on locomotor activity have 
previously been discussed (section 1.3.1.) and Boureau and Dayan (2011) have 
suggested these effects may be mediated by interactions with the dopaminergic 
system. Topographically, the organisation of the serotonergic efferent 
projections originating from the DRN would support the hypothesis that the 
strychnine-sensitive glycine receptors may mediate both locomotor and anxiety-
like responses (section 1.4.3.). While the dorsal and medial ascending 
pathways predominantly terminate in the striatum, globus pallidus and 
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substantia nigra (Michelsen et al, 2007); the ventral ascending pathway 
terminates in centres implicated in the mediation of anxiety-like behaviours such 
as the hypothalamic nuclei, the septum, the amygdala, cortical centres and the 
hippocampus (Michelsen et al, 2007).  
The data from the present study do not support the hypothesis of a functional 
interaction between the strychnine-sensitive glycine receptors and ethanol. 
However, there are several factors associated with the experimental design 
which may account for this. As previously discussed above, the order of drug 
administration may have influenced the behavioural outcomes. Previously, 
Maguire et al. (2013) reported that the ethanol mediated-potentiation of the 
strychnine-sensitive glycine receptors in the DRN was achieved at a 
concentration of 30 mM. In agreement, Mascia et al, (1996) reported that 
glycine induced currents in recombinantly expressed glycine receptors were 
potentiated by ethanol concentrations as low as 10 mM. However, the use of 
intracerebral microinjection as the route of administration makes the estimation 
of the concentration range within the DRN difficult to access and may be out 
with the range in which glycinergic inhibition is potentiated. Furthermore, the 
ethanol-mediated allosteric modulation of glycine receptor function is, similarly 
to strychnine, dependent upon the presence of the endogenous agonist. 
4.4. The effect of intra-DRN administration of ethanol on the exploration of 
the open and closed arms of the elevated plus-maze. 
4.4.1. Rationale 
The ICV administration of ethanol elicited an anxiolytic-like effect when 
measured in the elevated plus-maze in prior experiments. However, the 
anxiolytic-like effects of ethanol in the elevated plus-maze, when administered 
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into the lateral ventricle, did not appear to be sensitive to the antagonism of 
strychnine. Therefore, the administration of ethanol into the DRN was 
investigated in the elevated plus-maze. Previously, the administration of ethanol 
has been reported to suppress the neuronal excitation of the serotonergic 
neurons of the DRN in anaesthetised animals (Chu et al, 1984; Pistis et al, 
1997b). Therefore, the hypothesis was that the local administration of ethanol 
would elicit an anxiolytic-like effect. 
4.4.2. Method 
Male Sprague-Dawley rats weighing 250-300 g at the beginning of the 
experiment were implanted with guide cannulae targeted at the DRN (see 
section 2.2 and 2.3). The rats were left for 10 days in the home cage to recover. 
On day 11 post-surgery, animals were transported to the testing room. Under 
gentle retraint, the stylet was replaced with a 36 ga. needle protruding 2 mm 
beyond the tip of the cannula into the DRN. On day 11 post-surgery, animals 
were administered 4 g (n=5), 8 g (n=9), 16 g ethanol (n=7) or the aCSF 
vehicle (500 nl; n=8) into the DRN over 2 mins by means of the needle inserted 
via the guide cannula. The needle was left in place for a further 2 min to allow 
for diffusion of the solution from the tip of the injector. Following the 
administration of substances, the needle was replaced by the stylet. Animals 
were placed at the centre of an elevated plus maze facing an open arm (see 
section 2.7). Behaviour was recorded on a digital camera for 15 min and scored 
as 3 x 5 min time bins (number of open arm entries, percentage of total entries 
made into the open runways, percentage of total time spent in the open 
runways and the number of entries into the closed arms). Upon completion of 
the behavioural study the rats were killed humanly by cervical dislocation and 
the injection site was verified histologically in fixed sections of the injection site  
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Figure 4.10. – Representative schematic showing the distribution of microinjection sites 
targeted at the DRN. Panel A shows the experimental design, where the number of days 
denotes the number of days post-surgery. Panel B is a diagramatic representation of the DRN 
and surrounding area adapted from the coronal sections of Paxinos and Watson (1998). 
Numerical values indicate the posterior distance from Bregma. Following behavioural testing 
and subsequent schedule 1 procedure, 2% Chicago sky blue dye was administered into the 
DRN using the same injector used for administration of the testing solution. The brain was 
removed and fixed in 4% formalin for 48 hr and then transferred to a 30% sucrose solution for 
72 hr. Coronal sections (36 m) containing the DRN were mounted on gelatinised slides and 
stained using cresyl violet to visualise the topography of the brain. Filled circles show examples 
of cannulations which resulted in the successful administration of substances into the DRN and 
were included in the study. Open circles depict the location of injection sites excluded from the 
study either due to the administration of substances outside of the DRN or by the occlusion of 
the cerebral aqueduct. Histological assessment of the cannulations was performed by an 
observer blind to the treatment and behavioural history of the animals. 
 
was verified histologically in fixed sections of the DRN by an observer blind to 
the treatment the rats had received (figure 4.10.). The experiment was 
performed in three batches of 16, 24 and 8 animals respectively. Animals were 
tested over 12 days, with 4 animals tested in the elevated plus-maze on each 
day. Of the 48 animals which began the study, 2 animals were administered a 
higher dose of 16 g ethanol (data not shown), which resulted in an adverse  
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Figure 4.11. – The effect of intra-DRN administration of ethanol on the number and the 
percentage of entries made into the open arm entries in the elevated plus-maze. Following 
surgery, animals remained in the home cage for 10 days to recover. On the 11th day following 
surgery, animals were administered 4 µg (n=5), 8 µg (n=9) or 16 µg ethanol (n=7) or the aCSF 
vehicle (500 nl; n=8) into the DRN via indwelling cannulae prior to a 15 min exposure to the 
elevated plus-maze. Panel A shows the total number of entries made into the open runways of 
the elevated plus-maze; panel B expresses these as a percentage of entries made into the 
open and closed arms of the elevated plus-maze. Data are presented as the mean ± S.E.M. 
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Figure 4.12. – The effect of intra-DRN administration of ethanol on the percentage of the 
total time spent in the open runways and the number of closed arm entries in the 
elevated plus-maze. Following surgery, animals remained in the home cage for 10 days to 
recover. On the 11th day following surgery, animals were administered 4 µg (n=5), 8 µg (n=9) or 
16 µg ethanol (n=7) or the aCSF vehicle (500 nl; n=8) into the DRN via indwelling cannulae 
prior to a 15 min exposure to the elevated plus-maze. Panel A shows the percentage of the 
total time spent exploring the open runways of the elevated plus-maze. Panel B shows the total 
number of entries made into the enclosed runways of the elevated plus-maze. Data are 
presented as the mean ± S.E.M. 
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response and therefore no further animals were included in the study to 
investigate this dose of ethanol. In addition, 4 animals could not be 
administered the experimental solution on the test day as the cannulae became 
blocked. Histological identification of the target site identified 10 animals where 
the tip of microinjection needle was located outwith the target site. A further 3 
animals were identified as statistical outliers in the final analysis. The behaviour 
was analysed by a repeated measures ANOVA using treatment (dose of 
ethanol or aCSF) as the between-subjects factor analysed and time as the 
within-subjects factor. 
4.4.3. Results 
Ethanol was administered into the DRN to investigate the effect of potentiating 
the strychnine-sensitive glycine receptor-mediated inhibition of the serotonergic 
neurons. Therefore, it was hypothesised that the intra-DRN administration of 
ethanol would induce an anxiolytic-like response in the elevated plus-maze. 
However, the local administration of ethanol into the DRN did not significantly 
influence either the indices of anxiety-like behaviour or locomotor activity in the 
elevated plus-maze.  
Repeated measures ANOVA showed there was no main effect of ethanol on the 
number of open arm entries (F(3,25)=1.923; n.s.; figure 4.11.), the percentage 
of total entries made into the open runways (F(3,25)=0.437; n.s.; figure 4.11.), 
the percentage of total time spent exploring the open runways (F(3,25)=1.261; 
n.s.; figure 4.12.) and the number of closed arm entries (F(3,25)=2.154; n.s.; 
figure 4.12.). 
The number of open arm entries (F(2,50)=5.547; p<0.01), the percentage of 
total entries made into the open runways (F(2,50)=6.237; p<0.01) and the 
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number of closed arm entries (F(2,50)=5.864; p<0.01) varied significantly over 
the time bins. However, the percentage of the total time spent exploring the 
open runways was not significantly different across the time bins 
(F(2,50)=1.867; n.s.). 
There was no significant interaction between the administration of ethanol and 
the time bins on the number of open arm entries (time x ethanol; F(6,50)=0.385; 
n.s.; figure 4.11.), the percentage of total entries made into the open runways 
(time x ethanol; F(6,50)=0.494; n.s.; figure 4.11.), the percentage of total time 
spent exploring the open runways (time x ethanol; F(6,50)=0.379; n.s.; figure 
4.12.) and the number of closed arm entries (time x ethanol; F(6,50)=0.528; 
n.s.; figure 4.12.).   
4.4.4. Discussion 
The administration of ethanol directly into the DRN did not significantly influence 
any of the anxiety-like behaviours in the elevated plus-maze or alter the 
locomotor activity of the animals. Previously, Arizzi-LaFrance et al. (2006) 
directly administered 16 – 128 g of ethanol into the substantia nigra pars 
reticulate and reported a stimulation of locomotor activity in rats exposed to a 
locomotor activity box. Comparable, but modestly lower, doses were 
administered into the DRN in the present study. However, the lack of 
measurable behavioural outcomes when ethanol was administered into the 
DRN may be due to the lipophilic nature of ethanol (Greenshaw, 1986). The 
local administration of ethanal infused directly into the DRN may diffuse rapidly 
from the target site. However, the administration of higher doses may induce 
necrosis at the target site.  
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The primary aim of the present study was to investigate the in vivo role of the 
strychnine-sensitive glycine receptors expressed on the serotonergic neurons of 
the DRN. Collectively, the data support the hypothesis that the strychnine-
sensitive glycine receptors mediate anxiety-like behaviours, however, the 
effects of strychnine on anxiety-like behaviours in rats appear to be dependant 
upon the basal anxious state of the animal. In agreement, the administration of 
strychnine into the DRN of animals exposed to a weakly aversive environment, 
such as the locomotor activity box, or in animals previously habituated to a 
homologous stressor (i.e. the elevated open platform stressor) conveyed 
sensitivity to the anxiogenic-like effects mediated by the administration of 
strychnine into the DRN. Conversely, the administration of strychnine into the 
DRN of animals exposed to an aversive environment, such as the open field 
and elevated plus-maze, did not significantly influence anxiety. Similarly, 
McCool and Chappel (2007) have previously reported that the anxiolytic-like 
effects of the intra-amygdala administration of strychnine and taurine in the 
elevated plus-maze was dependent upon the basal anxiety state of the animals.  
In addition, the intra-DRN administration of strychnine induced a suppression of 
locomotor activity in animals administered aCSF into the lateral ventricle. 
However, the strychnine-mediated suppression of locomotor activity was absent 
in animals administered ethanol into the lateral ventricle. The mechanism which 
mediated the unveiling of this locomotor effect is unknown but may be related to 
recovery of the animals from the surgical procedure. As discussed in section 
4.3.4., it may be that the anxiogenic and inhibitory properties of strychnine may 
be dissociable. Furthermore, these distinct effects may be mediated by distinct 
populations of serotonergic neurons within the DRN. An additional aim of the 
project was to investigate the potential interaction between the strychnine-
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sensitive glycine receptors and the anxiolytic properties of ethanol. The data 
generated from the current study do not support such an interaction. However, 
this may have been due to factors related to the experimental design which will 
be discussed. 
McDermott and Kelly (2008) reported that the Sprague-Dawley rat was 
significantly more anxious and less active, as measured in the elevated plus-
maze and open field respectively, when compared to the Lister Hooded rat. 
Therefore, the strain of rat used in the present study may be inherently sensitive 
to anxiogenic stimuli. In agreement, previous studies in the laboratory have 
reported a low number of open arm entries, ratio open: total arm entires and 
time spent in the open runways in rats acutely exposed to the elevated plus-
maze (Storey et al. 2006). However, Stewart et al. (1993) reported that the 
alcohol preferring P line of rats had a higher level of anxiety in the elevated 
plus-maze and Geller-Seifter conflict task than the NP line. In agreement, 
similar results were reported for the Sardinian alcohol preferring line when 
compared to the non-preferring strain (Colombo et al, 1995). Nevertheless, 
there may still be merit in investigating the potential interaction between the 
strychnine-sensitive glycine receptors and the anxioyltic properties of ethanol in 
an alcohol preferring strain of rat. As Colombo et al. (1995) reported that alcohol 
preferring strains are more sensitive to the stimulant effects of ethanol. 
A comparison of all control groups can be seen in table 5.1. The number of 
enclosed arm entries in the elevated plus-maze appears to be relatively 
consistant in the control groups when compared between the systemic and 
centrally administered animals. Therefore, this would suggest that the route of  
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Experiment Treatment
Number of Open 
Arm Entries
Open Arm 
Entries (% of 
Total)
Time in the Open 
Arms (% of 
Total)
Number of 
Closed Arm 
Entries
3.2 I.P. Saline (n=10 ) 8.30 18.79 9.72 36.10
3.3 Intra-DRN aCSF (n=8 ) 2.75 10.91 2.82 21.38
3.4 Intra-DRN aCSF (n=4 ) 2.75 9.43 3.81 22.00
4.1 I.P. Saline (n=8 ) 8.63 23.53 8.63 29.25
4.2 ICV aCSF (n=4 ) 2.75 6.98 2.58 33.25
4.3 ICV aCSF and Intra-DRN aCSF (n=8 ) 3.39 9.65 3.08 32.50
4.4 Intra-DRN aCSF (n=8 ) 3.25 13.34 3.43 22.38
 
Table 5.1. – Comparison of the control groups associated with each experiment 
performed in the elevated plus-maze. The table demonstrates the performance of the control 
groups (either the administration of saline delivered via and i.p. administration of saline or the 
central administration of aCSF) in the elevated plus-maze over the course of 15 min. The 
number of closed arm entries, which is considered an approximate measure of locomotor 
activity, is relatively consistant between the groups. However, the number and percentage of 
the total entries made into the open runways and the percentage of the trial time spent in the 
open runways varies between the control groups. Of particular note is the decrease in all three 
measures of anxiety-like behaviour in the elevated plus-maze in animals administered the 
experimental solution centrally when compared with animals which are administered the saline 
vehicle systemically.    
 
administration had very little effect upon the locomotor activity of the animals in 
the elevated plus-maze. However, a comparison of the three indices of anxiety-
like behaviour in the elevated plus-maze (the number and percentage of entries 
into the open runways and the percentage of the trial time spent in the open 
arms) suggests that animals which have been administered the experimental 
solution centrally show a higher basal level of anxiety in elevated plus-maze as 
demonstrated by a decrease in the number and percentage of entries into the 
open runways and the percentage of the trial time spent in the open runways 
when compared to animals administered the vehicle solution systemically. 
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Therefore, the sensitivity of the elevated plus-maze to measure anxiogenic-like 
effects may be compromised by the high basal anxiety-state of the animals. 
This corroborates the hypothesis that the high-basal anxiety state of animals 
administered the vehicle solution centrally may have resulted in a ceiling effect 
which may haveconfounded the experimental findings. The inclusion of 
additional behavioural tests, which have shown sensitivity to treatments which 
modulate the serotonergic system, such as the Vogel or Geller-Seifter conflict 
tasks may have been recruited to the study. However, as was observed in the 
open field, the high basal anxiety state of the animals may be a confounding 
factor in the investigation of the strychnine-sensitive glycine receptors 
independent of the behavioural test used to access the emotional state of the 
animals.  
The high basal state of anxiety observed in the open field and elevated plus-
maze may be a consequence of the microinjection procedure. Acute restraint 
stress (15 mins) immediately prior to testing, which was necessary in the 
present study to administer substances into the DRN, has been reported to 
reduce the percentage of the total entries into and the time spent exploring the 
open runways of the elevated plus-maze (Gameiro et al, 2006). Furthermore, 
Cheeta et al. (2001) reported that single and groups housed animals were 
found to have significant differences in the social interaction test. Therefore, the 
necessity to individually house animals administered strychnine into the DRN 
may have been a contributing factor.   
Weis and Heller (1969) suggested that diameter of the cannulae used to 
administer substances into discreet nuclei must be minimal to account for 
damage to the target site. In the present study, attempts were made to minimise 
the effects of mechanical damage to the DRN by using 36 ga. microinjection 
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needles. However, the acute mechanical damage to the target site may have 
contributed to the high basal state of anxiety observed. In particular, the 
mechanical damage to the target site may have resulted in a local release of 
serotonin prior to the administration of strychnine. 
Greenshaw (1986) has previously suggested that the experimental outcomes in 
response to the administration of substances centrally are influenced by factors 
associated with the composition of the administered solution. In this respect, the 
concentration and the volume of the solution administered must be carefully 
considered. The volume of the solution must be minimal, as larger volumes can 
damage the target site mechanically by displacement. Therefore, in the present 
study the volume administered into the DRN was 500 nl, comparable to 
previous studies, and therefore unlikely to cause significant damage to the 
target site. However, the use of small injection volumes can damage the target 
site through osmotic pressures as this necessitates the use of higher 
concentrations of the substance. Unfortunately, this was not controlled for in the 
present study. Ideally, an inactive isomer of the experimental substance should 
be administered as an additional control group. A further consideration is the pH 
of the solution administered (Greenshaw, 1986), which was controlled for in the 
present study by the artificial cerebrospinal fluid (aCSF). However, the state-
specific nature of the data generated in the present study would suggest that 
the experimental outcomes were pharmacological in nature and not due to non-
specific effects. 
In addition, the lipid solubility of the solution is a consideration (Greenshaw, 
1986). Highly lipophilic compounds diffuse rapidly in the brain and therefore 
may evoke behavioural responses at sites distal to the target nuclei. In the 
present study, this may have influenced the central administration of ethanol 
172 

particularly within the DRN. The findings of the present study suggest that the 
ICV administration of ethanol may be an appropriate route of administration in 
the study of the anxiolytic properties of ethanol. The central administration of 
ethanol has appeal, as the concentration of ethanol within the CNS can be 
controlled. However, the ICV administration of ethanol may not mimic the 
distribution of ethanol within the CNS following the consumption of ethanol and 
therefore may have limited translational validity.  
Previous studies have investigated the effects of substances upon the 
serotonergic neurons in the DRN in vivo using the intracerebral microinjection 
technique (Higgins et al, 1988; Higgins and Elliot, 1991; Hillegaart, 1990; Hogg 
et al, 1994). However, an alternative approach to administer substances into the 
DRN was considered in the present study. In a process referred to as reverse-
microdialysis, substances can be administered centrally via an implanted 
microdialysis probe through the inclusion of the compound in the ringer solution 
which perfuses the probe (Molander and Soderpalm, 2005; Molander et al, 
2005; Chau et al, 2010). However, the administration of substances via 
microinjection was favoured in the present study as the microdialysis probe 
must be implanted directly into the target site, which can cause damage to the 
tissue proximal to the probe (Fumero et al, 1994). In addition, the implantation 
of a permanent microdialysis probe stimulates glial growth in the surrounding 
tissue and can limit the diffusion of substances across the membrane (Imperato 
and Di Chiara, 1984; Benveniste and Diemer, 1987). Therefore, the viability of 
administering substances via a permanent microdialysis probe is limited to 72 hr 
post-surgery. This would reduce the duration of the recovery period available to 
the animals and may exacerbate the high basal state of anxiety observed in the 
present study. 
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At the neuronal level, these state-dependant effects observed in the present 
study may due to the mechanism by which strychnine mediates the inhibition of 
the strychnine-sensitive glycine receptor. Previously, O’Connor et al. (1996) and 
Grudzinska et al. (2005) identified the residues which the mediate the binding of 
the antagonist to the glycine receptor. The binding site is localised at a distinct, 
but overlapping site to the endogenous agonist binding site. Therefore, the lack 
of measurable behavioural outcomes in response to the administration of 
strychnine may be due to the concentration of the endogenous agonist in the 
anxious state. Previous studies, have shown that both the open field and 
elevated plus-maze are anxiogenic stimuli (Pellow et al, 1985; Walsh and 
Cummings, 1976) and are therefore anticipated to facilitate serotonergic 
transmission originating from the serotonergic neurons of the DRN (Langen et 
al, 2002). A facilitation of serotonergic transmission from the DRN would be 
mediated by an increase in neuronal excitation. Therefore, it is inferred that the 
activation of the strychnine-sensitive glycine receptor upon exposure to the 
apparatus may be low or negligible. As described by Pellow et al. (1985), the 
elevated plus-maze was designed as an assay for the development and 
identification of novel anxiolytic compounds and therefore may be more 
sensitive to manipulations which alleviate anxiety as opposed to the facilitation 
of anxiety. 
In this regard it would of value to investigate the effects of activation of the 
strychnine-sensitive glycine receptors in the DRN on anxiety-like behaviours in 
future studies.  A study was performed in the elevated plus-maze to investigate 
the effects of the administration of glycine into the DRN. However, the 
endogenous agonists of the glycine receptor lack pharmacological specificity 
(section 1.5.4.), which may confound the interpretation of the data. In addition, 
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the extracellular concentrations of the endogenous agonist are regulated by 
membrane-bound transporters (section 1.5.3.). Therefore, this may necessitate 
the use of high concentrations to be administered and may results in non-
specific effects due to osmotic pressure. However, an alternative may be to 
administer GlyT1, GlyT2 or TauT inhibitors into the DRN to increase the local 
concentration of the endogenous agonist. Given the aversive components of the 
microinjection protocol and the nature of the behavioural tests of anxiety, it may 
advantageous to investigate a putative anxiolytic response as opposed to an 
anxiogenic response. 
Furthermore, it would be of significant value to directly measure the effects of 
strychnine and ethanol administration into the DRN on serotonin overflow at a 
terminal domain of the serotonergic neurons. Previous studies have made 
inference to the neuronal excitation of the serotonergic neurons originating from 
the DRN by investigating serotonin overflow in the vmPFC (Storey et al, 2006; 
Bland et al, 2003; Langen et al, 2002). Such an approach could be used in 
conjucture with the microinjection procedure; however, a more refined approach 
may be to implant a microdialysis probe into the DRN in addition to the vmPFC. 
Despite the disadvantages discussed above, this may mitigate the effects of the 
aversive components of the microinjection procedure, such as restraint, as 
strychnine could be infused in the ringer solution (Molander and Soderpalm, 
2005; Molander et al, 2005; Chau et al, 2010). An additional benefit to such an 
experimental approach would be that further information could be garnered in 
relation to the dose-dependent effects on the magnitude and duration of action 
of both ethanol and strychnine acting upon the strychnine-sensitive glycine 
receptors of the DRN. This may improve the validity of the experimental design 
as the both the concentration of both ethanol and strychnine and the duration of 
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the trial time spent in the appropriate behavioural tests could be modified 
appropriately. 
In conclusion, the present study has demonstrated that the recently identified 
population of strychnine-sensitive glycine receptors expressed in the DRN play 
a role in the mediation of anxiety-like behaviours. Due to the nature of the 
techniques used in the present study, future studies should aim to investigate 
the neurochemical response evoked by the intra-DRN administration of 
strychnine. Of particular interest, would be to dissociate the GABAergic-
mediated behaviours from the strychnine-sensitive glycine receptor-mediated 
behaviours as the GABAA receptors and glycine receptors occupy distinct sites 
(i.e. synaptic vs. extrasynaptic) on the neuronal membrane and may therefore 
play functionally distinct roles in the mediation of anxiety. 
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